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This thesis describes the efforts of the Leighton laboratory to develop a scalable synthetic route 
to access anti-tumor agent spongistatin 1, or analogs thereof.  In an effort to achieve this goal, 
several new chemical reaction platforms were established.  Though these novel chemical 
transformations were developed specifically for use in the total synthesis of spongistatin 1, their 
potential application to general polyketide synthesis has been demonstrated.  These 
methodological innovations have allowed our laboratory to take tremendous strides toward the 
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Chapter 1:Toward a Scalable Synthesis of Spongistatin 1 
1.1 Isolation and Bioactivity of Spongistatin 1 
Polyketide natural products of the polypropionate/polyacetate type have attained a 
privileged position in the medicinal community, as they often possess important biological and 
therapeutic properties.  In particular, spongistatin 1 (altohyrtin A) 1.1 has attracted a high level of 
interest from the medicinal community due to its extremely potent bioactivity as an antitumor 
agent (Figure 1.1). 
 
Figure 1.1: Spongistatin 1 
 
First reported in 1993, spongistatin 1 was discovered independently and simultaneously by 
the Pettit,1 Kitagawa/Kobayashi2 and Fusetani3 groups.  This naturally occurring polyketide was 
harvested as part of a family of bioactive bis-spirocycle marine macrolides isolated from a 
variety of sea sponges found in the Indian Ocean as well as in the seas surrounding Japan.  
Spongistatin 1 itself was found to be quite scarce; degradation of nearly 400 kg of sponge 







































material in hand, spongistatin 1’s extraordinary bioactivity as an anti-mitotic, anti-tumor agent 
was quickly discovered.  Spongistatin 1 was shown to have an average IC50 value of 0.12 nM 
against the NCI panel of 60 cancer cell lines, making it one of the most potent cancer cell growth 
inhibitory agents tested to date.4  Furthermore, curative responses at extremely low doses of 
spongistatin 1 were also observed in vivo as part of later human melanoma and ovarian 
carcinoma xenograft studies.5  Despite these promising preliminary biological results, however, 
the vanishingly small supply of the naturally product prevented comprehensive testing of 
spongistatin 1 as a potential chemotherapy agent. 
1.2 Previous Syntheses of Spongistatin 
Due to this confluence of scarcity and extraordinary potency, the spongistatin family has 
elicited an enormous amount of interest and effort from the synthetic chemistry community.  
While multiple research groups worldwide have completed numerous fragment syntheses, only 
seven research groups have been able to achieve complete total syntheses of spongistatin 1 
and/or 2 to date.  The work of Evans,6 Kishi,7 Smith,8 Paterson,9 Crimmins,10 Heathcock11 and 
Ley12 represent a profound demonstration of synthetic creativity and resiliency in the face of an 
exceedingly daunting architectural task.  Their syntheses of spongistatin necessitated the use of 
chemistry’s most powerful tools for polyketide synthesis and provided a challenging proving 
ground for the development of important new methodologies employed by numerous chemists 
today.13  In terms of increasing the medical community’s supply of spongistatin 1, the Smith 
group notably succeeded in producing 1.0 g of spongistatin 18g – an amount likely to be 
sufficient for all pre-clinical development trials – which has already produced some exciting in 




1.3 The Goal of a More Scalable Synthesis and Overall Strategy 
While the Smith group’s preparation of 1.0 g of spongistatin 1 has already served as a boon 
toward firmly establishing its importance as a medicinal drug target, the prospect of turning 
spongistatin 1 into a viable chemotherapy agent remains a formidable challenge.  The ultimate 
goal of making spongistatin 1, or an analog thereof, into a widely available antitumor agent still 
requires the development of a synthesis that can both facilitate the production of various analogs 
in addition to delivering the larger quantities necessary for clinical development.  Especially in 
the context of new medical technologies that utilize a relatively small number of potent 
antitumor molecules as “warheads” attached to antibody-drug conjugates,15 we believe that the 
development of a scalable, multi-gram synthesis of spongistain 1 would genuinely impact the 
scientific community’s ability to develop a powerful and accessible chemotherapy agent. 
To that end, we examined previous syntheses of spongistatin 1 and looked for 
opportunities to improve the overall efficiency and scalability of the total synthesis.  The most 
efficient syntheses of spongistatin 1 to date divide the molecule into two separate syntheses of 
the ABCD and EF hemispheres, which are joined by a late-stage Wittig coupling followed by a 
macrolactonization sequence (Figure 1.2).13  Seeing as the synthesis of these two hemispheres 
allows for a roughly convergent total synthesis, we opted to keep this late-stage hemisphere 
coupling strategy while looking to improve the overall efficiency of synthesizing the ABCD and 




Figure 1.2:  Established hemisphere coupling strategy 
 
1.4 ABCD Hemisphere Retrosynthetic Analysis 
Past efforts toward the synthesis of the ABCD hemisphere have frequently employed the 
Felkin-selective anti-aldol approach pioneered by the Evans group to join the AB and CD 
fragments.6c  This original coupling strategy has continued to serve as a high-yielding fragment 
coupling reaction while also providing exquisite stereocontrol over the concomitantly formed 
C(15) and C(16) stereocenters (Scheme 1.1).  Though this transformation could hardly be 
improved upon for use in small scale couplings, we felt that the multi-gram generation of the 
requisite complex fragment precursors, especially one as sensitive as the α-chiral-β,γ-unsaturated 
aldehyde 1.4, would entail an unacceptable amount of risk for such precious, late-stage material.  
As such, we decided to explore an alternative approach to coupling the AB and CD spiroketals 









































Scheme 1.1: The Evans aldol approach to the ABCD hemisphere 
 
When considering an alternative fragment coupling approach to the ABCD hemisphere, we 
wanted to pursue a strategy that would allow for an efficient coupling of the AB and CD 
spiroketals while also requiring fewer total steps for generating the spiroketals themselves.  With 
these goals in mind, the Leighton laboratory’s previous work employing a tandem 
silylformylation / Tamao oxidation sequence to generate complex polyketide motifs began to 





















































Scheme 1.2: Mechanism of tandem silylformylation / Tamao oxidation sequence 
 
 The tandem silylformylation / Tamao oxidation sequence depicted above not only 
provides access to complex polyketide stereochemical arrays such as 1.12 from simple 
homopropargylic silyl-ethers such as 1.6, but does so in a high-yielding, scalable procedure only 
requiring purification at the end of the sequence.  Since a reaction sequence with these 
characteristics was exactly the type of coupling strategy we wanted to employ in a multi-gram 
synthesis of spongistatin 1, we attempted to compare the product motif observed in substrate 
1.12 to the pertinent region of the ABCD hemisphere 1.3 (Scheme 1.3).  Satisfyingly, the 
highlighted C(13)-C(17) segment of the ABCD hemisphere mapped on quite closely to the 
product motif of our tandem sequence, indicating that the reaction platform could indeed serve as 
an effective method for installing the three requisite stereocenters as well as the desired olefin 






























































Scheme 1.3: Identification of ABCD fragment as tandem sequence substrate 
 
Despite the already appealing prospect of employing our tandem silylformylation / Tamao 
oxidation methodology as a strategy to build the C(13)-C17) array from the CD spiroketal 
toward the AB spiroketal, we began to consider the notion that this methodology might 
additionally be utilized as a fragment coupling procedure.   Though quite ambitious, this idea 
appeared to be a sound extension of the group’s current reaction platform, since it simply 
necessitated that the AB spiroketal be tethered to the silicon as part of its “allyl” transfer moiety 









































Scheme 1.4: Fragment coupling via tandem silylformylation/Tamao sequence  
 
On closer examination of this potential coupling strategy, however, two main concerns 
came to light.  The first being that the implementation of the tandem silylformylation / Tamao in 
its published form would require two equivalents of AB spiroketal – since only one undergoes 
the 1,5-anti allyl transfer (Scheme 1.2).  The sacrifice of a full equivalent of the elaborated AB 
spiroketal would be unacceptable in a scalable total synthesis of spongistatin 1, so this aspect of 
the tandem sequence would need to be modified.  The second concern centered on the fact that 
there was little precedence for making complex tiglic silanes (trans-crotyl silanes substituted at 
the 2 position), which is the required olefin geometry for obtaining the desired stereochemical 
triad seen in compound 1.14. 
With these concerns in mind, the initial goals of the synthesis of the ABCD hemisphere 
became clear.  Before any major synthetic effort could be undertaken, new methodologies would 














































silicon in a tiglic substitution pattern, in addition to selectively transferring a single equivalent of 
the AB spiroketal carried throughout the tandem sequence.  Efforts toward these methodological 
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Chapter 2: Methodology Work toward Intramolecular Fragment Coupling 
2.1 Group Precedence for an Asymmetric Silane Alcoholysis 
As described in the previous chapter, we believed we could achieve our goal of an efficient 
and scalable fragment coupling between the AB and CD spiroketals of spongistatin 1 through the 
use of the Leighton laboratory’s tandem silylformylation / Tamao oxidation sequence.1  
However, to effectively employ this methodology, we would have to develop a way to load only 
a single equivalent of AB spiroketal onto silicon before the reaction sequence.  Fortunately, our 
group had some useful precedent for accomplishing this task via an asymmetric silane 
alcoholysis (ASA) reaction.2  In the ASA reaction platform, the silane in question contains a 
non-transferable t-butyl group in addition to the desired, transferable allyl subunit (Scheme 2.1).  
By establishing the silicon-oxygen bond diastereoselectively, the chirality at silicon serves to 
direct which face of the silylformylated substrate will be allylated during the tandem sequence. 
 

































Though it might seem that this precedent already allows for the use of a single “allyl” AB 
spiroketal unit on silicon in conjunction with the t-butyl moiety, the method falls short due to its 
resistance to the Tamao oxidation work-up required for our desired coupling procedure (Scheme 
2.2). 
 
Scheme 2.2:  t-Butyl subunit incompatibility with Tamao oxidation 
 
As a result, the ASA reaction platform would have to be overhauled to find a suitable, non-
transferable subunit that would allow for diastereoselective silicon-oxygen bond formation while 
still being amenable to a Tamao oxidation at the end of the silylformylation tandem reaction 
sequence (Scheme 2.3). 
 













































2.2 Development of a Model ASA Reaction Assay and Initial Screening Results 
When considering the optimization and extension of the Leighton laboratory’s ASA 
reaction platform, it was important to think critically about the copper(I)-mediated reaction 
pathway and design a screening assay that would rapidly provide clear results.  To that end, we 
examined the copper-mediated silane alcoholysis reaction mechanism as described by Oestreich 
and co-workers3 and used it to develop a plausible catalytic sequence (Scheme 2.4). 
 
Scheme 2.4: Catalytic cycle for ASA model system 
The proposed catalytic cycle depicted above helped us establish several variables that could be 
screened independently, such as the non-transferable group on silicon (R), the chiral ligand (L) 











































To begin our investigation, we opted to use homopropargylic alcohol 2.15 (derived from 
the BF3•OEt2-mediated, propyne opening of enantioenriched epoxyhexane4) as a model for the 
CD spiroketal and a simple allyl subunit on silane 2.12 as a model for the AB spiroketal.  We 
chose to explore aryl derivitives as our first group of R substituent since aryl-silicon bonds are 
known to be more amenable to Tamao oxidations than alkyl-silicon bonds.5  To generate the 
desired aryl derivative silanes 2.12, precursor aryl Grignards or aryl lithiates were reacted with 
allyltrichlorosilane and then reduced with excess LAH (Scheme 2.5). 
 
Scheme 2.5: Accessing aryl-allyl silanes 
 
With the parent phenyl silane 2.23 in hand, a variety of chiral ligands and copper sources 
were screened. While none of these combinations served to provide any significant 
diastereoselectivity in setting the Si-O bond in silyl-ether 2.24, the screen still provided useful 
information for determining the best copper(I) source and the optimal classes of phosphine 
ligands to pursue in further ASA studies (Scheme 2.6). 
 
Scheme 2.6: Initial ASA screen with allylphenylsilane 
It was determined from our initial screen that CuOAc was the best source of copper(I) for 





























and released a relatively innocuous silyl-acetate 2.13 as its reaction byproduct.  CuCl, CuBr and 
CuI were all found to have low reactivity in terms of generating the desired copper hydride for 
the catalytic cycle, while CuOtBu and CuOTf were found to be too reactive and led to a mixture 
of products. 
As for the chiral phosphine ligands employed in the ASA reaction, two major trends 
became clear.  While electron rich phosphines were required to increase the basicity of the 
copper hydride, and thus allow it to react with alcohol 2.15 in the first step of the catalytic cycle 
(Scheme 2.4), if the phosphines were too electron rich, overreaction of the copper hydride led to 
a mixture of products.  A variety of phosphine classes and their relative reactivities in the ASA 
reaction are summarized below (Scheme 2.7, Scheme 2.8, Scheme 2.9, Scheme 2.10). 
 































Scheme 2.8: Ligand classes that were too sterically hindered to promote the ASA 
 
 





Scheme 2.10: Electron rich ligand classes that led to overreaction in the ASA 
 
With a variety of ligands now known to effectively promote the desired silicon-oxygen 















































silicon in an attempt to increase the reaction’s diastereoselectivity in the silcon-oxygen bond 
forming step.  Many aryl-allyl silanes were generated, all of which exhibited variable, albeit 
minimal, impacts on the diastereomeric ratio of products.  The highest diastereoselectivities 
obtained for generating silyl-ethers 2.41 by utilizing silanes 2.22 in an ASA chiral ligand screen 
are indicated below (Scheme 2.11). 
 
Scheme 2.11: Highest diastereoselectivities obtained using a variety of aryl silanes 
 
Since the selectivities obtained using the aryl silanes shown above were not particularly 
promising, we sought to move the steric bulk of the aryl ring in 2.22 closer to the site at which 
the chiral silicon-oxygen bond was forming (Scheme 2.12).  It was our hope that this 
modification would allow the aryl ring to better direct the chiral ligand on copper and thus 
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Scheme 2.12: Aryl-allyl silanes with steric bulk at the ortho position 
 
While this modification did indeed serve to improve the diastereoselectivity of the ASA 
reaction to 3:1 dr when using isopropyl derived silane 2.48, the increased steric bulk at the ortho 
position on the aryl ring was found to be incompatible with the requisite Tamao oxidation 
following the silylformylation tandem sequence.  The performance of various silanes 2.22 in the 
tandem silylformylation / Tamao oxidation tandem sequence were evaluated by affecting a silane 
alcoholysis between the silane in question and achiral alcohol 2.50.  The resulting silyl ether 2.51 
was then subjected to the tandem silylformylation / Tamao sequence (Scheme 2.13).  If the silane 
was not compatible with the Tamao oxidation, its diastereoselectivity in the ASA reaction was 
not pursued (as with silanes 2.47 and 2.49 above). 
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1) 3 mol% Rh(CO)2(acac)
C6H6, 60 °C













2.3 Exploring Alternative Silane Structural Motifs in the ASA Reaction 
Following the lackluster screening results of the aryl derived, allylsilanes described in the 
previous section, we turned our attention to exploring alternative silane structural motifs in the 
ASA reaction.  The first alternative we examined was a class of benzylic silane derivatives 2.53. 
We hoped that by moving the steric bulk on silicon one carbon away that these derivatives might 
participate in distinct, diastereoselective interactions with the ASA chiral ligand while still 
remaining compatible with the Tamao oxidation required after the tandem sequence (Scheme 
2.14). 
 
Scheme 2.14: Exploring benzylic silanes as an alternative structural motif  
 
Because substituted benzyl Grignards and benzyl lithiates are often not commercially 
available, a method for generating silanes of type 2.53 had to be identified.  As first 
demonstrated by Benkeser, the combination of trichlorosilane 2.56 and trialkylamines such as 
2.57 generates a reactive source of anionic trichlorosilicon 2.58 which can then act as a 
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1) 3 mol% Rh(CO)2(acac)
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variety of substituted benzylic silanes 2.53 from their precursor benzyl chlorides 2.60 as shown 
below (Scheme 2.15). 
 
Scheme 2.15: Accessing benzyl-allyl silanes 
 
As with the substituted aryl silanes 2.22 (Scheme 2.11), the benzylic silanes 2.53 were 
subjected to a battery of ASA reactions (Scheme 2.14) utilizing several classes of chiral ligands 
(Scheme 2.7).  The best diastereomeric ratios obtained with each silane are depicted below 
(Scheme 2.16). 
 
Scheme 2.16: Highest diastereoselectivities obtained using a variety of benzylic silanes 
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Though more highly substituted benzylic silanes, such as 2,6-di-t-butyl benzyl silane, could 
perhaps have been synthesized and examined in the ASA reaction, the disappointing results seen 
with the more readily accessible substrates depicted above led us to abandon benzylic silanes 
2.53 as a potential ASA structural motif. 
 Inspired by related work by Benkeser,6b we next turned our attention to benzhydryl silane  
2.67 as a potential parent compound for a new ASA structural motif that would still be amenable 
to Tamao oxidation.  Unfortunately, the synthesis of benzhydryl silane 2.67 was low yielding 
from known trichlorosilane 2.666b (Scheme 2.17). 
 
Scheme 2.17: Accessing benzhydryl silane 
 
Nonetheless, with some pure material in hand, we attempted to examine the effectiveness of 
silane 2.67 in the ASA reaction.  Surprisingly, we found that as the reaction progressed, 
diphenylmethane 2.69 was steadily cleaved from both silanes 2.67 and 2.68 (Scheme 2.18). 
 
Scheme 2.18: Exploring benzhydryl silane as an alternative ASA structural motif 
  
This result seemingly indicated that the doubly-benzylic, stabilized anion of diphenylmethane 
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would also explain the low yield of the allyl Grignard addition / LAH reduction of compound 
2.66.  Attempts to synthesize electron rich derivatives of benzhydryl silane 2.67, in the hope that 
they would be less susceptible to the benzhydryl cleavage pathway, were unsuccessful. 
 Undaunted by these repeated failures to find a structural class of silanes that would 
deliver high diastereoselectivities in the ASA reaction while still being amenable to Tamao 
oxidation following the tandem silylformylation sequence, we thought that the utilization of a 
chiral, α-substituted, benzylic silane 2.70 might allow us to achieve our methodological goals 
(Scheme 2.19). 
 
Scheme 2.19: Exploring chiral benzylic silanes as an alternative structural motif 
 
 While adding an extra layer of chiral induction to the ASA reaction platform might be 
seen as undesirable from an academic standpoint, given the practical ease by which the chiral, 
benzylic trichlorosilanes 2.74 could be accessed from their commercially available styrene 
precursors 2.73 (Scheme 2.20),7 we felt it was quite appropriate to explore this structural motif.  
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context of a fragment coupling sequence, where the value of the late-stage coupling components 
would far outweigh that of a chiral silane. 
 
Scheme 2.20: Accessing chiral benzylic-allyl silanes 
 
 Employing the reaction sequence shown above, a family of chiral, benzylic-allyl silanes 
2.75 were prepared for screening in the ASA reaction with a variety of chiral ligands (Scheme 
2.21).  (Note: ee’s of all chiral, benzylic silanes were determined via Tamao oxidation to the 
benzylic alcohol followed by Mosher’s ester analysis).8   To our delight, we obtained our first 
significant increase in the diastereoselectivity of the ASA reaction, observing a 
diasetereoselectivity of 3.9:1, when chiral, benzylic silane 2.79 was utilized in conjunction with 

























Scheme 2.21: Highest diastereoselectivities obtained using chiral, benzylic silanes 
 
 Attempts to modify the ortho-methyl, α-methyl substitution pattern on chiral, benzylic 
silane 2.79 in the hopes of further improving the silane’s performance in the ASA and tandem 
sequence were met with some difficulty.  As shown above, an attempt to utilize the α-isopropyl 
substituted chiral, benzylic silane 2.78 proved to be too hindered to undergo our requisite Tamao 
oxidation.  Further efforts to tether the α-methyl substituent to the ortho-methyl substituent 
through use of indene-derived silane 2.80 only served to decrease the substrate’s 
diastereoselectivity in the ASA reaction.  Since free rotation seemed critical for high 
diastereoselectivity, we next attempted to bulk up the chiral, benzylic silane by using a mesityl-
type substitution on the aryl ring. Unfortunately, the 2,6-methyl-substitution on the precursor 
styrene ring proved incompatible with the enantioselective hydosilylation reaction,7a generating 
silane 2.81 in an unacceptable 30% ee. 
These difficulties not withstanding, we felt that silane 2.79 generated enough 



















Considering there were now three stereocenters participating in the ASA reaction (specifically, 
the alcohol stereocenter, the benzylic silane stereocenter and the chiral ligand on copper), we felt 
it would be instructive to analyze the relative strength of the chiral matching components by 
running a series of experiments summarized in Table 2.1.  As can be seen in the data table 
below, the strongest matching effect was observed between the (S)-BINAP ligand (S)-2.87 and 
the (S)-chiral, benzylic silane (S)-2.79 (entries 1 and 3 vs. entries 2 and 4).  The chirality of the 
alcohol substrate 2.15, in contrast, exhibited a much weaker match/mismatch effect on the 
diastereoselectivity (entries 1 and 2 versus entries 3 and 4).  These results were reassuring in the 
sense that for the real fragment coupling of spongistatin 1 the chirality of the CD spiroketal 
alcohol 2.7 would be set, while the enantiomer of silane 2.75 and the chiral ligand on copper 
could be independently matched to give the desired stereochemical product. 
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With these exciting ASA diastereoselectivity results for chiral, benzylic, allylsilane 2.79 in 
hand, we next turned our attention toward the synthesis of tiglic silanes.  The tiglic silane motif 
more accurately represents the AB spiroketal coupling fragment 2.8, and we were hopeful that 
the increase in differentiated steric bulk on silicon would lead to even greater 
diastereoselectivities in the ASA reaction. 
 
2.4 Development of a Robust Anti-1,4-Hydrosilylation Reaction 
Though the 1,4-hydrosilylation of dienes is well precedented,9 the most effective strategies 
employ late transition metal catalyst (such as palladium) and proceed via a syn-1,4-
hydrosilylation mechanism to give Z-allylsilane products.10  To our knowledge, only one 
example of a method for anti-1,4-hydrosilylation has been reported.11  This method, pioneered 
by the Le Gendre group, utilizes a titanium catalyst to affect the unusual regio- and 
diastereoselectivity seen in the reaction (Scheme 2.22). 
 
Scheme 2.22: Anti-1,4-bis-hydrosilylation reported by the Le Gendre group 
 
The bis-hydrosilylation shown above allows for the use of Cp2TiF2 as an inexpensive, 
bench stable pre-catalyst, which, upon heating in the presence of phenylsilane 2.89, converts to 
the active titanium hydride species 2.92 required for the catalytic cycle proposed by the Le 












Scheme 2.23: Postulated tiglylation catalytic cycle (Le Gendre) 
[Note: the σ-bond rotation of intermediate 2.94 has been added for mechanistic clarity]. 
 
While this anti-1,4-hydrosilylation reaction looked promising for generating tiglic silanes 
of type 2.8, the reaction described by Le Gendre begins to follow an unproductive pathway when 
only one equivalent of diene 2.93 is used (Scheme 2.24). 
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This undesired dehydrogenative, double silylation mechanism was further explored by the Le 
Gendre group, and their postulated mechanism for the dehydrogenative pathway is shown below 
(Scheme 2.25). 
 



































As depicted at the start of the catalytic cycle, the Le Gendre group proposed that continued 
heating of tiglylation catalyst 2.92 converts it to titanium species 2.99, presumably by reaction of 
two equivalents of titanium catalyst 2.92 to release H2 and binuclear titanium(III) silyl complex 
[Cp2Ti(SiH2Ph)]2 as a secondary pre-catalyst.12  This new titanium(III) species then undergoes a 
series of σ-bond metatheses to catalyze the dehydrogenative double silylation reaction that 
generates silacycle 2.101.  This mechanism was further supported by the Le Gendre group’s 
demonstration that extended heating of Cp2TiF2 in THF followed by the later addition of 
isoprene 2.90 at room temperature led to exclusive silacycle 2.98 formation.  In contrast, the 
large excess of isoprene 2.90 used in Scheme 2.22 likely prevented the conversion of tiglylation 
catalyst 2.92 to dehydrogenative catalyst 2.99 through a concentration-dependent competitive 
inhibition of the catalytic breakdown pathway by the diene substrate. 
While the dehydrogenative double silylation pathway (Scheme 2.25) is certainly 
fascinating, if we were to effectively employ the titanium mediated tiglylation reaction (Scheme 
2.23) to generate our AB spiroketal fragment coupling partner 2.8, a method for exclusively 
accessing the anti-1,4-hydrosilylation pathway in the presence of ca. 1.0 equivalent of the 
precious AB-silane precursor would need to be devised.  Fortunately, the Le Gendre group did 
indicate one successful example of affecting mono-tiglylation (Scheme 2.26). 
 







 23 °C, THF Si H
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By using a pre-made titanium(II) catalyst (Cp2Ti(PMe3)2) to initiate the desired 
titanium(II)-titanium(IV) tiglylation cycle at room temperature, the undesired generation of a 
titanium(III) catalytic species at higher temperatures is completely obviated.  Thus, using 
Cp2Ti(PMe3)2 as the reaction catalyst, the anti-1,4-hydrosilylation chemistry was successfully 
extended to the mono-tiglylation of benzylic silanes in the Leighton laboratory. 
 
Scheme 2.27: Successful mono-tiglylation of benzylsilane with Cp2Ti(PMe3)2 
 
 While the extension of this mono-tiglylation reaction to benzylsilane 2.103 gave us hope 
that the titanium-mediated anti-1,4-hydrosilylation could be compatible with the chiral, benzylic 
silanes necessary for high diastereoselectivities in the ASA reaction (Chapter 2, Section 3), we 
found the required Cp2Ti(PMe3)2 catalyst to be quite unstable and difficult to rely on for 
reproducible results.  Considering our ultimate goal was to use this methodology in the context 
of a multi-gram fragment coupling between two late-stage intermediates, the need to find a 
robust method for carrying out this transformation was of the utmost importance.  As such, we 
decided to revisit the use of stable catalyst precursor Cp2TiF2 to hopefully affect the mono-
tiglylation of benzylic silane 2.103 without forming any undesirable and inseparable silacyle 














Scheme 2.28: Attempt to mono-tiglylate benzylsilane with Cp2TiF2 precatalyst in THF 
 
To our surprise, all attempts to activate Cp2TiF2 for the tiglylation of benzylsilane 2.103 in 
dry THF were unsuccessful.  After some screening, it was found that 1,4-dioxane was better 
suited for promoting the activation of the titanium pre-catalyst.  While it was not completely 
clear why switching to this more Lewis-basic solvent was necessary to successfully alter the 
reaction substrate from phenylsilane 2.89 to benzylsilane 2.103, we have tentatively attributed it 
to a subtle augmentation of the electron density on Cp2TiF2 that allows it to undergo initial 
activation with the presumably less reactive benzylsilane.  Unfortunately, even after discovering 
the efficacy of 1,4-dioxane in promoting the catalyst activation, we still found the ratio of desired 
mono-tiglylated product 2.104 to undesired silacycle product 2.105 to be 2:1 (Scheme 2.29). 
 
Scheme 2.29: Mono-tiglylation of benzylsilane using Cp2TiF2 in 1,4-dioxane  
 
3 mol% Cp2TiF2
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Following this disappointing result, we became increasingly concerned that we would be 
unable to find a robust reaction platform to efficiently generate tiglic silane 2.8.  In a final 
attempt to modify the reaction conditions in order to promote the exclusive formation of tiglic 
silane 2.104 by minimizing the production of silacycle 2.105, we reanalyzed the pathway in 
which the undesired dehydrogenative catalyst forms. 
As previously discussed, the desired titanium(IV) catalytic species 2.92 converts to the 
undesired titanium(III) species 2.99 when heated (Scheme 2.25).  The degree to which this 
catalyst breakdown is observed is heavily dependent on the concentration of the substrate diene 
2.93, presumably because it takes two free titanium(IV) species 2.92 reacting with one another to 
degrade to the unwanted titanium(III) species 2.99 (vide supra).  We took this to mean that when 
the titanium(IV) species 2.92 engages diene 2.93 it becomes unavailable for participation in the 
catalytic breakdown pathway with other titanium(IV) molecules 2.92.  Given our belief that this 
was the case, we thought that we could perhaps disrupt the catalyst breakdown pathway by 
adding a Lewis-basic phosphine to the reaction mixture in order to stabilize the free titanium(IV) 
species 2.92 as it forms under the Cp2TiF2 activation conditions. 
Given the ability of Cp2Ti(PMe3)2 to promote the desired mono-tiglylation, we first 
thought to use PMe3 as a source of stabilizing phosphine.  However, due to the pyrophoricity of 
PMe3, we opted to screen more stable phosphine additives instead.  The results of this screen are 




Table 2.2: Phosphine additive screen in 1,4-anti-hyrosilylation reaction 
 
To our delight, the addition of certain phosphine ligands had a dramatic impact on the 
degree to which the undesired dehydrogenative silylation pathway was observed.   As seen in 
Table 2.2, there was a direct relationship between the phosphine cone-angle and stabilization of 
the desired titanium(IV) species at the start of the catalytic cycle.  The addition of PEt3, which 
has a small cone angle, did not improve the product to silacycle ratio beyond what was initially 
observed when the reaction was run in the absence of phosphine (Scheme 2.29).  On the other 
hand, the use of PCy3, which has a large cone angle, prevented the breakdown of the 
titanium(IV) species almost entirely, giving a 20:1 ratio of product to silacycle.  It was found that 
utilization of 4 equivalents of phosphine relative to titanium (12 mol%) was the optimal amount 
needed to promote the desired tiglylation pathway (Entry 3), as the beneficial effect disappeared 
3 mol% Cp2TiF2
Phosphine Additive
Activate at 45 °C




































when only 2 equivalents were used (Entry 4) and diminished when 10 equivalents were used 
(Entry 5).  
Having optimized the reaction conditions for the mono-tiglylation of benzylsilane 2.103, 
we eagerly synthesized chiral, benzylic silane 2.108 (Scheme 2.30), so that we could attempt the 
anti-1,4-hydrosilylation on this key substrate. 
 
Scheme 2.30: Generation of chiral, benzylic silane 2.108 
 
To further define the dependence of monotiglylation on the phosphine ligand for silane 2.108, 
several more phosphine additives were screened, with the results summarized in Table 2.3 
below.  Somewhat surprisingly, no reaction was observed when the mono-tiglylation was 
attempted in the absence of a phosphine additive (Entry 1).  Though this was an unexpected 
result, it was plausibly consistent with our previous observation that the titanium pre-catalyst 
required a more Lewis-basic solvent (i.e. 1,4-dioxane) in order to react with deactivated 
benzylsilane substrates (Scheme 2.29).  Given the deactivation of our more hindered α-
substituted, benzylic silane 2.108, it now seemed that an even greater amount of Lewis-base 
activation was required for the Cp2TiF2 pre-catalyst to initiate the tiglylation process.  
Fortunately, our phosphine additives readily imparted this increased Lewis-base activation, as a 
variety of electron-rich phosphines with large cone-angles were found to effectively promote the 
mono-tiglylation reaction (Entries 2-4).  After comparing several phosphine additives, PCy3 
remained the optimal ligand, providing the desired product in 78% isolated yield (Entry 3). 
1.2 equiv Cl3SiH,
0.5 mol% [Pd(allyl)Cl]2












Table 2.3: Phosphine screen for mono-tiglylation of chiral, benzylic silane 2.108  
 
 
2.5 Synergistic Effects of Chiral, Benzylic, Tiglyl-Silanes in the ASA Reaction 
With the synthesis of chiral, benzylic, tiglyl-silane 2.109 fully optimized, it was time to 
examine its performance in the ASA reaction.  As stated previously, the tiglic silane motif more 
accurately represents the AB spiroketal coupling fragment 2.8 depicted in Scheme 2.3, and we 
were hopeful that the increased differentiation in the steric bulk on silicon would lead to even 




































Scheme 2.31: Synergistic match case of chiral, benzylic, tiglyl-silane in ASA 
 
Gratifyingly, tiglic silane 2.109 indeed showed a strong synergistic effect with the chiral 
phosphine ligand employed in the ASA (Scheme 2.31).  Though the reaction was a bit slower 
(80% conversion after two days at RT), the triply differentiated and doubly differentiated 
matched cases now gave selectivities as high as 6:1 and 5:1 dr respectively – a substantial 
improvement over the chiral, benzylic, allyl-silane 2.79 examined in Table 2.1.  In the cases 
where the chiral phosphine and chiral silane were mismatched, selectivities less than 1:2 were 
observed, with chiral induction of the phosphine ligand found to be slightly dominant over the 
chiral induction from the silane. 
 With good diastereoselectivities finally being observed in the ASA reaction, we were 
emboldened to attempt the synthesis of an even more sterically congested chiral, benzylic silane 
in the hopes of achieving excellent diastereoselectivity in the ASA.  While we had already 
determined that increasing the steric bulk at the α-position on the chiral, benzylic silanes was 
incompatible with the Tamao oxidation following the tandem silylformylation sequence (silane 
2.78 in Scheme 2.21), we thought there might still be an opportunity to expand the steric bulk at 
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- (S)-Tol-BINAP 6.0 : 1.0 dr
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at the ortho position in silane 2.109 from methyl to isopropyl, we might be able to increase the 
benzylic silane’s interaction with the chiral ligand used in the ASA while minimally disrupting 
the steric environment at silicon during the Tamao oxidation. 
After some experimentation, it was found that the synthesis of the precursor ortho-
isopropyl styrene 2.114 could either be achieved through a one-step Stille coupling procedure13 
or a more economical, two-step Suzuki-Molander coupling procedure14 (Scheme 2.32). 
 
Scheme 2.32: Syntheses of ortho-isopropyl styrene precursor 2.114 
 
With ortho-isopropyl styrene 2.114 in hand, a gram-scale enantioselective hydrosilylation / 
reduction procedure was performed to give chiral, benzylic silane 2.118 in good yield with 
minimal catalyst loading (Scheme 2.33). 
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With significant quantities of ortho-isopropyl, chiral, benzylic silane 2.118 at our disposal, we 
next carried out our first gram-scale anti-1,4-hydrosilylation, which proceeded quite smoothly to 
generate chiral, benzylic tiglylsilane 2.119 in good yield (Scheme 2.34). 
 
Scheme 2.34: Gram-scale synthesis of ortho-isopropyl tiglylsilane 2.119 
 
Our newly accessed ortho-isopropyl tiglylsilane was next screened with a wide variety of 
chiral ligands in the ASA reaction, a small sampling is represented in Table 2.4.  As was the case 
for ortho-methyl tiglylsilane 2.109 (Scheme 2.31) the (S)-Tol-BINAP triply differentiated 
matched case proved to be the most diastereoselective chiral ligand in the ASA reaction (Entry 
1).  Although switching from ortho-methyl tiglylsilane 2.109 to ortho-isopropyl tiglylsilane 
2.119 only resulted in a modest boost in diastereoselectivity (6:1 to 7:1), a substantial effect on 
the overall ASA reaction rate was observed across a variety of ligands.  For example, using the 
ortho-isopropyl tiglylsilane 2.119 and the matched (S)-Tol-BINAP ligand, full conversion was 
reached for the ASA in 24 h (Entry 1), a marked improvement over the 80% conversion reached 
in 48 h using the ortho-methyl tiglylsilane 2.109 (Scheme 2.31).  Even the mismatched (R)-Tol-
BINAP was found to go to complete conversion after two days (Entry 2).  Notably, both the 
achiral PCy3 and (S)-Xylyl-MeO-BIPHEP ligands rapidly proceeded to full conversion in only 6 
h (Entries 4-5), with the (S)-Xylyl-MeO-BIPHEP giving a matched diastereoselectivity of nearly 
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Table 2.4: ASA Ligand screen with ortho-isopropyl, chiral, benzylic tiglylsilane 
 
Given that (S)-Xylyl-MeO-BIPHEP exhibited good diastereoselectivity at a relatively fast 
rate, we though we might be able to increase the ASA diastereomeric ratio by cooling this 
reaction down.  To our immense satisfaction, we found that this ASA reaction could successfully 
be run at 0 °C for 24 h in deuterated toluene to give the desired product in 10.7 : 1.0 dr (Scheme 
2.35). 
 








































































2.12010.7 : 1.0 dr, Full Conversion
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This groundbreaking result marked the end of our search for new ASA substrate and ligand 
combinations as we felt the information obtained from this model study could be readily applied 
to the real coupling system (Scheme 2.3).  The last methodological hurdle that remained was the 
confirmation that the ortho-isopropyl, chiral, benzylic, tiglic silyl-ether 2.120 was still a 
competent substrate for our tandem silylformylation / Tamao oxidation protocol. 
 Up until this point, the absolute stereochemical configuration of the ASA reaction 
product had yet to be assigned.  Though one might imagine a series of derivitizations that would 
allow us to either grow a crystal or run an extensive array of nOe experiments to assign the 
silicon stereocenter, we felt that a simpler, indirect method would suffice for the time being.  As 
demonstrated in our group’s recent publication,1 the tandem silylformylation / Tamao oxidation 
sequence is most diastereoselective when the 1,5-anti diol can simultaneously direct protonation 
of the transient enol species to give a 1,2-anti relationship between the adjacent methyl and 
alcohol stereocenters (Chapter 1, Section 1, Scheme 1.2).  Given our newfound ability to direct 
the tiglic transfer fragment to either alcohol face via the ASA reaction platform, we could 
potentially generate a 1,5-syn diol tandem silylformylation product that would be expected to 
give lower diastereoselectivity in the Tamao oxidation as the 1,5-syn alcohols each direct the 
proton to opposite faces of the intermediate enol.  Thus, if these two tandem silylformylation / 
Tamao oxidation reactions were set up side-by-side, the reaction that proceeds more smoothly 
and with higher overall diastereoselectivity could be tentatively assigned as the one generating 
the desired 1,5-anti diol product. 
 Following this line of reasoning, a series of reactions were carried out to generate the 
pertinent silyl-ether starting materials (Scheme 2.36).  Achiral alcohol 2.50 was first converted to 
a 1:1 mixture of silyl-ether 2.121 to be used as a control in the tandem silylformylation / Tamao 
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oxidation sequence.  Next, silyl-ethers 2.122 and 2.123 were formed using opposite enantiomers 
of alcohol 2.15 with unknown, albeit identical, stereochemistry at silicon derived from the ASA 
matched case reaction utilizing tiglic silane (S)-2.119 and (S)-Tol-BINAP. 
 
Scheme 2.36: Generation of key silyl-ethers for tandem silylformylation / Tamao 
 
With silyl-ethers 2.121, 2.122 and 2.123 successfully synthesized, the tandem 
silylformylation / Tamao oxidation sequence was carried out for each substrate.  As summarized 
in Scheme 2.37, the results of these experiments were clear.  First and foremost, the viability of 
the tandem fragment coupling sequence as envisioned in Scheme 2.3 was established as silyl-
ether 2.121 cleanly afforded complex polyketide fragment 2.126 in approximately 75% yield and 
in 6:1 overall dr.  Furthermore, the stereochemistry of silyl-ethers 2.122 and 2.123 at silicon was 
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give complex polyketide fragment 2.128 in good yield and good overall diastereoselectiviy – 
thus indicating the formation of the desired, 1,5-anti diol product. 
 
Scheme 2.37: Tandem silylformylation / Tamao sequence establishing chirality at Si 
 
The exciting results depicted in Scheme 2.37 served as a strong proof-of-concept for our 
overarching goal of efficiently coupling the AB and CD spiroketals of spongistatin 1 via an 
intramolecular, tandem silylformylation / Tamao oxidation sequence to generate the complex 
polyketide motif observed in compound 2.128.  With both the ASA reaction and the tandem 
silylformylation / Tamao oxidation sequence successfully demonstrated on model system 2.125, 
it was time to devote our attention to the total synthesis of the AB and CD fragments of 
spongistatin 1, in order to attempt our fragment coupling strategy on the real system.  
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Chapter 3: Syntheses of AB and CD Fragments and Attempted Coupling 
3.1 Synthesis of the CD Fragment and Preliminary ASA Results 
As described in Chapter 1 and more specifically depicted in Chapter 2, Scheme 2.3, our 
main goal in the scalable synthesis of the ABCD hemisphere of spongistatin 1 was to affect the 
large-scale coupling of the AB and CD spiroketal from simplified coupling partners 3.2 and 3.3 
while simultaneously establishing the complex C(13)-C(17) polyketide stereochemical array 
highlighted in compound 3.1 (Scheme 3.1). 
 
Scheme 3.1: Retrosynthetic analysis for AB and CD spiroketal fragment coupling 
 
In order to utilize the asymmetric silane alcoholysis (ASA) reaction platform developed in 
Chapter 2, however, the CD fragment would have to be coupled pre-spiroketalization in order to 
access the requisite alcohol moiety at C(19).  Thus, we designed an acyclic CD spiroketal 
equivalent 3.5 that could be readily transketalized to the desired CD spiroketal following the key 
















































Scheme 3.2: Acyclic CD spiroketal equivalent 3.5 for use in fragment coupling 
 
Since our main goal was to quickly discern whether or not acyclic CD fragment 3.5 could 
be a competent coupling partner in the ASA / tandem sequence depicted above, our first 
generation retrosynthesis was fairly straightforward, utilizing aldol technology to bring several 
subunits together while simultaneously setting multiple fragment stereocenters (Scheme 3.3). 

































































Scheme 3.3: Retrosynthetic strategy for generating acyclic CD fragment 3.5 
 
Though the synthesis of aldehyde 3.9 was already known,1 we modified the route to 
improve its operational ease and scalability (Scheme 3.4).  The stereocenter present in target 
aldehyde 3.9 comes from the chiral pool, as this subunit synthesis begins with the reduction of 
(D)-malic acid 3.13.  Though previous syntheses called for a tedious chromatographic 
purification of the extremely polar triol 3.12, we found this to be unnecessary, as protection of 
the crude material provided ketal 3.15 in good yield over the two-step sequence.  It is worth 
noting that the diethyl-ketal thermodynamically prefers to form the desired 5-membered ring in 
compound 3.15 as opposed to the alternative 6-membered ring.2 The requisite 3,3-
dimethoxypentane 3.14 for this protection was prepared by pre-ketalization of 3-pentanone in 

































3.9, but we found the Swern oxidation procedure to be equally effective and easier to run on a 
multi-gram scale. 
 
Scheme 3.4: Approach to CD subunit aldehyde 3.9 
 
With ready access to aldehyde 3.9, we next turned our attention to the synthesis of 
aldehyde 3.10 and silyl-enol ether 3.11 (Scheme 3.3).  Silyl-enol ether 3.11 is commercially 
available, but could also be prepared in low to moderate yields via an Organic Syntheses prep.3  
The synthesis of aldehyde 3.10 commenced with the hydrolytic kinetic resolution of 
epichlorohydrin to give (R)-3.16 in high ee (Scheme 3.5).4   The enantioenriched epichlorohydrin 
was next regioselectively opened with propyne in moderate yield to provide alkynol 3.17 on 
large scale.  The primary chloride on 3.17 was then displaced with NaCN to generate nitrile 3.18 
in good yield (Caution: it was critical to avoid an aqueous workup of this reaction to prevent the 
release of cyanide gas from any unreacted NaCN).  After some experimentation, muti-gram 
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trichloroacetimidate 3.19 protection.  Though usable, this procedure was not ideal, as it required 
the tedious removal of the resulting trichloroacetamide reaction byproduct (alternative base-
mediated protection conditions using PMB-Cl were found to be ineffective). 
 
Scheme 3.5: Multi-gram synthesis of nitrile 3.20 in route to aldehyde 3.10  
 
With large amounts of nitrile 3.20 in hand, we attempted to convert it to desired aldehyde 
3.10 using a variety of DIBAl-H reduction conditions (Table 3.1).  Though this reaction was 
occasionally successful, we found it to be unacceptably inconsistent in terms of yield, 
reproducibility and purity of the isolated product.  Despite several weeks of attempted 
optimization we had no choice but to abandon this route to aldehyde 3.10 (and our stockpile of 








































Table 3.1: DIBAl-H reduction conditions 
 
In an effort to design a more robust synthesis of CD subunit 3.10, we hoped to use an 
ozonolysis reaction to generate the desired aldehyde from terminal alkene 3.24 (Scheme 3.6).  
Our new synthesis began again with the hydrolytic kinetic resolution of epichlorohydrin, this 
time with the opposite catalyst enantiomer, to generate large quantities of compound (S)-3.16.  
This epoxide was opened with vinyl Grignard and the resulting crude hydroxyalkene was 
distilled from KOH to give allyl epoxide 3.22.  Epoxide 3.22 was then opened with propyne to 
give alkynol 3.23 in good yield.  This alcohol was far more amenable to PMB protection as 

























-78 °C 1 hr
9
5.0 eq
No Rxn (Insoluble S.M.)EtOAc / H2O-78 °C 1 hrHexanes 5.0 eq
Trace Pdt0.5 M HCl-78 °C 1 hrCH2Cl2 5.0 eq
DIBAl-H
Et2O
12% Pdt10% Tartaric Acid-78 °C 1 hrCH2Cl2 5.0 eq
35% Pdt (Brown Crud...)10 % Tartaric Acid0 °C 2.5 hrTHF 2.5 --> 5.0 eq
Clean Rxn, Trace Pdt post work-upSaturated Tartaric Acid0 °C 2 hrTHF 2.5 --> 5.0 eq
25% Pdt (Brown Crud) + PMB-OH!10 % Tartaric Acid0 °C 5 hrTHF 2.5 --> 5.0 eq
45% Pdt (Brown Crud...)0 °C 2.5 hrTHF 2.5 --> 5.0 eq
62% Pdt








Scheme 3.6: Multi-gram synthesis of alkene 3.24 in route to aldehyde 3.10 
 
Gratifyingly, alkene 3.24 was readily converted to aldehyde 3.10 via ozonolysis using trace 
sudan(III) dye to carefully monitor consumption of the alkene,5 since overreaction led to some 
degradation of the alkyne.  With clean aldehyde 3.10 finally in hand, we were able to probe its 
selectivity in the BF3•OEt2 mediated Mukaiyama aldol reaction with silyl-enol ether 3.11.  As 
predicted by Evans,6 the β-OPMB substituted aldehyde effectively controlled the open transition-
state addition of the silyl-enol ether to give the 1,3-anti addition product 3.25 in 5:1 dr.  Next, 
alcohol 3.25 was methylated using Meerwein salt (Me3OBF4) and Proton Sponge to circumvent 
the standard NaH/MeI conditions, which caused alcohol 3.25 to eliminate to its corresponding 
enone.  Though a large excess of methylating reagent was required for full conversion (ca. 5 
equiv), CD fragment subunit 3.8 could be obtained in good yield following a critical 1.0 M acetic 
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Scheme 3.7: Generation of CD fragment subunit 3.8 via Mukaiyma aldol 
 
Given that the methylation step to generate compound 3.8 was less than ideal, requiring a 
large excess of reagents, we paused to consider an alternative strategy for generating methyl-
ether 3.8 (Scheme 3.8).  By simply modifying the ozonolysis conditions used to react alkene 
3.24, we were able to generate dimethyl acetal 3.26 in good yield.  With this acetal in hand, we 
attempted to generate methyl-oxocarbenium species 3.27 in situ and directly add silyl-enol ether 
3.11 to this reactive species in an effort to selectively generate compound 3.8 in one step.  
Unfortunately, all attempts toward this goal were met with little success.  Despite screening a 
variety of Lewis acids (BF3, TMSOTf, TiCl, Ti(OiPr)4) the reaction yield was quite low and 
showed little diastereoselectivity, with a slight preference for the undersired methyl-ether 
diastereomer.  In light of these disappointing results, we returned to the reasonably effective 
strategy depicted in Scheme 3.7 and continued onward with the CD fragment synthesis. 
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Scheme 3.8: Attempt to generate methyl-ether 3.8 from oxocarbenium 3.27 
 
With both ketone 3.8 and aldehyde 3.9 in hand, we set out to join them stereoselectively 
through a Paterson aldol reaction.  To our great satisfaction, this reaction not only proved to be 
highly efficient in terms of yield, but also provided the desired alcohol 3.28 in 10:1 dr – an 
impressive display of chiral reagent control using (-)-DIP-Chloride.  Furthermore, the minor 
diastereomer at the methyl-ether center, resulting from the earlier Mukaiyama aldol reaction, 
could be chromatographically separated from the desired product at this point.  Alcohol 2.28 was 
readily TES protected to give compound 2.29, but the final reaction required to generate ASA 
precursor alcohol 3.5 failed, as PMB deprotection only afforded undesired lactol 3.30 upon 
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Scheme 3.9: Paterson aldol and attempted completion of acyclic CD fragment 
 
Considering the propensity of δ-substituted keto-alcohols to cyclize to their corresponding 
lactols, we sought an alternative approach to reveal the requisite alcohol for the ASA reaction 
while masking the ketone in another form.  The strategy we hoped to employ involved packaging 
the ketone as bicyclic-ketal 3.31, which we were able to successfully generate through a 
modified In(OTf)3 catalyzed transketalization procedure.7  The resulting bicyclic alcohol 3.31 
was readily protected with TBSOTf, incidentally providing a solid, crystalline intermediate (not 
shown), and the requisite free-alcohol 3.32 was revealed through a DDQ-mediated PMB 
deprotection (Scheme 3.10).  (Note: It is critical to use free alcohol 3.32 shortly after its 
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Scheme 3.10: Synthesis of revised CD fragment - bicyclic alcohol 3.32 
 
With our route to the revised CD fragment 3.32 complete, we eagerly tested this 
functionalized, homopropargylic alcohol in preliminary ASA reactions (Chapter 2, Section 5) 
with ortho-isopropyl, chiral, benzylic tigylsilane (R)-3.33 (Scheme 3.11). 
 
Scheme 3.11: Preliminary ASA reactions with CD fragment bicyclic alcohol 3.32 
 
Though far from optimized, the preliminary results above served as a clear proof-of-concept that 
the ASA reaction conditions were indeed compatible with our revised CD fragment 3.32.  Upon 
isolation of silyl-ether 3.34, the ASA adduct was immediately subjected to our standard 
silylformylation / Tamao oxidation conditions (Scheme 3.12). 
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A) 1.2 equiv Silane, 24 hrs
B) 1.7 equiv Silane, 48 hrs A) 60% Yield, 5:1 dr












Scheme 3.12: Preliminary tandem silylformylation / Tamao oxidation sequence 
 
Following isolation of the major reaction products, we were delighted to find that the 
tandem silylformylation / Tamao oxidation sequence worked reasonably well, providing tandem 
sequence products 3.35 and 3.36 in about 60% combined yield.  Complex polyketide fragment 
3.35 was our desired tandem sequence product, so we were quite pleased to isolate it in 40% 
yield and >10:1 dr.  It was at first puzzling that compound 3.35 could be isolated in such high 
diastereopurity given that the starting material silyl-ether 3.34 was only a 5:1 dr mixture.  
However, considering the bias of the tandem silylformylation sequence to provide 1,5-anti diol 
products8 in addition to the increased steric bulk provided by the substituted bicyclic ketal in 
silyl-ether 3.34, one might assume that the minor diastereomer was unable to undergo the 
tiglylation event following silylformylation; thus, allowing for its ready removal from the desired 
reaction products during purification.  Generation of complex polyketide enone 3.36 could only 
have resulted from elimination of the desired keto-diol 3.35 (presumably during the Tamao 
oxidation), so its isolation still served to demonstrate that the majority of silyl-ether 3.34 
diastereomer successfully underwent the tandem silylformylation sequence. 
The exciting results depicted in Scheme 3.11 and Scheme 3.12 firmly convinced us that the 
ASA / tandem silylformylation / Tamao oxidation sequence could indeed serve as the key 





































of the preliminary key reactions shown above were only moderate, we felt that a full 
optimization of all the reaction conditions would best be reserved for the “real” coupling 
between the fully elaborated AB spiroketal and CD fragment.  As such, we next shifted our focus 
to the synthesis of the AB spiroketal for participation in our complete fragment coupling 
procedure.  
 
3.2 Synthesis of the AB Fragment and Attempted Anti-1,4-Hydrosilylation 
When considering the synthesis of the AB fragment of spongistatin 1, we attempted to 
design a convergent synthesis that would allow for rapid access to desired diene 3.37.  Our first 
generation retrosynthesis is shown below (Scheme 3.13).  This initial retrosynthetic strategy also 
relies on an aldol coupling for joining key subunits 3.39 and 3.40 and employs an enyne 
methathesis to generate diene 3.40 from alkyne 3.41.  The tertiary carbinol in subunit 3.41 would 
hopefully be set utilizing a novel, silane-mediated methallylation reaction that will be described 




Scheme 3.13: First generation retrosynthesis of AB spiroketal diene 3.37 
 
Our initial efforts directed toward the synthesis of subunit 3.42 attempted to parlay the 
scalable chemistry demonstrated in the beginning of Scheme 3.6 to our new synthetic target 
(Scheme 3.14).  Thus, we attempt to convert allyl epoxide (S)-3.22 to desired subunit 3.42 via a 
BF3•OEt2 mediated TMS-acetylene opening followed by a Wacker oxidation.  Though the 
































on this substrate afforded none of the desired product, seemingly due to functional group 
incompatibility with the electron-rich, internal alkyne. 
 
Scheme 3.14: First efforts toward the synthesis of AB fragment subunit 3.42 
 
In light of the failed Wacker oxidation shown in Scheme 3.14, we devised an alternative 
approach to AB fragment subunit 3.42 (Scheme 3.15).  In this new strategy, we again employed 
the epoxide opening/closing/opening sequence successfully utilized above, only this time adding 
an isopropenyl group to epichlorohydrin (R)-3.16, instead of an allyl group, to provide alkynol 
3.46 in large quantities.  1,1-disubstituted alkene 3.46 was then subjected to several ozonolysis 
conditions, but side-reactions with the electron rich TMS-alkyne again prevented the isolation of 
desired product 3.42.  Despite this setback, we eventually found compound 3.46 to be amenable 
to the operationally simple, one-pot oxidative cleavage conditions reported by Nicolaou,9 
providing desired AB fragment subunit 3.42 in excellent yields. 
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Scheme 3.15: Successful synthesis of AB fragment subunit 3.42 via oxidative cleavage 
 
 With a route to AB fragment subunit 3.42 firmly established, we next turned our attention 
to the proposed diasteresoselective methallylation of this β-hydroxy ketone.  Based on literature 
precedent from our research group, it was known that strained silanes could affect a tandem 
aldol-allylation sequence on aldehydes to produce tertiary carbinols (Scheme 3.16).10 
 
Scheme 3.16: Group precedence for tandem aldol-allyation chemistry 
 
It was our hope that a modification of this procedure could be applied to the synthesis of the AB 
spiroketal to potentially generate either intermediate 3.53 or intermediate 3.55 (Scheme 3.17). 
ClO
Isopropenyl Grignard, Et2O




KOH, 3 Å MS
100 °C
O

















1) Acetone:H2O 10:1, 3 h
2,6 Lutidine, NMO, OsO4 (2 mol%)
























Scheme 3.17: Syn selective generation of 1,3- tertiary carbinol using a pinacol-silane 
 
To probe the strategy laid out above, we first sought to synthesize methallyl-trichlorosilane 
3.56 and use it to generate pinacol-silane 3.50 (Scheme 3.18). 
 


























































Though the synthesis of pinacol-silane 3.50 depicted above was low yielding, it did serve 
to provide the desired reagent in multi-gram quantities.  Thus, using pinacol-silane 3.50 we 
screened several reaction temperatures in benzene to see if we could affect the desired 
diastereoselective, methallylation of β-hydroxy ketone 3.42.  To our great satisfaction, this 
reaction platform, which was originally only applicable to aldehydes,10 worked quite nicely on 
our β-hydroxy ketone substrate 3.42, presumably through the activation pathway depicted in 
Scheme 3.17.  As seen below, the best diastereoselectivities were obtained when the reaction was 
allowed to proceed slowly over 4 days at 40 °C (Scheme 3.19). 
 
Scheme 3.19:  Temperature screen for methallylation of β-keto alcohol 3.42  
 
Given our success with reagent 3.50 we opted to continue with our synthesis of the AB 
spiroketal fragment instead of pursuing the slightly more step-economical reaction with silane 
3.54 to directly generate ketone 3.55 (Scheme 3.17).  To access ketone 3.55, we subjected alkene 
3.53 to the oxidative cleavage conditions describe above (Scheme 3.15).9  Unfortunately, as 
observed in the case of δ-substituted hydroxy ketone 3.29 cyclizing to form lactol 3.30 (Scheme 
3.9), the desired δ-substituted hydroxy ketone could only be isolated as lactol 3.57 in moderate 
yields following the oxidation.  Incidentally, this result implies that the use of silane 3.54 to 
directly generate ketone 3.55 from alcohol 3.42 would likely have been unsuccessful.  To obviate 
this lactolization problem, we first bis-protected diol 3.53 with TESOTf and then proceeded with 
the oxidative cleavage of alkene 3.58.  This new protocol proceeded smoothly, providing ketone 














A) 60 °C, 1 d, 5.5:1 dr
B) 40 °C, 4 d, 9:1 dr




Scheme 3.20:  Accessing aldol coupling partner, keto-alkyne 3.59 
 
With potential aldol coupling partner 3.59 in hand, we shifted our efforts toward the 
generation of aldehyde 3.64 (Scheme 3.21).  As seen below, the synthesis once again began with 
the vinyl Grignard opening of enantioenriched epichlorohydrin (R)-3.16 to give allyl-alcohol 
(S)-3.21.  This primary chloride was displaced with NaCN to give nitrile 3.60 in good yield 
(Caution: it was critical to avoid an aqueous workup of this reaction to prevent the release of 
cyanide gas from any unreacted NaCN).  Nitrile 3.60 was then converted to methyl ester 3.62 
through a base mediated hydrolysis followed by methylation of the intermediate free acid 3.61.  
Alkene 3.63 was successfully obtained using an acid-mediated PMB protection using PMB-




1) Acetone:H2O 10:1, 3 h
2,6-Lutidine, NMO, OsO4 (2 mol%)












1) Acetone:H2O 10:1, 3 h
2,6-Lutidine, NMO, OsO4 (2 mol%)


















Scheme 3.21:  Accessing aldol coupling partner, aldehyde 3.64 
 
Our first attempt to couple ketone 3.59 and aldehyde 3.64 using a Mukaiyama aldol 
reaction was only met with moderate success (Scheme 3.22).  Complex polyketide fragment 3.66 
was obtained in 60% yield and 4:1 dr as the β-OPMB substituted aldehyde 3.64 controlled the 
approach of silyl-enol ether 3.65 to give the expected 1,3-anti addition product 3.66 as the major 
diastereomer.6  Since the 1,3-syn stereochemical relationship shown in compound 3.67 was 
desired, we hoped to simultaneously install the requisite acetate functionality as well as invert 
the carbinol stereocenter by using a Mitsunobu reaction procedure.11  Unfortunately, all efforts to 
employ the Mitusnobu reaction only resulted in elimination to the undesired enone 3.68, forcing 
us to reexamine our aldol coupling strategy. 
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Scheme 3.22:  Mukaiyama aldol followed by attempted Mitsunobu reaction 
 
Given that Mukaiyama aldol conditions gave the undesired stereochemical outcome at the 
newly formed carbinol center, we sought to explore closed transition-state, boron-enolate aldol 
chemistry in the hopes of directly obtaining the desired stereocenter shown in compound 3.70 
(Scheme 3.23). 
 













































































Though we did succeed in overturning the stereochemical outcome of the aldol coupling, as the 
results in Scheme 3.23 show, we only did so in moderate diastereoselectivity even when the β-
OPMB substituted aldehyde 3.64 was replaced with a β-OTES substituted aldehyde 3.71. 
 In light of these unsatisfactory results, we next attempted to employ a Paterson aldol 
protocol in the hopes that the chiral boron reagent would override any substrate preference in 
directing the stereochemical outcome of the coupling (Scheme 3.24).  Fortunately, this reaction 
did serve to provide compound 3.72 in 13:1 dr, though only in moderate yield following its 
acetylation and complete purification as compound 3.73. 
 
Scheme 3.24: Paterson aldol coupling to form acyclic AB fragment alkyne 3.73 
 
With reliable methods established to set all of the stereocenters in the AB fragment, we 
next worked to install the critical diene moiety necessary for the ultimate fragment coupling 
between the AB and CD spiroketals (Scheme 3.25).  Going back to TMS-alkyne 3.69, we 
screened several conditions to remove the TMS group and provide free alkyne 3.74.  Standard 
K2CO3/MeOH and TBAF/AcOH conditions were both found to be indiscriminant, causing 
unwanted deprotection of the TES ethers during the reaction.  A more exotic method utilizing 
AgNO3 in a mixture of protic solvents, however, proved to be quite effective, so long as a 
solution of sat. NH4Cl was added at the end of the reaction to precipitate out AgCl and protonate 






























3.74 proceeded in high yields due to the ruthenium catalyst’s ability to coordinate the 
homopropargylic heteroatom.12  Small amounts of dimerized diene products were observed (ca. 
5%) in addition to desired diene 3.75, but these could be effectively separated from the product 
through careful chromatographic purification. 
 
Scheme 3.25: Conversion of alkyne 3.69 to diene 3.75 via enyne metathesis 
 
With gram-quantities of keto-diene 3.75 in hand, we returned to our Paterson aldol subunit 
coupling reaction and were pleased to obtain similar results to those reported in Scheme 3.24 
(Scheme 3.26). 
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Our next objective was to affect the spiroketalization of acyclic precursor 3.77.  To that 
end, subjection of compound 3.77 to CSA/MeOH conditions, served to cleave all of the 
molecule’s silyl-ether bonds and effectively promoted spiroketalization to provide the 
thermodynamically preferred, doubly-anomeric spiroketal 3.78 in excellent yield (Scheme 3.27).  
The axial, tertiary alcohol of 3.78 was then reprotected using an excess of TESOTf to give key 
AB fragment intermediate 3.37 in good yield.  It should be noted that while this reaction was 
somewhat sluggish, attempts to subject alcohol 3.78 to more forcing protection conditions led to 
unwanted silylation of the acetate α to its carbonyl.  Several mild spiroketalization conditions 
were also screened in an attempt to spiroketalize acyclic compound 3.78 without removing the 
desired tertiary TES group.  Unfortunately, the best of these conditions (PPTS/EtOH, RT, 1 h) 
only provided spiroketal 3.79 in 66% yield and as a 1:3 mixture of diastereomers, with the 




Scheme 3.27: Spiroketalization to generate key AB fragment 3.37 
 
With AB spiroketal fragment 3.37 finally in hand, we eagerly subjected it to our optimized 
anti-1,4-hydrosilylation conditions (Chapter 2, Scheme 2.34) to begin the key ABCD fragment 
coupling procedure envisioned in Scheme 3.2.  To our deep dismay, none of the desired tiglic 
silane 3.81 could be isolated, despite numerous attempts to execute the hydrosilylation (Scheme 
3.28).  After running a battery of control experiments, it was eventually determined that the 
titanium mediated anti-1,4-hydrosilylation chemistry was incompatible with several Lewis-basic 
functional groups.  In particular, model esters such as 3.82 prevented the reaction entirely, 









































Scheme 3.28: Failed anti-1,4-hydrosilylation of AB fragment 3.37 
 
The distressing results shown above stuck a major blow to our hopes of attaining a high-
yielding and scalable fragment coupling sequence as first described in Chapter 1.  Though one 
might envision a synthetic strategy that allows for the masking of the offending ester 
functionalities in AB fragment 3.37, in order to allow for the use of the methodology developed 
in Chapter 2, we felt this would add an unacceptable level of inefficiency to what we hoped 
would ultimately be one of several streamlined fragment syntheses ultimately brought together to 
generate multi-gram quantities of spongistatin 1. 
Yet while the application of our proposed ASA / tandem silylformylation / Tamao 
oxidation fragment coupling strategy was fading into improbability, a potential solution to our 
fragment coupling conundrum was manifesting itself in the work of a Leighton group post-doc 
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Chapter 4: Methodology Work toward Intermolecular Fragment Coupling 
4.1 Developing a Fragment Coupling Procedure by Intermolecular Crotylation 
As described at the conclusion of Chapter 3, our intramolecular fragment coupling strategy 
for joining the AB and CD spiroketals of spongistatin 1 was facing some potentially 
irreconcilable difficulties.  Fortunately, the contemporary work of Dr. Hyunwoo Kim would 
prove to be the inspiration for a revised fragment coupling strategy (Scheme 4.1).1 
 
Scheme 4.1: Sc(OTf)3 mediated crotylation of hindered aldehydes 
 
As depicted above, Dr. Kim’s key insight was that the Leighton laboratory’s known 
allylation and crotylation reagents derived from diamine 4.12 could be activated with catalytic 
quantities of Sc(OTf)3, imbuing them with the reactivity required to selectively crotylate even the 
most sterically hindered and electronically deactivated classes of aldehydes.  Most notably, 
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provide complex polyketide fragment 4.5 in excellent yield, diastereoselectivity and 
enantioselectivity. 
Given the exciting results depicted in Scheme 4.1, we began to consider the possibility of 
attaining our scalable and efficient coupling of the AB and CD fragments of spongistatin 1 
through a similar Sc(OTf)3 catalyzed intermolecular crotylation / Tamao oxidation sequence 
depicted below (Scheme 4.2). 
 
Scheme 4.2: Proposed intermolecular crotylation / Tamao oxidation coupling 
 
In order to utilize this revised coupling strategy, however, a method for generating the 
angelic silane motif shown in compound (R,R)-4.6 would have to be identified.  The 
stereochemical rationale for the use of an angelic silane coupling partner in the intermolecular 
approach as opposed to the tiglic silane coupling partner formerly required in the intramolecular 
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Scheme 4.3: Stereochemical consequences of silane olefin geometry 
 
As can be seen in Scheme 4.3, generation of the desired 1,2-syn stereochemical outcome in 
compound 4.11 requires opposite olefin geometries in the “allyl” moiety depending on whether 
the transfer from silicon occurs intermolecularly or intramolecularly.  In the intramolecular case, 
the trans olefin geometry is required to deliver the 1,2-syn methyl relationship, since the 
allylation necessarily approaches the tethered RCD portion of the aldehyde (transition state 4.10).  
For the intermolecular case, the cis olefin geometry is required to deliver the 1,2-syn methyl 
relationship, since the RCD portion of the aldehyde can achieve the equatorial orientation shown 
in transition state 4.13. 
 Fortunately, unlike the synthesis of tiglic silanes (Chapter 2, Section 4), the synthesis of 
angelic silanes is well precedented, with several 1,4-hydrosilyaltion reactions known to give the 
desired product motif.3  Selecting Tsuji’s syn-1,4-hydrosilylation of dienes with trichlorosilane3b 
as our desired reaction platform, we first sought to determine this transformation’s functional 
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chemistry previously described (Chapter 2, Section 4 and the conclusion of Chapter 3).  To that 
end, we ran several control experiments shown below (Scheme 4.4). 
 
Scheme 4.4: Functional group compatibility with syn-1,4-hydrosilylation reaction 
 
The conversion of isoprene 4.14 to trichlorosilane 4.15 was simply a reproduction of 
Tsuji’s extraordinarily efficient and selective hydrosilylation chemistry.3b  Following that first 
control experiment, several dienes of type 4.17 were synthesized to probe the functional group 
compatibility of the syn-1,4-hydrosilylation.  After some experimentation, it was found that this 
reaction manifold was completely compatible with esters and carbonates to provide products 
such as 4.19.  These results gave us hope that the syn-1,4-hydrosilylation protocol could be 
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moieties.  However, the syn-1,4-hydrosilylation functional group was found to be wholly 
incompatible with silyl ethers, as subjection of diene 4.20 led to deprotection and subsequent 
decomposition of the resulting alcohol.  Though not ideal, this silyl-ether incompatibility was an 
inconvenience we felt we could design our AB fragment synthesis around.  Thus, with the 
functional group compatibility of this syn-1,4-hydrosilylation procedure established, we 
continued our exploration of the proposed intermolecular coupling reaction in a simple model 
system. 
 Our first task in designing a model system for the intramolecular fragment coupling of the 
AB and CD fragments of spongistatin 1 was to generate an appropriate surrogate for CD 
silacycle-aldehyde 4.7 (Scheme 4.2).  This proved to be reasonably straightforward (Scheme 
4.5), as we once again employed Jacobsen’s HKR to generate enantioenriched 1,2-epoxyhexane 
(S)-4.224 and used a BF3•THF-mediated propyne opening reaction to generate homopropargylic 
alcohol 4.23 in excellent yield.  This alcohol 4.23 was then protected with chlorodiphenylsilane 
and immediately subjected to silylformylation conditions that successfully provided model 
silacycle-aldehyde 4.25 in excellent yield. 
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With model aldehyde 4.25 in hand, we next set up the intermolecular fragment coupling 
procedure using angelic-trichlorosilane 4.19 complexed with diamine (R,R)-4.1 to form (R,R)-
4.26 (Scheme 4.6) as a surrogate for AB coupling partner (R,R)-4.6 (Scheme 4.2). 
 
Scheme 4.6: Fragment coupling by crotylation / Tamao oxidation – Model System 
 
The results depicted above were very exciting in the sense that coupled complex polyketide 
fragment 4.27 was successfully isolated in excellent yield over the 2 step sequence.  This 
constituted the first example of fragment coupling by crotylation mediated by the Leighton 
group’s chiral diamine ligand 4.1 in conjunction with catalytic quantities of Sc(OTf)3.  Yet much 
to our surprise, though compound 4.27 was obtained in high yield, it was only isolated as a 2:1 
mixture of diastereomers under our standard Tamao oxidation conditions.5  Because our standard 
protic Tamao conditions provided high diastereoselectivity in both our tandem silylformylation / 
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80% Yield over 3 Steps




4.1), we felt that its unexpected failure in this intermolecular fragment coupling sequence 
merited an in-depth analysis. 
 It seemed that the main difference between the highly selective crotylation / Tamao 
oxidation sequence shown in Scheme 4.1 and the failure to achieve high diastereoselectivity in 
the intermolecular fragment coupling sequence shown in Scheme 4.6 was the substitution at the 
2 position of the allyl transfer moiety (i.e. the angelic position).  As such, we sought to generate a 
sample set of complexed silanes with varying substitution patterns at the 2 position in order to 
determine their impact on the Tamao oxidation selectivity.  The results of these experiments are 
summarized below (Scheme 4.7). 
 
























1) 5 mol % Sc(OTf)3
CH2Cl2, 0 °C, 1 hr
2) KF, H2O2
1:1 THF:MeOH(R,R)-4.26
80% Yield over 3 Steps

























1) 5 mol % Sc(OTf)3
CH2Cl2, 0 °C, 1 hr
2) KF, H2O2
1:1 THF:MeOH(R,R)-4.32 75% Yield over 3 Steps

























1) 5 mol % Sc(OTf)3
CH2Cl2, 0 °C, 1 hr
2) KF, H2O2
1:1 THF:MeOH(R,R)-4.30 74% Yield over 3 Steps























1) 5 mol % Sc(OTf)3
CH2Cl2, 0 °C, 1 hr
2) KF, H2O2
1:1 THF:MeOH(R,R)-4.28 75% Yield over 3 Steps




As can be seen in the scheme above, the larger the substituent at the 2 position, the worse the 
Tamao oxidation selectivity became.  This remote steric effect was very disheartening as the 
envisioned angelication coupling partner (R,R)-4.6 would necessarily be substituted with the 
entire AB spiroketal at the 2 position.  Given this requirement, it became critical for us to 
identify alternative Tamao oxidation conditions that would restore the reaction’s 
diastereoselectivity if we were to succeed in utilizing our revised fragment coupling strategy to 
synthesize the ABCD hemisphere of spongistatin 1. 
Fortunately, the Tamao oxidation is an extremely well investigated transformation, and 
there were a myriad of conditions to be examined.6  A summary of our extensive exploration is 
represented in Table 4.1 below. 
 
  R Solvent Peroxide Additive Time (Temp)  dr / Elim. 
1) -OAc THF/MeOH 13x H2O2 4x KF 1 h (RT) 2:1 / >6:1 
              
2) H THF/MeOH 13x H2O2 4x KF 1 h (RT) 6:1 / >6:1 
              
3) -OBn THF/MeOH 13x H2O2 4x KF 1 h (RT) 2.5:1 / 5:1 
 
4) -OBn THF/MeOH 13x H2O2 4x TBAF 3 h (RT) 1:1/None 
 
5) -OBn DMF m-CPBA 4x KF 20 h (RT) Mess 
 
6) -OBn DMF 13x H2O2 4x KHF2 20 h (RT) 1.3:1 / 2:1 
 
7) -OBn DMF 13x H2O2 Ac2O/KHF2 20 h (RT) Mess 
 
8) -OBn THF/MeOH 13x H2O2 13x KHCO3 <20 h (RT) 5:1 / 2:1 
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12) Me THF/MeOH 13x H2O2 1x KHCO3 4 h (RT) 10:1 / 2:1 
 
13) Me THF/MeOH 13x H2O2 0.2x KHCO3 8 hr (RT) 8:1 / 2.4:1 
 












2 days (RT) 
 
6:1 / 2.8:1 
 










1 x K3PO4 
 
30 min (RT) 
 
6:1 / 2.3:1 
 
18) Me MeOH 13x H2O2 1x K2HPO4 1.5 h (RT) 5:1 / 1.3:1 
 
19) Me THF/MeOH 13x H2O2 1x Hunig's 8 h (RT) 8:1 / 2.3:1 
 
20) Me THF/MeOH 13x H2O2 13x KOH 10 min (RT) All Elim 
              
 
21) Me THF/MeOH 13x H2O2  AcOH/TBAF 24 h (RT) 1.5:1/None  
 
22) Me THF/MeOH 13x H2O2 4x HF•Pyr 24 h (RT) Minimal Rxn 
              
23) Me THF/MeOH 13x H2O2 4x KF 1.5 h (RT) 3:1 / 3:1 
 
24) Me THF/MeOH 13x H2O2 4x KHF2 24 h (RT) Minimal Rxn 
 
25) Me THF/MeOH 13x H2O2 4x CsF 10 min (RT) 4:1 / 4:1 
 
26) Me THF/MeOH 13x H2O2 4x CsF 1.5 h (0°C) 4:1 / 6:1 
              
 
27) Me THF/iPrOH 13x H2O2 CsF 24 h (RT) 5:1 / 20:1 
 
28) Me iPrOH 13x H2O2 CsF 1.5 h (RT) 5:1 / 20:1 
 
29) Me iPrOH 13x H2O2 KF <10 h (RT) 5:1 / 7:1 
              
30) Me iPrOH 13x H2O2 1x KHCO3 <10 h (RT) 10:1 / 8:1 
 
31) Me iPrOH 13x H2O2 1x KHCO3 5 h (RT) 10:1 / 8:1 
 
32) -OBn iPrOH 13x H2O2 1x KHCO3 24 h (RT) 8:1 / 8:1 
 
Table 4.1: Optimization of Tamao oxidation reaction conditions 
Table Notes: -OAc and -OBn indicate CH2CH2OAc and CH2CH2OBn, respectively. 




As can be seen in the above table, utilization of mild base mediated Tamao conditions, instead of 
fluoride, as well as switching to isopropanol as a solvent system led to improved 
diastereoselectivities of coupled product 4.35 while minimizing unwanted elimination to side-
product 4.36.  The best results (Entries 31 and 32) are shown below with their isolated yields 
(Scheme 4.8). 
 
Scheme 4.8: Optimized Tamao oxidation following fragment coupling by crotylation 
 
With the diastereoselectivity of the Tamao oxidation restored, our model system results 
gave us confidence that our revised, intermolecular fragment coupling strategy could indeed be 
employed to bring the fully elaborated AB and CD spiroketals together while simultaneously 
installing the full stereochemical array depicted in compound 4.8 (Scheme 4.2). 
 
4.2 Fragment Coupling by Crotylation - Staged by Asymmetric Isoprenylation  
Given the exciting results achieved in our fragment coupling model systems (Scheme 4.8), 
we felt it was important to divert some attention away from the total synthesis of spongistatin 1 
























1) 5 mol % Sc(OTf)3
CH2Cl2, 0 °C, 1 hr
2) KHCO3, H2O2
iPrOH, 24 h, RT(R,R)-4.32 73% Yield over 3 Steps

























1) 5 mol % Sc(OTf)3
CH2Cl2, 0 °C, 1 hr
2) KHCO3, H2O2
iPrOH, 24 h, RT(R,R)-4.30 62% Yield over 3 Steps




Since not all alkyne substrates are amenable to enyne metathesis, we sought to develop a more 
general method for installing the diene functionality required for our fragment coupling by 
crotylation procedure. 
When considering various strategies for installing a diene moiety in the context of 
polyketide total synthesis, we thought that the asymmetric isoprenylation of aldehydes would be 
a useful approach, as it would additionally serve to set a carbinol stereocenter.  Though two 
distinct methods for the enantioselective isoprenylation of aldehydes are known,7 neither of them 
posses the scope, practicality and scalability we hoped to achieve in a general fragment coupling 
method.  This being the case, we sought to extend our robust, strained silane reaction platform1 
to this new synthetic application.  In practice, it seemed that if we could generate strained silane 
reagent 4.37 from isoprenyl-trichlorosilane 4.38 we would be well on our way toward achieving 
our goal (Scheme 4.9).  All efforts to synthesize reagent precursor 4.38 by directly metallating 
isoprene 4.398 and reacting it with tetrachlorosilane were met with significant purification 
difficulties. After some experimentation, however, a scalable, two-step approach was developed 




Scheme 4.9: Synthesis of isopenyl-trichlorosilane 4.38 
 
With multi-gram quantities of trichlorosilane 4.38 in hand, we next performed a large scale 
complexation reaction with diamine (R,R)-4.1 to generate desired reagent (R,R)-4.37 (~80% 
yield, 80g).  This reagent was stored as a stock solution in CH2Cl2 for use in a variety of 
isoprenylation reactions (Scheme 4.10).  To our great satisfaction, our new stained silane 
isoprenylation reagent (R,R)-4.37 provided the desired diene products in high yield and high 












b.p. = 95 °C / 65 mm Hg
83% Yield, 29g




















Scheme 4.10: Enantioselective isoprenylation of aldehydes with strained silane 4.37 
 
Given the successful application of our new reagent (R,R)-4.37 on a variety of simple 
aldehydes, we sought to test its efficacy on a more complex, chiral aldehyde of the type likely to 
be encountered in polyketide synthesis.  Thus, we embarked on the synthesis of chiral aldehyde 
4.53 beginning with an enantioselective syn-crotylation of hydrocinnamaldehyde 4.42 using our 
known silane reagent (R,R)-4.50.  The product of this reaction, alcohol 4.51, was subsequently 






















1) 5 mol % Sc(OTf)3





























Scheme 4.11: Synthesis and successful isoprenylation of chiral aldehyde 4.53 
 
Following the subjection of chiral aldehyde 4.53 to our new isoprenylation reagent (R,R)-4.37, 
we were pleased to isolate diol 4.54, following an exhaustive TBAF work-up, in good yield and 
excellent diastereoselectivity as shown above. 
 With ready access to a variety of relevant diene-polyketide fragments now possible, our 
next goal was to demonstrate their viability in our intermolecular fragment coupling by 
crotylation method.  Acetylation of dienes 4.43 and 4.54 provided fragment coupling precursors 
4.55 and 4.58.  These dienes were subjected to the syn-1,4-hydrosilylation and diamine 
complexation conditions described in Scheme 4.4 and Scheme 4.6 to give angelic silane coupling 






1) 5 mol % Sc(OTf)3
























2) 1.3 equiv PPh3











1) 5 mol % Sc(OTf)3
CH2Cl2, 0 °C, 1 hr
















Scheme 4.12: Generation of angelic silane fragment coupling partners 
 
 The angelic silanes generated in Scheme 4.12 were immediately reacted with aldehyde 
coupling partners 4.42 and 4.53 to complete the fragment coupling procedure (Scheme 4.13).  
The products of these reactions were worked up with excess TBAF to provide the corresponding 
complex polyketide fragment products.  To our delight, this general procedure worked quite 
well, providing complex polyketide fragments in 73-79% overall yield (3 step yield from starting 
dienes 4.55 and 4.58).  Also, the procedure was amenable to using the isoprenylation reagent’s 
opposite enantiomer (S,S)-4.57 to provide complex polyketide fragment 4.63 in excellent overall 

































































Scheme 4.13: Fragment coupling by crotylation as a general method 
 
The final application of our newly established fragment coupling by crotylation procedure 
was to use it to crotylate a silacycle aldehyde of type 4.7 followed by our optimized Tamao 
oxidation to provide the polyketide array highlighted in structure 4.8 (Scheme 4.2).  Thus, 
acetate 4.58 was converted to angelic silane (R,R)-4.60 (Scheme 4.12) and reacted with 
silacycle-aldehyde 4.25 (Scheme 4.14).  Pleasingly, we were able to isolate silacycle product 





















1) 10 mol % Sc(OTf)3
CH2Cl2, 0 °C, 2 h






1) 10 mol % Sc(OTf)3
CH2Cl2, 0 °C, 2 h




















1) 10 mol % Sc(OTf)3
CH2Cl2, 0 °C, 2 h




















1) 10 mol % Sc(OTf)3
CH2Cl2, 0 °C, 2 h
















1) 10 mol % Sc(OTf)3
CH2Cl2, 0 °C, 2 h










































This silacycle 4.66 was then subjected to our optimized Tamao oxidation conditions (Scheme 
4.8) to gratifyingly provide complex polyketide fragment 4.67 in 73% yield and 5:1 overall dr.  
(Note: Sterochemical proofs verifying the newly formed stereocenters are included in the 
experimtental section for Chapter 4). 
 
Scheme 4.14: Fragment coupling by crotylation / Tamao oxidation sequence 
 
With our intermolecular fragment coupling by crotylation / Tamao oxidation strategy 
successfully showcased on the model substrates shown above, we eagerly looked forward to 
applying this method to the fully elaborated AB and CD fragments of spongistatin 1.  Work 
























1) 10 mol % Sc(OTf)3
CH2Cl2, 0 °C, 2 hr
2) 1 equiv TBAF•3H2O
0 °C - RT, 16 h































5:1 dr from Tamao
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Chapter 5: Large Scale Synthesis of AB Fragment and ABCD Coupling 
5.1 The Scalable Synthesis of AB Fragment Spiroketal-Diene 
Confident that our intermolecular fragment coupling by crotylation / Tamao oxidation 
sequence described in Chapter 4 could be employed to join the AB and CD fragments of 
spongistatin 1, we next embarked on the development of a truly scalable synthesis of the AB 
fragment of spongistatin 1.  Though a first generation synthesis of the AB fragment had already 
been established (Chapter 3, Section 2), the advent of our enantioselective isoprenylation 
methodology (Chapter 4, Section 2) inspired the more concise retrosynthesis of the AB 
spiroketal-diene 5.1 shown below (Scheme 5.1). 
 













































As depicted above, our retrosynthesis takes advantage of the doubly-anomeric nature of the AB 
spiroketal 5.1 by concluding with an acid-mediated, thermodynamically controlled 
spiroketalization of acyclic diene 5.2. We proposed that diene 5.2 would arise from the 
implementation of our asymmetric isoprenylation reaction on an aldehyde 5.3 and that aldehyde 
5.3 would be formed through a convergent aldol coupling of aldehyde subunit 5.4 and densely 
functionalized ketone 5.5.  The chirality of these key subunits could potentially be set through 
the use of an enantioselective hydrogenation and an enantioselective allylation procedure, which 
will be described below. 
 When considering the synthesis of tertiary alcohol 5.5, it came to our attention that there 
were no direct methods to obtain it through the enantioselective allylation of acetylacetone 5.7, 
as proposed in Scheme 5.1.  This seemed to be a consequence of the fact that the vast majority of 
known enantioselective ketone allylation strategies are only effective on aryl ketone substrates.1  
Furthermore, even if the most promising of these allylation strategies1f were found to be 
amenable to our particular substrate, in order to obtain the desired product in high-yield, one of 
the ketone moieties in acetylacetone 5.5 would have to be selectively protected and then revealed 
following the allylation procedure. 
Given our unwavering commitment to the development of an expedient and scalable 
synthesis to access large quantities of the AB spiroketal 5.1, this multi-step work-around for the 
enantioselective allylation of acetylacetone was deemed unacceptable.  As such, we considered a 
novel application of our strained silane reagents2 in the context of β-diketone allylation.  Though 
our strained silane reagents were known to be wholly incapable of allylating ketones, even in the 
presence of Sc(OTf)3, we thought that the latent nature of β-diketones to exist as their enol 




Scheme 5.2: Seminal enantioselective allylation of β-diketones 
 
To our delight, our proposed application of strained silane (S,S)-5.8 to the enantioselective 
allylation of acetylacetone 5.7 worked exceedingly well.  As depicted in our mechanistic scheme 
above, we believe that the enol form of acetylacetone 5.10 initially reacts with chlorosilane 
(S,S)-5.8 to generate a local equivalent of HCl.  As seen in other applications of the Leighton 
laboratory’s silane reagents,3 protonation by Br∅nsted acid strongly augments the electrophilicity 
of the strained silanes.  Given that silane (S,S)-5.8 was tethered to acetylacetone 5.10 in the form 
of a vinylogous silyl-ester 5.11, the intramolecular proximity of the otherwise unreactive 
carbonyl allows for the enantioselective allylation event to occur.  In-depth mechanistic 
elucidation, expansion of the substrate scope to unsymmetrical β-diketones, and extension of this 
reaction platform to enantioselective crotylations have been dutifully and beautifully achieved 
through the tireless work of Dr. Wesley Chalifoux.  The culmination of these studies has resulted 




























1) CH2Cl2, RT, 1.2 equiv (S,S)-5.8 









For the purposes of our scalable synthesis of the AB fragment of spongistatin 1, we felt it 
was important to develop conditions under which chiral diamine (S,S)-5.13 could be recovered 
following the enantioselective allylation of acetylacetone 5.7 (Scheme 5.3).  To this end, we 
developed a sequential TBAF/HCl work-up that allowed for the isolation of alcohol 5.9 in good 
yield and facilitated excellent recovery of the chiral diamine (S,S)-5.13.  Tertiary alcohol 5.9 was 
then TES protected to afford ketone 5.14 in excellent yield. 
 
Scheme 5.3: Large-scale access to ketone subunit 5.14 
 
With large quantities of ketone 5.14 in hand, we turned our attention to the scalable 
synthesis of subunit 5.6 (Scheme 5.1).  Before beginning this task, we first had to select an 
appropriate protecting group for the ester functionality that could be carried through the ABCD 
fragment coupling sequence.  A survey of the spongistatin literature5 indicated that the alloc 
group would be most amenable to late-stage deprotection,6 but considering that our key fragment 
coupling by crotylation procedure required a palladium(0) mediated 1,4-hydroslilylation 
(Chapter 4, Section 1), we worried that this protecting group would not survive.  This fear was 
confirmed in model study experiments, which led us to ultimately select the TMSE protecting 




O 1) CHCl3, RT, 4 hrs
2) 1.2 equiv TBAF•3H2O











9.3g / 65 mmol 92% Recovered
58g / 110 mmol
10g /100 mmol











O Me OH CH2Cl2, -78 °C




9.3g / 65 mmol 97% Yield





Scheme 5.4: Protecting group screen under 1,4-hydrosilylation conditions 
 
Once we had selected an appropriate ester protecting group, we sought to synthesize β-keto 
ester 5.24 (Scheme 5.5).  Our first efforts toward this synthetic goal centered on using a Claisen-
type reaction between chloroformate 5.22 and ketone 5.23 to access the desired β-keto ester 5.24.  
This proved to be unsuccessful under a variety of conditions.  We also attempted to augment the 
overall functional group reactivity in the Claisen-type reaction by replacing substrates 5.22 and 
5.23 with ester 5.25 and acyl chloride 5.26, respectively.  This method did provide some of the 
desired product, albeit in unacceptably low yields.  Next, we attempted to access β-keto ester 
5.24 through a successive aldol coupling between ketone 5.25 and aldehyde 5.27 followed by 
oxidation.  Though this method worked to some degree, the results of these experiments were 
both low yielding and irreproducible.  Finally, we attempted a bis-acetylation of TMS-ethanol 
followed by a dianionic BOM-Cl alkylation7 of the resulting β-keto ester 5.29 to obtain desired 
product 5.24.  This two-step sequence worked in good yield and was quite amenable to large-
+ H-SiCl3
1 mol% Pd(PPh3)4
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HO PO
1) 5% Hoveyda-Grubbs II
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scale production as shown below (Note: the 1 M HCl work-up of compound 5.29 was critical to 
preventing its rearrangement to an unknown side-product). 
 
Scheme 5.5: Large-scale bis-acetylation and alkylation to give β-keto ester 5.24 
 
The conversion of β-keto ester 5.24 to alcohol subunit 5.32 proceeded smoothly over a 
three-step operation, only requiring chromatography at the conclusion of the sequence (Scheme 
5.6).  β-keto ester 5.24 successfully underwent Noyori hydrogenation to establish the alcohol 
stereocenter in 96% ee.8  Though this reaction was performed under typical hydrogenation 
conditions, it was found that the use of 1:1 THF:MeOH mixed solvent system was critical for 
clean conversion to product.  Alcohol 5.30 was readily TES protected to give compound 5.31, 
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2 equiv LHMDS
4) 1 equiv AcCl






22g / 185 mmol bp = 15 mm Hg / 113 °C
1) 1 equiv LHMDS
   -78 °C, THF (1.0 M)






1) 1.05 equiv NaH, THF, 0 °C
2) 1.1 equiv n-BuLi, -78 °C
3) 1.0 equiv BOM-Cl






30g / 147 mmol 65% Yield / 86% BRSM
31g / 96 mmol
83% Yield 




















































excellent overall yield.  It is worth noting, however, that the rate of debenzylation was greatly 
dependent on the quality of the Pd(OH)2 employed, requiring anywhere from 1.5-6 h.  The 
reaction progress was carefully monitored and stopped before significant hydrogenative cleavage 
of the TES-ether could occur.9  (Note: Due to these inconsistent reaction times, a continued 
search for a reliable combination of reaction solvent and palladium source is recommended). 
 
Scheme 5.6: Large-scale hydrogenations used to access alcohol 5.32 
 
With ketone subunit 5.14 and alcohol subunit 5.32 in hand, we sought to bring these 
compounds together through a Paterson aldol reaction (Scheme 5.7).  First, alcohol 5.32 was 
oxidized to aldehyde 5.33 using Swern oxidation conditions.  The crude aldehyde 5.33 was 
filtered over a pad of pH 7 buffered SiO2 gel and taken on to the Paterson aldol reaction without 
further purification.  The Paterson aldol proceeded smoothly to provide desired coupled fragment 
5.34 in high overall diastereoselectivity.  Though this product was difficult to separate from the 
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Ca. 42g / Ca. 96 mmol 72% Yield over 3 Steps












for the straightforward purification of acetate 5.35 by column chromatography.  The entire three-
step sequence was highly efficient, providing acetate 5.35 in 72% overall yield on large-scale. 
 
Scheme 5.7: Large-scale Paterson aldol providing access to alkene 5.35 
 
After producing large quantities of alkene 5.35 we next converted it to desired aldehyde 
5.36 through the use of an ozonolysis procedure followed by a PPh3-mediated reduction of the 
resulting ozonide.  Though we found aldehyde 5.36 to be sensitive to purification by SiO2 gel 
chromatography, we were able to isolate the desired compound in acceptable purity by triturating 
out the unwanted phosphines from a solution of hexanes.  (Note: Small amounts of leftover 
phosphines exhibited no deleterious effects on the subsequent chemistry).  With aldehyde 5.36 
finally in hand, we subjected it to the asymmetric isoprenylation reagent (R,R)-5.37 developed in 
Chapter 4, Section 2 (Scheme 4.10).  Gratifyingly, the isoprenylation procedure worked quite 
well on this highly functionalized polyketide fragment, providing lactol 5.38 following a mild 
TBAF•3H2O work up and filtration over a plug of SiO2 gel to remove the chiral diamine 
(Scheme 5.8).  This lactol 5.38 was taken on without further purification to the acid-mediated 
Me
O OTESMe
1) (-)Ipc2BCl, Et3N, 0 °C
2)  -78 °C, Aldehyde 5.33
3) H2O2 in MeOH / pH 7






















11g / 33 mmol
72% Yield over 3 Steps
15.1 g Pdt / 23.4 mmol
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spiroketalization, which pleasingly cleaved both of the silyl-ethers in the molecule and provided 
the doubly-anomeric AB-spiroketal 5.39 as a single isolable diastereomer in 66% yield over the 
three-step sequence. 
 
Scheme 5.8: Large-scale diastereoselective isoprenylation and spiroketalization  
 
Since none of the intermediates on our route were crystalline solids that could be readily 
submitted for X-ray analysis, we paused at this point to run a battery of COSY and nOe 
experiments on AB-spiroketal 5.39 in order to confirm the molecule’s relative stereochemical 
configuration.  To our satisfaction, all of the pertinent nOe relationships were observed (Scheme 
5.9).   Furthermore, if we are to assume that the absolute stereochemical induction of the well 
precedented Noyori hydrogenation8 held true for the generation of alcohol 5.30, then this nOe 
analysis served to confirm the correct absolute stereochemical configuration of AB-spiroketal 







1) O3, -78 °C , CH2Cl2
2) 1.2 equiv PPh3






1) 5 mol% Sc(OTf)3
CH2Cl2, 0 °C, 2 h
2) 1.1 equiv
TBAF•3H2O
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Ca. 22g / Ca. 31 mmol
5.38
5.38
66% Yield over 3 Steps





Scheme 5.9: nOe correlations assigning all stereocenters in AB spiroketal 5.39 
 
 With the relative stereochemistry of AB-spiroketal diene 5.39 fully established, it was 
nearly time to test the AB fragment in the key intermolecular fragment coupling sequence.  All 
that remained was the protection of the free, tertiary alcohol in compound 5.39.  Though we had 
previously been able to TES protect this position with TESOTf (Chapter 3, Section 2, Scheme 
3.27) we also knew from control studies performed in Chapter 4, Section 1 (Scheme 4.4) that 
silyl-ethers were not compatible with the upcoming syn-1,4-hydrosilylation procedure.  Thus, we 
embarked on a lengthy search for a suitable protecting group that would satisfy all our synthetic 




















Table 5.1: Protecting group screen for hindered, axial 3° alcohol 5.39 
 
As seen in the table above, due to the extraordinarily hindered stereochemical environment 
surrounding the axial, tertiary alcohol position of spiroketal 3.59, very few functional groups 
were amenable to its protection.  Though we were able to affect its protection using acetetic 
anhydride in conjunction with a somewhat exotic InCl3 catalyzed procedure,10 it was not clear 
how we would selectively deprotect this group in the presence of spongistatin 1’s secondary 
acetate on the A ring.  Trichloroacetic anhydride turned out to provide reasonable protection of 
alcohol 3.59 (ca. 75% yield), but it was later found to be incompatible with the 1,4-
hydrosilylation procedure.  Somewhat surprisingly, trifluoracetic anhydride (TFAA) was 























































trifluoroacetate 5.41 in nearly quantitative yields (Scheme 5.10).  The TFA ester was remarkably 
stable on our molecule, including its ability to survive the 1,4-hydrosilylation reaction, 
presumably as a consequence of its extremely congested steric environment and short bond-
lengths.  Furthermore, it was found after some experimentation that the TFA ester could be 
mildly and selectively cleaved by stirring compound 5.41 in a concentrated solution of NH3 in 
ethanol. 
 
Scheme 5.10: Trifluoroacetate as a suitable protecting group for 3° alcohol 3.59 
 
With the full elaboration of the AB fragment spiroketal-diene 5.41 complete, it is worth 
taking a moment to comment on the remarkable scalability of the synthetic route described in 
this section.  As has been noted throughout the schemes, every reaction in this sequence has been 
performed on greater than a 10g scale (and often greater than a 20g scale) while still giving high 
yields of product. The longest linear sequence for the entire AB fragment is 12 steps with only 
14 total steps required for the entire sequence.  The overall yield of the elaborated AB fragment 
synthesis is 17.9% (23.7% BRSM).  Furthermore, the number of chromatographies in the 
sequence has been minimized to just 5 full chromatographic purifications.  This last 
accomplishment has greatly facilitated the large-scale execution of the route, resulting in the 
ability for a single chemist to readily synthesize over 34.5g of the complete AB fragment 5.41 in 























16g / 28 mmol
2.0 M NH3
EtOH, RT, 24 h94% Yield(Deprotection)
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synthetic efforts of this author have resulted in the generation of 43.5g of the AB fragment, a 
picture of which is included below (     Figure 5.1). 
 
     Figure 5.1: Over 40g of the fully elaborated AB fragment of spongistatin 1 
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5.2 Key Coupling Reaction and Final Elaboration of the ABCD Hemisphere 
Given the unexpected failure of our previous intramolecular coupling strategy at the end of 
Chapter 3, we approached the intermolecular coupling of the fully elaborated AB and CD 
fragments with some trepidation.  Thanks to the diligent work of Dr. Ryan Shade, several grams 
of the PMB protected CD fragment bicycle 5.42 (Chapter 3, Section 1) were available for 
immediate use with the large stockpile of AB fragment diene 5.41 generated above.  
 The first task required for the intermolecular coupling sequence was the conversion of 
PMB protected CD fragment bicycle 5.42 to silacycle-aldehyde 5.44 (Scheme 5.11).  This 
sequence proceeded smoothly, efficiently providing compound 5.44.  Due to the sensitivity of 
the silacycle-aldehyde moiety to purification by SiO2 gel chromatography, compound 5.44 was 
taken on to the key coupling reaction without purification. 
 
Scheme 5.11:  Preparation of CD silacycle-aldehyde fragment coupling partner 5.44 
 
At this point, AB spiroketal diene 5.41 was converted to angelic silane (R,R)-5.46 
according to the method developed in Chapter 4, Section 1 (Scheme 5.12).  Pleasingly, this 
operation proceeded smoothly on the fully functionalized AB spiroketal, efficiently providing 
silane (R,R)-5.46, which was also taken on to the key coupling without purification. 
DDQ (pH 7 Buffer)
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2) 1 mol% Rh(acac)(CO)2

















Scheme 5.12: Preparation of angelic-silane coupling partner (R,R)-5.46 
 
Now that coupling partners 5.44 and (R,R)-5.46 had been fully prepared, the stage was set 
to attempt our key intermolecular fragment coupling by crotylation / Tamao oxidation sequence 
with the aim of uniting the ABCD hemisphere of spongistatin 1.  Thus, we reacted angelic-silane 
(R,R)-5.46 with silacycle-aldehyde 5.44 in the presence of catalytic Sc(OTf)3 and utilized our 
mild TBAF•3H2O conditions to work up the reaction (Scheme 5.13).  To our unparalleled 
delight, the key fragment coupling worked as envisioned, providing the coupled ABCD 
hemisphere silacycle 5.47 in 55% yield over the three-step sequence from diene 5.41. The 
efficiency of this fragment coupling averages to over 80% yield per step, a remarkable 
achievement considering the complexity of the fragment coupling substrates involved and the 
number of chemical manipulations successfully achieved.  It is worth noting that a significant 
amount of unreacted silacycle-aldehyde 5.44 was recovered during the reaction purification (ca. 
30%), indicating that the conversion of diene 5.41 to angelic-silane (R,R)-5.46 was the limiting 
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that this reaction was performed on the gram-scale (1.3g / 1.1 mmol of coupled ABCD fragment 
was isolated), effectively demonstrating the transformation’s general robustness and potential for 
use in a muli-gram synthesis of spongistatin 1.     
 
Scheme 5.13: Intermolecular ABCD fragment coupling by crotylation 
 
With successfully coupled ABCD silacycle 5.47 in hand, we next subjected it to our 
optimized Tamao oxidation conditions described in Chapter 4, Section 1 and shown in Scheme 
5.14 below.  As was expected, the large steric bulk of the AB spiroketal had a detrimental effect 
on the diastereoselectivity of our protic Tamao oxidation (4:1 dr).  Despite this result, we were 
still able to generate compound 5.48 in good overall yield, fully establishing the highly 
functionalized polyketide array that bridges the AB and CD spiroketals of spongistatin 1.  










































55% Yield over 3 Steps from 5.41
30% Recovered Aldehyde 5.44
5.47
1) 10 mol% Sc(OTf)3
     CH2Cl2, 0 °C, 2 h
2) 1.0 equiv TBAF•3H2O





cleanly isolate the desired diastereomer of compound 5.48 through careful chromatographic 
purification. 
 
Scheme 5.14: Tamao oxidation to establish complex ABCD polyketide array 
 
Having successfully employed our fragment coupling by crotylation / Tamao oxidation 
sequence to join the AB and CD fragments of spongistatin 1, all that remained in our synthesis 
was the formation of the CD spiroketal and final elaboration of the ABCD fragment.  
Unfortunately, a cursory screen of potential Lewis and Br∅nsted acids gave us little hope of 
kinetically setting the desired “non-anomeric” CD spiroketal;11 the doubly-anomeric CD 
spiroketal was consistently isolated in a ratio ranging from 3:1 dr using HF•H2O to 8:1 dr using 
CSA.  However, since the Smith group had already demonstrated the ability to reequilibrate the 
C(23) center of spongistatin 1 to the desired anomer using HClO4/Ca(ClO4)2 once the entire 
macrolide was assembled,12 we chose to simply carry the undesired, but readily prepared, 











































Scheme 5.15: Final elaboration of the protected C(23)-epi-ABCD hemisphere 5.50 
 
As shown above, the final elaboration of the C(23)-epimer of ABCD hemisphere 5.50, was 
achieved in good yield over a three-step sequence.  This marked the completion of our ABCD 
fragment synthesis.  Though not technically a formal synthesis of spongistatin 1 due to 














































    DMAP, CH2Cl2
2) Ac2O, Et3N 


























compound 5.50 could be converted to known intermediates from previous total syntheses of 
spongistatin 1.5  
 
5.3 Long-Term Goals of the Leighton Group’s Spongistatin Research Program 
Though the completed synthesis of the ABCD fragment of spongistatin 1 was an exciting 
achievement, the overarching goal of the Leighton laboratory always centered on the desire to 
develop a synthetic strategy that would allow spongistatin 1, or an analog thereof, to reach the 
global market as a potent chemotherapy agent.  In light of the recent discovery by the Smith 
group, that a diminutive, ABEF congener of spongistatin 1 5.51 retains a significant amount of 
anti-tumor bioactivity relative to the natural product 5.52 (Scheme 5.16),13 we began to consider 
a plausible strategy for the rapid the synthesis of a variety of bioactive analogs of spongistatin 1. 
 
Scheme 5.16: Relative bioactivity of a diminutive ABEF congener of spongistatin 1 
 
The findings above imply that the CD spiroketal is the least critical structural motif 
contributing to spongistatin’s breathtaking biological potency.  Though Smith’s diminutive form 

































































Average IC50 0.12 nM
against 60 cell lines
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a slightly more elaborate, yet still simplified, version of the CD fragment could potentially 
restore the level of bioactivity that captured the interest of the medicinal chemistry community.  
This modification could serve to drastically decrease the overall effort required to synthesize the 
entire molecule, bringing the spongistatin class of anti-tumor molecules a significant step closer 
to implementation as a chemotherapy agent.  
For the biological screening of these spongistatin CD-analogs to be realized, however, we 
would need to have ready access to large quantities of both the AB and EF fragments of 
spongistatin 1 in order to couple them with a variety of CD fragment variants.  As described in 
Chapter 5, Section 1, a substantial supply of the AB fragment of spongistatin 1 has been supplied 
through the work of this author.  Using the intermolecular fragment coupling by crotylation 
chemistry, developed in Chapter 4, Section 1 and successfully implemented in Chapter 5, Section 
2, we believe we have a powerful reaction platform in place to join the AB fragment to a variety 
of CD analogs, so long as they possess pendant aldehyde functionality.  To this end, we thought 
it prudent to work on further optimizing our fragment coupling conditions with the fully 
elaborated AB-spiroketal 5.41 by testing it on two model aldehydes representing potential CD 




Scheme 5.17: AB spiroketal fragment coupling with a model TES-aldehyde  
 
As depicted above, use of the fragment coupling procedure with simple aldehyde 5.53 
afforded a modest improvement in yield over our initial coupling of the AB and CD fragments of 
spongistatin 1 (Scheme 5.13).  Though we had expected this reaction to be high yielding, a 
significant loss in yield was attributed to the deprotection of the TES ether seen in compound 
5.54 during the TBAF work-up – a presumably fixable problem.  Much greater improvement in 
yield was observed when our optimized coupling conditions were applied to the union of the AB 
spiroketal to silacycle-aldehyde 5.55, providing coupled silacycle product 5.56 in an excellent 
74% yield over the three step sequence (Scheme 5.18).  This silacycle was further converted to 


































59% Yield over 3 Steps from 5.41
Significant TES deprotection
1) 10 mol% Sc(OTf)3
     CH2Cl2, 0 °C, 2 h
2) 1.0 equiv TBAF•3H2O











Scheme 5.18: AB spiroketal fragment coupling with a model silacycle-aldehyde 
 
With these exciting results firmly demonstrating the viability of appending our large 
stockpile of AB spiroketal to a variety of CD fragment analogs, we believe that the Leighton 
group’s spongistatin research program has taken tremendous strides toward achieving our 
ultimate goal of developing a synthetic strategy that would allow spongistatin 1, or an analog 







































74% Yield over 3 Steps from 5.41
1) 10 mol% Sc(OTf)3
     CH2Cl2, 0 °C, 2 h
2) 1.0 equiv TBAF•3H2O































gram synthesis of the EF fragment of spongistatin 1 is currently being pursued by Dr. Paul Tanis, 
while the very capable Linda Suen concurrently explores the development of CD fragment 
analogs rationally designed to accommodate potential antibody-drug conjugation.14  Though this 
author’s direct contribution to the Leighton laboratory’s spongistatin research program has come 
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Chapter 6:Experimental Information for Chapter 4 
 
General Information.  Unless otherwise stated, all chemical compounds were purchased 
from common commercial sources. All reactions were carried out under an atmosphere of 
nitrogen in flame or oven-dried glassware with magnetic stirring unless otherwise 
indicated. Degassed solvents were purified by passage through an activated alumina 
column. Thin-layer chromatography (TLC) was carried out on glass backed silica gel 
TLC plates (250 µm) from Silicycle; visualization by UV light, phosphomolybdic acid 
(PMA), p-Anisaldehyde (p-Anis) or potassium permanganate (KMnO4) stain. Gas 
chromatographic analyses were performed on a Hewlett-Packard 6890 Series Gas 
Chromatograph equipped with a capillary split-splitless inlet and flame ionization 
detector with electronic pneumatics control using either a Supelco β-Dex 120 (30 m x 
0.25 mm) or Supelco β-Dex 325 (30 m x 0.25 mm) capillary GLC column. HPLC 
analysis was carried out on an Agilent 1200 Series using either a Chiralpak AD-H (250 × 
4.5 mm ID) column or Chiralcel OD (250 × 4.5 mm ID) column. 1H NMR spectra were 
recorded on a Bruker DPX-300 (300 MHz), Bruker DRX-300 (300 MHz), Bruker AVIII 
nano bay-400 (400 MHz), Bruker AVIII single bay-400 (400 MHz), Avance III 500 (500 
mHz) or a Avance III 500 Ascend magnet (500 MHz) spectrometer and are reported in 
ppm from CDCl3 internal standard (7.26 ppm). Data are reported as follows: (bs= broad 
singlet, s = singlet, d = doublet, t = triplet, q = quartet, p = quintet, h = hextet, sep = 
septet, m = multiplet, dd = doublet of doublets, ddd = doublet of doublet of doublets, 
dddd = doublet of doublet of doublet of doublets; coupling constant(s) in Hz; 
integration). Proton decoupled 13C NMR spectra were recorded on a Bruker DRX-300 
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(300 MHz), Bruker AVIII single bay-400 (400 MHz), Bruker AVIII nano bay-400 (400 
MHz), Avance III 500 (500 mHz) or a Avance III 500 Ascend magnet (500 MHz) 
spectrometer and are reported in ppm from CDCl3 internal standard (77.0 ppm). Infrared 
spectra were recorded on a Nicolet Avatar 370DTGS FT-IR. Optical rotations were 
recorded on a Jasco DIP-1000 digital polarimeter. (APCI)-MS was conducted on a JMS-
LCmate LCMS (JEOL).  
 
 
General Procedure 1: Isoprenylation of Aldehydes 
A solution of aldehyde (1.0 equiv) in anhydrous CH2Cl2 (0.1 M) was cooled to 0 
°C and isoprenylation reagent (R,R)-4.37 (1.1 equiv a from a 0.6 M stock solution in CH-
2Cl2) was added followed by Sc(OTf)3 (0.05 equiv).  The resulting mixture was stirred 
vigorously at 0 °C until complete consumption of aldehyde was observed by reaction 
aliquot 1H NMR analysis (typically 1-2 h).  The reaction was quenched at 0 °C with a 1 
M solution of TBAF in THF (3.0 equiv) and then allowed to warm to room temperature.  
(Note: For concomitant TES removal during work-up, 4.0 equiv of TBAF was used).  
The resulting mixture was concentrated to an amber oil, and the crude product was 









General Procedure 2: Fragment Coupling by Crotylation 
A flame-dried sealed tube was charged with Pd(PPh3)4 (0.01 equiv), evacuated 
and back-filled with N2.  The starting material diene (1.0 equiv) was transferred to the 
sealed tube in a solution of anhydrous C6H6 (0.1 M) under an atmosphere of N2. 
Trichlorolsilane (2.0 equiv) was added to the solution and the sealed tube was screwed 
closed.  The reaction vessel was placed in a 70 °C bath and the light yellow solution was 
stirred for 12-16 h.  The resulting amber solution was allowed to cool to room 
temperature before being cannulated into a flame-dried, 2-neck roundbottom flask.  The 
sealed tube was rinsed with anhydrous C6H6 (2 x 0.4 M), and the wash solution was 
cannulated into the 2-neck roundbottom flask.  The reaction mixture was concentrated 
down to a crude amber oil using air-free technique.  (Note: air-free technique involved 
placing the roundbottom flask in a 40 °C water bath, connecting it to an adjacent -78 °C 
cold-finger and carefully reducing the pressure with a manometer partitioned through the 
pump manifold.  Upon complete removal of solvent, the entire system was back-filled 
with N2). 
The resulting hydrosilylated product was retaken in anhydrous CH2Cl2 (0.1 M) 
and diamine•2HCl salt (R,R)-4.1 or (S,S)-4.1 (1.0 equiv) was added at room temperature.  
The resulting white slurry was cooled to 0 °C and distilled DBU (4.0 equiv) was added to 
the reaction mixture over 10 min.  As DBU was added, the white salts solvated upon 
deprotonation and the solution took on an amber hue.  After an additional 5 min of 
stirring, the solution was thawed to room temperature.  After 2 h, the solvent was 
removed using air-free technique until the resulting yellow oil became opaque and 
foamy. (Note: air-free technique involved placing the roundbottom flask in a room 
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temperature water bath, connecting it to an adjacent -78 °C cold-finger and carefully 
reducing the pressure with a manometer partitioned through the pump manifold.  Upon 
complete removal of solvent, the entire system was back-filled with N2). The resulting oil 
was retaken in anhydrous Et2O (0.1 M) and shaken vigorously for 5-15 min until the 
DBU•HCl salts precipitated out as a white solid.  This heterogeneous solution was stirred 
vigorously for an additional 3-5 h to until the DBU•HCl salts became a very fine white 
precipitate.  The tinted yellow supernatant was filter-cannulated using Teflon tubing into 
a flame-dried, 2-neck roundbottom flask.  Et2O (0.2 M) was added to rinse the leftover 
DBU•HCl salts and the flask was shaken vigorously.  The supernatant was again filter-
cannulated into the new 2-neck roundbottom flask.  This process was repeated a second 
time with a final Et2O wash (0.4 M).  The solvent was again removed using air-free 
technique (room temperature bath) until the resulting yellow oil became opaque and 
foamy. 
The resulting crotyl-silane was retaken in anhydrous CH2Cl2 (0.1 M) and cooled 
to 0 °C.  The aldehyde coupling partner (1.0 equiv) was added to the cooled mixture 
followed by Sc(OTf)3 (0.10 equiv).  The reaction mixture was stirred vigorously at 0 °C 
for 2 h before being quenched with TBAF.  (Note: For concomitant TES removal during 
work-up, 4.0 equiv of TBAF in a 1 M solution of THF was used, and the solution was 
subsequently allowed to warm to room temperature.  For more mild removal of the 
diamine-silane, the reaction was quenched with 1.0 equiv of solid TBAF•3H2O and the 
surrounding 0 °C bath was allowed to slowly expire over 12-16 h).  The quenched 
reaction mixture was concentrated down to a thick oil, and this crude material was 
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purified by silica gel chromatography to afford the desired fragment coupled product as 
well as any unreacted starting material aldehyde.  
 
 
A flame-dried, 2-neck, 500 mL roundbottom flask was charged with CuCl (684 
mg, 6.91 mmol, 0.05 equiv) and equipped with a flame-dried reflux condenser (Note: a 
24/40 glass adapter joint was attached to the top of the condenser to allow for adequate 
reaction ventilation and N2 flow).  Et2O (280 mL, 0.5 M) was added to the flask, and the 
mixture was stirred to create a green slurry.  Et3N (23.1 mL, 166 mmol, 1.2 equiv) was 
added and the mixture took on a green/brown color.  The flask was cooled to 0 °C and 
2,3-dibromopropene 4.40 (13.5 mL, 138 mmol, 1.0 equiv) was added.  Trichlorosilane 
(16.7 mL, 166 mmol, 1.2 equiv) was slowly added to the solution at 0 °C in 4 mL 
portions every 10 min (Caution: HCl salts immediately formed upon each trichlorosilane 
addition and a strong exotherm occurred!  The reaction solvent occasionally refluxed in 
the condenser, but was effectively contained).  10 min after the final trichlorosilane 
addition, the reaction mixture was allowed to thaw to room temperature.  After 2.5 h of 
stirring, full conversion to product was confirmed by 1H reaction aliquot NMR analysis.  
The thick reaction mixture was filter-cannulated into a flame-dried, 2-neck, 1-L 
roundbottom flask.  The remaining HCl salts were washed with additional Et2O (2 x 100 
mL) which were also filter-cannulated into the new 1-L flask.  The majority of the 
solvent was removed using air-free technique until the crude reaction product was highly 
Br
Br H-SiCl3, Et3N
Et2O, 5 mol% CuCl
Cl3Si
Br





concentrated in Et2O. (Note: air-free technique involved placing the roundbottom flask in 
a room temperature water bath, connecting it to an adjacent -78 °C cold-finger and 
carefully reducing the pressure to 100 mm Hg with a manometer partitioned through the 
pump manifold.  Upon adequate concentration of solvent, the entire system was back-
filled with N2).  This salty, concentrated oil was transferred to a flame-dried distillation 
apparatus via syringe (Note: lots of smoke fumed off the salty, brown/yellow reaction 
crude during this purification process).  Distillation (b.p. 95 °C at 65 mm Hg) afforded 
allyl-trichlorosilane 4.41 (29.2g, 115 mmol, 83% yield) as a smoky, colorless oil (Note: 
the product is moisture sensitive and fumes if exposed to air).  1H NMR (500 MHz, 
CDCl3) δ 5.74 (dt, J = 2.3, 1.1 Hz, 1H), 5.63 (d, J = 2.2 Hz, 1H), 2.92 (d, J = 1.2 Hz, 2H); 
13C NMR (125 MHz, CDCl3) δ 121.7, 120.6, 38.8. 
 
 
A flame-dried 500 mL roundbottom flask was charged with Pd(PPh3)4 (9.02g, 7.8 
mmol, 0.05 equiv).1  The flask was evacuated and back-filled with N2 before being 
charged with benzene (165 mL, 1.0 M) to create a yellow solution.  Allyl-trichlorosilane 
4.41 (39.7g, 156 mmol, 1.0 equiv) was added to the solution followed by 
tributyl(vinyl)tin (50.3 mL, 172 mmol, 1.1 equiv).  The roundbottom flask was equipped 
with a flame-dried reflux condenser, and the resulting mixture was heated to reflux.  The 
refluxing solution turned dark red over time.  After refluxing for 2 h, nearly full 
                                                











conversion to the desired product was observed by reaction aliquot 1H NMR analysis.  
The reflux condenser was replaced with a flame-dried, 8 in. vigreux column and 
distillation head.  The majority of the reaction solvent was boiled off over 1 hour (120 °C 
oil bath).  The resulting concentrated reaction crude was carefully transferred to a flame-
dried distillation apparatus via syringe.  Distillation (b.p. 99 °C at 100 mm Hg) afforded 
isoprenyl-trichlorosilane 4.38 (17.3g, 86 mmol, 55% yield) as a smoky colorless oil 
(Note: the product is moisture sensitive and fumes if exposed to air).  1H NMR (400 MHz, 
CDCl3) δ 6.46 (ddd, J = 17.6, 10.8, 0.8 Hz, 1H), 5.34-5.17 (m, 4H), 2.60 (d, J = 1.1 Hz, 
2H); 13C NMR (100 MHz, CDCl3) δ 138.0, 137.2, 119.5, 115.3, 28.0. 
 
 
A flame-dried 3-L, 2-neck roundbottom flask was charged with diamine•2HCl 
salt (R,R)-4.1 (96.6g, 184 mmol, 1.0 equiv) and CH2Cl2 (615 mL, 0.3 M).  The slurry 
was cooled to 0 °C and isoprenyl-trichlorosilane 4.38 (37g, 184 mmol, 1.0 equiv) was 
added.  Distilled DBU (110 mL, 736 mmol, 4.0 equiv) was added to the mixture at 0 °C 
over 10 min.  As DBU was added, the white salts solvated upon deprotonation and the 
solution took on an amber hue.  After an additional 5 min of stirring, the solution was 
thawed to room temperature.  After 1 h, reaction aliquot NMR analysis showed full 
conversion to the desired product.  The solvent was removed using air-free technique 


















(~0.6 M in CH2Cl2)
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placing the roundbottom flask in a room temperature water bath, setting up an adjacent -
78 °C cold-finger and carefully reducing the pressure with a manometer partitioned 
through the pump manifold.  Upon complete removal of solvent, the entire system was 
back-filled with N2). Pentane (600 mL) was then added to the oil at room temperature, 
and the solution was shaken vigorously for 5-15 min until the DBU•HCl salts precipitated 
out into a fine white solid.  This heterogeneous mixture was stirred vigorously for an 
additional 1 h.  The tinted yellow supernatant was filter-cannulated using Teflon tubing 
into a dry 1-L, 2-neck roundbottom flask.  Pentane (300 mL) was added to the leftover 
DBU•HCl salts and the flask was shaken vigorously.  The supernatant was again filter-
cannulated into the new 1L, 2-neck roundbottom flask.  This process was repeated a 
second time with a final pentane wash (150 mL).  The solvent was again removed using 
air-free technique until the resulting oil became opaque and foamy.  The product oil was 
transferred to a flame-dried 500 mL roundbottom flask to provide isoprenylation reagent 
(R,R)-4.37 (ca. 85g, 147 mmol, 80% Yield) as a stock solution in CH2Cl2 (~0.6 M).  A 
small aliquot of this stock solution was concentrated for characterization.  1H NMR (500 
MHz, CDCl3) δ 7.43 (dd, J = 8.4, 2.5 Hz, 4H), 7.30 (t, J = 8.8 Hz, 4H), 6.38 (dd, J = 
17.4, 10.4 Hz, 1H), 5.17 (d, J = 17.4 Hz, 1H), 5.08 (d, J = 12.0 Hz, 3H), 4.16 (d, J = 16.3 
Hz, 1H), 4.03 (d, J = 15.2 Hz, 1H), 3.89 (d, J = 15.2 Hz, 1H), 3.80 (d, J = 16.3 Hz, 1H), 
2.81 (ddd, J = 11.9, 9.2, 2.9 Hz, 1H), 2.73 (ddd, J = 11.9, 9.3, 3.0 Hz, 1H), 1.97 (d, J = 
15.4 Hz, 1H), 1.88 (d, J = 15.5 Hz, 1H), 1.84-1.54 (m, 4H), 1.13 (tt, J = 12.7, 10.2 Hz, 
2H), 1.01 (qd, J = 13.6, 12.7, 4.1 Hz, 1H), 0.91 (tt, J = 12.0, 6.4 Hz, 1H); 13C NMR (125 
MHz, CDCl3) δ 141.5, 140.3, 139.9, 139.5, 131.2, 129.9, 129.0, 120.5, 120.2, 117.3, 





Hydrocinnamaldehyde 4.42 (3.8 mL, 28.8 mmol, 1.0 equiv) was reacted with 
(R,R)-4.37 (1.1 equiv) according to general procedure 1.  Purification by silica gel 
chromatography (gradient 10%, 25% EtOAc/Hexanes) afforded 4.43 (5.56g, 27.5 mmol, 
95% Yield) as a pale yellow oil.  The isolated diene was either used immediately or 
frozen in a solution of benzene for long-term storage.  The enantiomeric excess of 4.43 
was determined to be 94% ee by chiral HPLC analysis (see HPLC chromatogram below).  
[α]D = +21° (c 2.0, CH2Cl2); Rf = 0.3 (15% EtOAc/Hexanes, PMA); 1H NMR (500 MHz, 
CDCl3) δ 7.37-7.28 (m, 2H), 7.28-7.18 (m, 3H), 6.42 (dd, J = 17.6, 11.0 Hz, 1H), 5.25 (d, 
J = 17.6 Hz, 1H), 5.22-5.09 (m, 3H), 3.82 (dq, J = 8.9, 4.7 Hz, 1H), 2.88 (dt, J = 13.9, 8.3 
Hz, 1H), 2.79-2.70 (m, 1H), 2.56 (dd, J = 13.9, 3.7 Hz, 1H), 2.32 (dd, J = 13.9, 9.0 Hz, 
1H), 1.94-1.80 (m, 2H), 1.72 (bs, 1H); 13C NMR (125 MHz, CDCl3) δ 143.0, 142.1, 
138.4, 128.4, 128.4, 125.8, 118.5, 114.3, 69.1, 40.1, 38.8, 32.2; IR (cast film) 3382, 3027, 
2931, 1594, 1496, 1454, 1392, 1083, 993, 900 cm-1; LRMS (FAB+) calc’d for C14H18O 






















1) 5 mol % Sc(OTf)3




























Benzaldehyde 4.44 (51 µL, 0.5 mmol, 1.0 equiv) was reacted with (R,R)-4.37 (1.1 
equiv) according to general procedure 1.  Purification by silica gel chromatography (10% 
EtOAc/Hexanes) afforded 4.45 (84 mg, 0.48 mmol, 96% Yield) as a pale yellow oil.  The 
enantiomeric excess of 4.45 was determined to be 86% ee by chiral HPLC analysis (see 
HPLC chromatogram below).  [α]D = -41° (c 1.8, CH2Cl2); Rf = 0.3 (10% 
EtOAc/Hexanes, PMA); 1H NMR (400 MHz, CDCl3) δ 7.35-7.17 (m, 5H), 6.33 (dd, J = 
17.6, 10.8 Hz, 1H), 5.24 (d, J = 17.6 Hz, 1H), 5.11-4.98 (m, 3H), 4.75 (ddd, J = 9.3, 4.0, 
2.0 Hz, 1H), 2.62 (ddd, J = 14.1, 4.0, 1.1 Hz, 1H), 2.47 (ddd, J = 14.2, 9.2, 0.8 Hz, 1H), 
1.94 (d, J = 2.4 Hz, 1H); 13C NMR (125 MHz, CDCl3) δ 144.1, 142.7, 138.3, 128.4, 
127.6, 125.8, 118.9, 114.3, 72.2, 42.2; IR (cast film) 3382, 3086, 3032, 2930, 1594, 1454, 
1393, 1137, 1083, 1054, 993, 901cm-1; LRMS (FAB+) calc’d for C12H14O [M]+ 174.24, 
found 174.22. 
 
Cinnamaldehyde 4.46 (63 µL, 0.5 mmol, 1.0 equiv) was reacted with (R,R)-4.37 
(1.1 equiv) according to general procedure 1.  Purification by silica gel chromatography 
(15% EtOAc/Hexanes) afforded 4.47 (88 mg, 0.44 mmol, 88% Yield) as a pale yellow 
oil.  The enantiomeric excess of 4.47 was determined to be 86% ee by chiral HPLC 
analysis (see HPLC chromatogram below).  [α]D = +7° (c 0.6, CH2Cl2); Rf = 0.3 (15% 
EtOAc/Hexanes, PMA); 1H NMR (400 MHz, CDCl3) δ 7.46-7.38 (m, 2H), 7.38-7.31 (m, 
2H), 7.31-7.23 (m, 1H), 6.65 (dd, J = 15.9, 1.1 Hz, 1H), 6.45 (dd, J = 17.6, 11.0 Hz, 1H), 
6.28 (dd, J = 15.9, 6.4 Hz, 1H), 5.35 (d, J = 17.6 Hz, 1H), 5.26-5.14 (m, 3H), 4.50 
(ddddd, J = 7.9, 6.1, 4.5, 3.1, 1.2 Hz, 1H), 2.65 (ddd, J = 14.0, 4.8, 1.0 Hz, 1H), 2.52 
(ddd, J = 14.0, 8.4, 0.8 Hz, 1H), 1.92 (d, J = 3.2 Hz, 1H); 13C NMR (125 MHz, CDCl3) δ 
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142.4, 138.5, 136.8, 131.7, 130.2, 128.6, 127.7, 126.5, 119.0, 114.4, 70.8, 40.1; IR (cast 
film) 3369, 3027, 2929, 1595, 1494, 1449, 1392, 1099, 1026, 992, 966, 902 cm-1; LRMS 
(FAB+) calc’d for C14H16O [M]+ 200.28, found 200.08. 
 
α-Methyl-trans-cinnamaldehyde 4.48 (70 µL, 0.5 mmol, 1.0 equiv) was reacted 
with (R,R)-4.37 (1.1 equiv) according to general procedure 1.  Purification by silica gel 
chromatography (10% EtOAc/Hexanes) afforded 4.49 (102 mg, 0.475 mmol, 95% Yield) 
as a pale yellow oil.  The enantiomeric excess of 4.49 was determined to be 87% ee by 
chiral HPLC analysis (see HPLC chromatogram below).  [α]D = +18° (c 2.4, CH2Cl2); Rf 
= 0.3 (10% EtOAc/Hexanes, PMA); 1H NMR (400 MHz, CDCl3) δ 7.42-7.19 (m, 5H), 
6.58 (s, 1H), 6.46 (dd, J = 17.6, 11.0 Hz, 1H), 5.37 (d, J = 17.7 Hz, 1H), 5.26-5.16 (m, 
3H), 4.38 (ddd, J = 8.9, 4.3, 1.9 Hz, 1H), 2.70 (ddd, J = 14.0, 4.2, 1.1 Hz, 1H), 2.49 (dd, J 
= 14.0, 8.9 Hz, 1H), 1.96 (d, J = 1.4 Hz, 2H), 1.88 (d, J = 6.0 Hz, 1H); 13C NMR (125 
MHz, CDCl3) δ 142.9, 139.6, 138.4, 137.6, 129.0, 128.1, 126.5, 125.8, 118.6, 114.3, 75.5, 
38.6, 13.6; IR (cast film) 3384, 3086, 2952, 1595, 1492, 1444, 1390, 1335, 1154, 1074, 




To a solution of 4.42 hydrocinnamaldehyde (2.63 mL, 20.0 mmol, 1.0 equiv) 






1) 5 mol % Sc(OTf)3












>20:1 dr, 96% ee
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(R,R)-4.50 (14.1g, 24.0 mmol, 1.2 equiv) at 0 °C. 2  The reaction mixture was stirred for 1 
h at 0 °C before being quenched with a 1 M solution of TBAF in THF (60 mL, 60 mmol, 
3.0 equiv).  The resulting mixture was allowed to warm to room temperature and was 
then concentrated down to a thick oil.  This crude residue was purified by silica gel 
chromatography (gradient 5%, 15% EtOAc/Hexanes) to afford alkene 4.51 (3.47g, 18.24 
mmol, 91% Yield) as a colorless oil.  The diastereoselectivity of the reaction was 
determined to be >20:1 by 1H NMR analysis.  The enantiomeric excess of 4.51 was 
determined to be 96% ee by chiral HPLC analysis (see HPLC chromatogram below).  
[α]D = +30° (c 5.0, CH2Cl2); Rf = 0.6 (25% EtOAc/Hexanes, PMA); 1H NMR (400 MHz, 
CDCl3) δ 7.42-7.30 (m, 2H), 7.30-7.20 (m, 3H), 5.93-5.73 (m, 1H), 5.21-5.08 (m, 2H), 
3.58 (ddd, J = 8.9, 5.2, 3.2 Hz, 1H), 2.93 (ddd, J = 13.7, 10.1, 5.3 Hz, 1H), 2.71 (ddd, J = 
13.7, 9.8, 6.7 Hz, 1H), 2.44-2.29 (m, 1H), 1.89 (dddd, J = 13.5, 10.0, 6.7, 3.2 Hz, 1H), 
1.82-1.63 (m, 2H), 1.10 (d, J = 6.9 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 142.3, 140.9, 
128.5, 128.4, 125.8, 115.5, 74.1, 43.8, 35.9, 32.5, 14.4; IR (cast film) 3384, 2936, 2866, 
1496, 1454, 1417, 1373, 1037, 997, 914 cm-1; LRMS (FAB+) calc’d for C13H18O [M]+ 
190.28, found 190.11. 
 
 
To a solution of alcohol 4.51 (1.90g, 10.0 mmol, 1.0 equiv) in anhydrous CH2Cl2 
(100 mL, 0.1 M) was added Et3N (2.1 mL, 15.0 mmol, 1.5 equiv) followed by TES-Cl 
                                                
2 Commercially available asymmetric crotylation and allylation reagents such as EZ-CrotylMix and can be 












(2.0 mL, 12.0 mmol, 1.2 equiv) and DMAP (367mg, 0.3 mmol, 0.3 equiv).  The mixture 
was stirred at room temperature, and the reaction progress was monitored by TLC 
analysis.  At 1.5 h, the reaction was quenched with MeOH (0.6 mL, 15.0 mmol, 1.5 
equiv) and concentrated down to a salty oil.  This oil was retaken in hexanes and filtered.  
The resulting solution was concentrated and purified by silica gel chromatography 
(gradient 0%, 3% EtOAc/Hexanes) to afford silyl-ether 4.52 (2.98g, 9.78 mmol, 98% 
Yield) as a colorless oil.  [α]D = +14° (c 4.0, CH2Cl2); Rf = 0.8 (5% EtOAc/Hexanes, 
PMA); 1H NMR (400 MHz, CDCl3) δ 7.35 (t, J = 7.5 Hz, 2H), 7.25 (d, J = 7.4 Hz, 3H), 
5.94 (ddd, J = 17.5, 10.5, 7.3 Hz, 1H), 5.22-5.02 (m, 2H), 3.71 (q, J = 5.5 Hz, 1H), 2.93-
2.74 (m, 1H), 2.65 (ddd, J = 13.5, 9.8, 6.7 Hz, 1H), 2.45 (h, J = 6.8 Hz, 1H), 1.81 (dtd, J 
= 9.8, 6.2, 3.5 Hz, 2H), 1.22-0.97 (m, 12H), 0.72 (q, J = 7.9 Hz, 6H); 13C NMR (100 
MHz, CDCl3) δ 142.8, 141.1, 128.4, 125.7, 114.2, 75.9, 43.3, 36.2, 31.8, 15.5, 7.1, 5.3; 
IR (cast film) 2955, 2912, 2877, 1456, 1415, 1239, 1074, 1006, 912 cm-1; LRMS (FAB+) 
calc’d for C19H31OSi [M-H]+ 303.53, found 303.31. 
 
 
Oxygen gas was bubbled through a solution of alkene 4.52 (1.0g, 3.28 mmol, 1.0 
equiv) solvated in CH2Cl2 (33 mL, 0.1 M). The solution was cooled to -78 °C while still 
being sparged with oxygen.  O3 was bubbled through the solution at -78 °C until the 
solution took on a dark blue color (15 min).  The solution was then purged with oxygen 







2) 1.3 equiv PPh3








added to the cold solution, which was then removed from the cold bath and allowed to 
thaw to room temperature under an atmosphere of N2.  After 15 h, the reaction was 
concentrated down to a yellow oil caked with solids.  This oil was retaken in hexanes (33 
mL, 0.1 M) and stirred vigorously for 10 min to triturate out most of the phosphines.  The 
white slurry was filtered and concentrated to an oil with intermittent solids.  The 
trituration process was repeated a second time to provide a pale yellow oil with minimal 
solids.  The crude material was purified by silica gel chromatography (gradient 1%, 3% 
EtOAc/Hexanes, pH 7 buffered SiO2 gel3) to afford aldehyde 4.53 (904 mg, 2.95 mmol, 
90% Yield) as a pale yellow oil.  [α]D = +39° (c 1.5, CH2Cl2); Rf = 0.4 (5% 
EtOAc/Hexanes, PMA); 1H NMR (500 MHz, CDCl3) δ 9.82 (d, J = 1.1 Hz, 1H), 7.37-
7.26 (m, 2H), 7.26-7.16 (m, 3H), 4.20 (td, J = 6.3, 3.8 Hz, 1H), 2.73 (ddd, J = 13.7, 10.7, 
6.0 Hz, 1H), 2.66-2.58 (m, 1H), 2.58-2.50 (m, 1H), 1.86 (dddd, J = 26.1, 13.8, 11.0, 6.4 
Hz, 2H), 1.13 (d, J = 7.0 Hz, 3H), 0.99 (t, J = 7.9 Hz, 9H), 0.63 (q, J = 8.2 Hz, 6H); 13C 
NMR (125 MHz, CDCl3) δ 205.0, 141.6, 128.5, 128.2, 126.0, 71.9, 51.4, 36.5, 32.2, 8.0, 
6.9, 5.2; IR (cast film) 2954, 2913, 2878, 1707, 1645, 1457, 1238, 1103, 1009 cm-1; 
LRMS (FAB+) calc’d for C18H30O2Si [M]+ 306.52, found 306.29. 
 
 
                                                
3 pH 7 buffered SiO2 gel was prepared my adding 10% pH 7 buffer (by mass) to a 
roundbotttom flask half filled with SiO2 gel.  The resulting mixture was rotated on a 






1) 5 mol % Sc(OTf)3
CH2Cl2, 0 °C, 1 hr












78% Yield, >15:1 dr
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Aldehyde 4.53 (904 mg, 2.95 mmol, 1.0 equiv) was reacted with (R,R)-4.37 (1.1 
equiv) according to general procedure 1.  Purification by silica gel chromatography (25% 
EtOAc/Hexanes) afforded diol 4.54 (599 mg, 2.30 mmol, 78% Yield) as a pale yellow 
oil.  The isolated diene was either used immediately or frozen in a solution of benzene for 
long-term storage.  The diastereoselectivity of the reaction was determined to be >15:1 by 
1H NMR analysis.  [α]D = +18° (c 3.5, CH2Cl2); Rf = 0.3 (25% EtOAc/Hexanes, PMA); 
1H NMR (400 MHz, CDCl3) δ 7.37-7.28 (m, 2H), 7.28-7.16 (m, 3H), 6.42 (dd, J = 17.6, 
10.8 Hz, 1H), 5.29 (d, J = 17.6 Hz, 1H), 5.22-5.08 (m, 3H), 4.03 (td, J = 6.7, 6.1, 1.9 Hz, 
1H), 3.91 (ddd, J = 8.7, 4.4, 1.8 Hz, 1H), 2.98 (bs, 1H), 2.82 (ddd, J = 13.8, 10.0, 5.7 Hz, 
1H), 2.68 (ddd, J = 13.8, 9.6, 6.4 Hz, 1H), 2.50-2.36 (m, 3H), 2.03-1.83 (m, 1H), 1.81-
1.67 (m, 1H), 1.62 (qt, J = 6.9, 2.0 Hz, 1H), 1.02 (d, J = 7.0 Hz, 3H); 13C NMR (100 
MHz, CDCl3) δ 142.9, 142.1, 138.3, 128.5, 128.4, 125.8, 118.4, 114.4, 76.1, 74.6, 40.8, 
37.7, 37.0, 32.5, 4.7; IR (cast film) 3357, 2943, 1594, 1496, 1454, 1389, 1094, 1030, 973, 
901 cm-1 ; LRMS (FAB+) calc’d for C17H25O2 [M+H]+ 261.38, found 261.25. 
 
 
To a solution of alcohol 4.43 (5.56g, 27.5 mmol, 1.0 equiv) solvated in anhydrous 
THF (275 mL, 0.1 M) was added Et3N (5.8 mL, 41.3 mmol, 1.5 equiv) followed by Ac2O 
(3.1 mL, 33.0 mmol, 1.2 equiv) and DMAP (1.0g, 8.25 mmol, 0.3 equiv).  The mixture 
was stirred at room temperature and the reaction progress was monitored by TLC 
analysis.  At 1.5 h, the reaction was concentrated down to a white, salty oil.  This crude 










afford acetate 4.55 (6.50g, 26.6 mmol, 97% Yield) as a pale yellow oil.  The isolated 
diene was either used immediately or frozen in a solution of benzene for long-term 
storage.  [α]D = -5° (c 2.0, CH2Cl2); Rf = 0.8 (10% EtOAc/Hexanes, PMA); 1H NMR 
(500 MHz, CDCl3) δ 7.35-7.27 (m, 2H), 7.24-7.16 (m, 3H), 6.38 (dd, J = 17.6, 10.7 Hz, 
1H), 5.38 (d, J = 17.7 Hz, 1H), 5.18-5.09 (m, 3H), 5.05 (t, J = 1.5 Hz, 1H), 2.73 (ddd, J = 
13.9, 10.1, 6.0 Hz, 1H), 2.68-2.56 (m, 2H), 2.44 (ddd, J = 13.9, 6.6, 1.0 Hz, 1H), 2.05 (s, 
3H), 1.99-1.84 (m, 2H); 13C NMR (125 MHz, CDCl3) δ 170.7, 142.3, 141.6, 138.3, 
128.4, 128.3, 125.9, 118.5, 114.2, 72.4, 36.7, 35.6, 31.9, 21.2; IR (cast film) 3028, 2932, 
1736, 1596, 1454, 1373, 1239, 1029, 994, 902 cm-1 ; LRMS (FAB+) calc’d for C16H21O2 
[M+H]+ 245.34, found 245.23. 
 
 
Diene 4.55 (17 mg, 0.07 mmol, 1.0 equiv) was reacted according to the first 
section of general procedure 2 in a sealed NMR tube.  This small scale reaction was 
performed in C6D6 so that the intermediate, hydrosilylated compound 4.56 could be 
observed and confirmed by 1H and 13C NMR.  1H NMR (400 MHz, C6D6) δ 7.20-7.11 
(m, 2H), 7.06 (td, J = 6.7, 1.7 Hz, 3H), 5.23 (qt, J = 6.7, 1.0 Hz, 1H), 5.08 (tdd, J = 8.0, 
5.3, 4.4 Hz, 1H), 2.66-2.41 (m, 2H), 2.36-2.15 (m, 4H), 1.86-1.59 (m, 2H), 1.68 (s, 3H), 
1.36 (d, J = 6.6 Hz, 3H); 13C NMR (100 MHz, C6D6) δ 169.3, 141.3, 128.4, 128.3, 127.9, 
127.7, 127.4, 126.9, 126.0, 125.4, 71.1, 43.5, 35.7, 31.9, 27.4, 20.3, 14.0.  Some excess 
















Diene 4.55 (452 mg, 1.85 mmol, 1.0 equiv) was coupled with 
hydrocinnamaldehyde (244 µL, 1.85 mmol, 1.0 equiv) according to general procedure 2 
using diamine (R,R)-4.1.  The crude material was purified by silica gel chromatography 
(20% EtOAc/Hexanes) to afford compound 4.61 (556 mg, 1.46 mmol, 79% Yield over 3 
steps) as a colorless oil.  The diastereoselectivity of the reaction was determined to be 
>10:1 by 1H NMR analysis.  [α]D = +46° (c 1.9, CH2Cl2); Rf = 0.3 (15% EtOAc/Hexanes, 
PMA); 1H NMR (400 MHz, CDCl3) δ 7.37-7.27 (m, 4H), 7.27-7.15 (m, 6H), 5.12 (tt, J = 
8.5, 4.6 Hz, 1H), 4.98 (d, J = 1.3 Hz, 1H), 4.92 (s, 1H), 3.58 (dt, J = 8.1, 3.9 Hz, 1H), 
2.86 (ddd, J = 13.7, 9.7, 5.8 Hz, 1H), 2.77-2.56 (m, 3H), 2.37-2.17 (m, 3H), 2.03 (s, 3H), 
1.99-1.70 (m, 4H), 1.58 (bs, 1H), 1.05 (d, J = 6.9 Hz, 3H); 13C NMR (100 MHz, CDCl3) 
δ 170.6, 148.2, 142.1, 141.4, 128.4, 128.4, 128.3, 126.0, 125.8, 113.4, 71.6, 71.1, 43.8, 
41.1, 36.1, 32.8, 31.9, 21.1, 12.4; IR (cast film) 3460, 3027, 2930, 1735, 1496, 1454, 













1) 10 mol % Sc(OTf)3
CH2Cl2, 0 °C, 2 h
















Diene 4.55 (380 mg, 1.55 mmol, 1.0 equiv) was coupled with aldehyde 4.53 
(475mg, 1.55 mmol, 1.0 equiv) according to general procedure 2 using diamine (R,R)-
4.1.  The crude material was purified by silica gel chromatography (35% 
EtOAc/Hexanes) to afford compound 4.62 (504 mg, 1.15 mmol, 74% Yield over 3 steps) 
as a colorless oil.  The diastereoselectivity of the reaction was determined to be >10:1 by 
1H NMR analysis.  [α]D = +19° (c 1.4, CH2Cl2); Rf = 0.3 (30% EtOAc/Hexanes, PMA); 
1H NMR (500 MHz, CDCl3) δ 7.35-7.25 (m, 4H), 7.25-7.15 (m, 6H), 5.13 (p, J = 6.1 Hz, 
1H), 4.90 (d, J = 3.9 Hz, 2H), 3.87-3.74 (m, 1H), 3.66 (dd, J = 8.7, 2.5 Hz, 1H), 2.82-
2.58 (m, 5H), 2.53 (bs, 1H), 2.35 (dt, J = 14.9, 7.4 Hz, 2H), 2.20 (dd, J = 14.8, 5.3 Hz, 
1H), 2.04 (s, 3H), 1.97-1.81 (m, 3H), 1.78-1.61 (m, 2H), 1.11 (d, J = 6.8 Hz, 3H), 0.95 (d, 
J = 7.0 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 170.7, 147.9, 141.8, 141.4, 128.4, 128.4, 
128.3, 126.0, 125.9, 113.3, 79.1, 76.1, 72.0, 43.2, 39.9, 38.3, 37.0, 35.9, 32.5, 31.9, 21.1, 
16.3, 5.4; IR (cast film) 3404, 2932, 1735, 1496, 1457, 1374, 1242, 1090, 1029, 968 cm-1 












1) 10 mol % Sc(OTf)3
CH2Cl2, 0 °C, 2 h






















1) 10 mol % Sc(OTf)3
CH2Cl2, 0 °C, 2 h
















Diene 4.55 (367 mg, 1.50 mmol, 1.0 equiv) was coupled with aldehyde 4.53 
(460mg, 1.50 mmol, 1.0 equiv) according to general procedure 2 using diamine (S,S)-4.1.  
The crude material was purified by silica gel chromatography (gradient 35%, 45% 
EtOAc/Hexanes) to afford compound 4.63 (520 mg, 1.18 mmol, 79% Yield over 3 steps) 
as a colorless oil.  The diastereoselectivity of the reaction was determined to be >10:1 by 
1H NMR analysis.  [α]D = -6° (c 2.0, CH2Cl2); Rf = 0.3 (40% EtOAc/Hexanes, PMA); 1H 
NMR (500 MHz, CDCl3) δ 7.37-7.12 (m, 10H), 5.05-4.95 (m, 2H), 4.93 (s, 1H), 3.88 (d, 
J = 9.8 Hz, 1H), 3.60 (dd, J = 8.4, 3.6 Hz, 1H), 3.07-2.88 (m, 2H), 2.80-2.56 (m, 3H), 
2.37 (dt, J = 12.2, 8.6 Hz, 3H), 2.23 (dd, J = 14.2, 6.9 Hz, 1H), 2.05 (s, 3H), 1.99-1.79 
(m, 2H), 1.73 (dddd, J = 13.5, 9.9, 6.5, 3.0 Hz, 1H), 1.02 (d, J = 6.9 Hz, 3H), 0.89 (d, J = 
7.1 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 170.9, 147.9, 142.6, 141.3, 128.5, 128.5, 
128.4, 128.3, 126.0, 125.8, 114.1, 74.2, 73.7, 72.6, 41.6, 40.6, 39.3, 35.4, 35.3, 33.0, 31.7, 
21.2, 12.1, 11.8.; IR (cast film) 3382, 3024, 2932, 1734, 1496, 1459, 1374, 1242, 1030, 
970 cm-1 ; LRMS (FAB+) calc’d for C28H39O4 [M+H]+ 439.61, found 439.17. 
 
 
To a solution of diol 4.54 (667 mg, 2.56 mmol, 1.0 equiv) solvated in anhydrous 
THF (26 mL, 0.1 M) was added Et3N (1.1 mL, 7.68 mmol, 3.0 equiv) followed by Ac2O 
(0.61 mL, 6.40 mmol, 2.5 equiv) and DMAP (156 mg, 1.28 mmol, 0.5 equiv).  The 
mixture was stirred at room temperature and the reaction progress was monitored by TLC 
analysis.  At 2 h, the reaction was concentrated down to a white, salty oil.  This crude 














diacetate 4.58 (630 mg, 1.82 mmol, 72% Yield) as a pale yellow oil.  The isolated diene 
was either used immediately or frozen in a solution of benzene for long-term storage.  
[α]D = -3° (c 2.0, CH2Cl2); Rf = 0.8 (30% EtOAc/Hexanes, PMA); 1H NMR (500 MHz, 
CDCl3) δ 7.35-7.24 (m, 2H), 7.24-7.13 (m, 3H), 6.36 (dd, J = 17.6, 10.9 Hz, 1H), 5.43 (d, 
J = 17.6 Hz, 1H), 5.20 (td, J = 7.1, 3.5 Hz, 1H), 5.16 (d, J = 10.9 Hz, 1H), 5.13-5.07 (m, 
1H), 5.04 (s, 1H), 4.96 (dt, J = 7.9, 5.3 Hz, 1H), 2.69-2.55 (m, 2H), 2.50 (qdd, J = 13.8, 
7.1, 1.0 Hz, 2H), 2.06 (s, 3H), 2.01 (s, 3H), 2.01-1.94 (m, 1H), 1.94-1.81 (m, 2H), 1.02 
(d, J = 7.0 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 170.6, 170.4, 142.3, 141.4, 138.0, 
128.4, 128.3, 125.9, 118.7, 114.5, 74.8, 72.2, 38.4, 34.5, 33.2, 31.8, 21.1, 9.5; IR (cast 
film) 2958, 1736, 1455, 1372, 1236, 1023, 903 cm-1 ; LRMS (FAB+) calc’d for C21H29O4 




Diene 4.58 (35 mg, 0.10 mmol, 1.0 equiv) was reacted according to the first 
section of general procedure 2 in a sealed NMR tube.  This small scale reaction was 
performed in C6D6 so that intermediate, hydrosilylated compound 4.59 could be observed 
and confirmed by 1H and 13C NMR.  1H NMR (400 MHz, C6D6) δ 7.24-7.11 (m, 2H), 
7.11-6.99 (m, 3H), 5.33-5.23 (m, 1H), 5.18 (ddd, J = 8.9, 5.6, 4.0 Hz, 1H), 5.12 (dt, J = 
8.5, 4.1 Hz, 1H), 2.61-2.38 (m, 4H), 2.34 (dt, J = 14.9, 0.9 Hz, 1H), 2.21 (dd, J = 14.2, 
8.9 Hz, 1H), 1.97-1.79 (m, 1H), 1.79-1.67 (m, 2H), 1.70 (s, 3H), 1.65 (s, 3H), 1.38 (d, J = 

















128.4, 128.4, 128.2, 127.9, 127.8, 127.7, 127.5, 127.4, 127.0, 126.0, 125.7, 73.5, 71.6, 
41.6, 40.1, 33.7, 32.1, 27.3, 20.2, 20.1, 14.1, 9.6.  Some excess trichlorosilane was also 
observed by 1H NMR (400 MHz, C6D6) δ 5.40 (s). 
 
 
Diene 4.58 (506 mg, 1.47 mmol, 1.0 equiv) was coupled with 
hydrocinnamaldehyde 4.42 (194 µL, 1.47 mmol, 1.0 equiv) according to general 
procedure 2 using diamine (R,R)-4.1.  The crude material was purified by silica gel 
chromatography (20% EtOAc/Hexanes) to afford compound 4.64 (528 mg, 1.10 mmol, 
75% Yield over 3 steps) as a colorless oil.  The diastereoselectivity of the reaction was 
determined to be >10:1 by 1H NMR analysis.  [α]D = +29° (c 0.9, CH2Cl2); Rf = 0.4 (25% 
EtOAc/Hexanes, PMA); 1H NMR (500 MHz, CDCl3) δ 7.35-7.27 (m, 4H), 7.27-7.16 (m, 
6H), 5.04 (tt, J = 8.3, 4.0 Hz, 2H), 4.96 (s, 1H), 4.89 (s, 1H), 3.61 (dq, J = 6.9, 3.3 Hz, 
1H), 2.87 (ddd, J = 15.1, 10.3, 5.3 Hz, 1H), 2.65 (dtd, J = 36.3, 9.7, 9.3, 6.4 Hz, 3H), 2.40 
(dd, J = 14.2, 3.4 Hz, 1H), 2.31-2.16 (m, 2H), 2.07 (s, 3H), 2.00 (s, 3H), 1.98-1.78 (m, 
3H), 1.74 (tdd, J = 9.8, 6.2, 3.1 Hz, 1H), 1.67 (d, J = 2.9 Hz, 1H), 1.01 (d, J = 7.0 Hz, 
3H), 0.98 (d, J = 6.9 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 170.7, 170.3, 148.1, 142.2, 
141.2, 128.5, 128.4, 128.4, 128.3, 126.0, 125.8, 113.6, 74.0, 72.1, 71.5, 43.5, 40.3, 39.3, 
36.1, 33.7, 32.9, 32.1, 21.1, 21.0, 12.4, 10.0; IR (cast film) 3444, 3028, 2946, 1735, 1643, 













1) 10 mol % Sc(OTf)3
CH2Cl2, 0 °C, 2 h


















Diene 4.58 (506 mg, 1.47 mmol, 1.0 equiv) was coupled with aldehyde 4.53 (450 
mg, 1.47 mmol, 1.0 equiv) according to general procedure 2 using diamine (R,R)-4.1.  
The crude material was purified by silica gel chromatography (40% EtOAc/Hexanes) to 
afford compound 4.65 (579 mg, 1.07 mmol, 73% Yield over 3 steps) as a colorless oil.  
The diastereoselectivity of the reaction was determined to be >10:1 by 1H NMR analysis.  
[α]D = +23° (c 1.3, CH2Cl2); Rf = 0.4 (40% EtOAc/Hexanes, PMA); 1H NMR (500 MHz, 
CDCl3) δ 7.35-7.26 (m, 4H), 7.26-7.15 (m, 6H), 5.08-4.97 (m, 2H), 4.92 (d, J = 6.1 Hz, 
2H), 3.86-3.78 (m, 1H), 3.62 (t, J = 5.7 Hz, 1H), 2.95 (d, J = 3.9 Hz, 1H), 2.81 (ddd, J = 
13.7, 10.2, 5.6 Hz, 1H), 2.71-2.54 (m, 3H), 2.41 (ddd, J = 18.6, 13.9, 5.3 Hz, 2H), 2.33 
(bs, 1H), 2.16 (dd, J = 14.2, 9.3 Hz, 1H), 2.08 (s, 3H), 2.02 (s, 3H), 2.04-1.95 (m, 1H), 
1.90 (dddd, J = 14.9, 11.6, 8.3, 4.8 Hz, 3H), 1.72 (dtd, J = 12.6, 5.8, 2.9 Hz, 1H), 1.63 
(tdd, J = 7.9, 6.0, 5.3, 3.0 Hz, 1H), 1.04 (d, J = 6.9 Hz, 3H), 1.00 (d, J = 7.1 Hz, 3H), 0.99 
(d, J = 7.2 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 171.4, 170.4, 148.4, 142.1, 141.1, 
128.5, 128.4, 128.3, 126.1, 125.8, 113.8, 76.9, 74.1, 74.1, 72.3, 41.8, 40.6, 39.1, 38.2, 
37.2, 34.0, 32.7, 32.2, 21.1, 21.0, 14.6, 9.9, 6.7; IR (cast film) 3447, 2936, 1735, 1455, 















1) 10 mol % Sc(OTf)3
CH2Cl2, 0 °C, 2 h




















A flame-dried, 500 mL roundbottom flask was equipped with an overhead, 
mechanical stirrer and charged with Et2O (250 mL, 0.15 M).  The roundbottom flask was 
cooled to -78 °C, and condensed propyne (ca. 5 mL, 90.0 mmol, 2.4 equiv) was 
cannulated in from an adjacent volumetric flask also at -78 °C.  A 2.5 M solution of n-
BuLi in hexanes (22.5 mL, 56.3  mmol, 1.5 equiv) was syringed into the cold solution 
causing the reaction mixture to become white and thick (Note: mechanical stirring of this 
thick solution was critical to obtain a high yield).  After 10 min of stirring the thick 
solution, (S)-1,2-epoxyhexane (S)-4.22 (4.52 mL 37.5 mmol, 1.0 equiv) was added via 
syringe.1  After an additional 10 min of stirring, distilled BF3•OEt2 (5.1 mL, 41.3 mmol, 
1.1 equiv) was added dropwise over 10 min (Note: slow addition of BF3•OEt2 was critical 
for maintaining low reaction temperatures and high regioselectivity of the epoxide 
opening).  The solution was stirred for an additional 30 min before being quenched with 
sat. NaHCO3 (75 mL) at -78 °C.  The resulting mixture was thawed to room temperature 
over 1 h.  The aqueous phase was separated and then back extracted with Et2O (2 x 100 
mL).  The combined organic layers were dried over MgSO4, filtered, and carefully 
concentrated (10-20 °C on the rotary evaporator) to a yellow, salty oil.  Distillation (b.p. 
91 °C at 12 mm Hg) afforded homopropargylic alcohol 4.23 (4.62g, 33.0 mmol, 88% 
yield) as a fragrant, colorless oil.  [α]D = +4° (c 4.1, CH2Cl2); Rf = 0.7 (25% 
EtOAc/Hexanes, p-Anis - stains orange/pink); 1H NMR (400 MHz, CDCl3) δ 3.71 (tdd, J 













Hz, 1H), 1.90 (bs, 1H), 1.84 (t, J = 2.5 Hz, 3H), 1.59-1.50 (m, 2H), 1.49-1.26 (m, 4H), 
0.94 (t, J = 7.0 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 78.3, 75.4, 70.2, 35.9, 27.8, 27.7, 
22.7, 14.0, 3.5; IR (cast film) 3374, 2958, 2929, 2861, 1449, 1124, 1081, 1031, 907 cm-1 ; 
LRMS (FAB+) calc’d for C9H17O [M+H]+ 141.23, found 141.15. 
 
 
To a solution of alcohol 4.23 (701 mg, 5.0 mmol, 1.0 equiv) solvated in 
anhydrous CH2Cl2 (50 mL, 0.1 M) was added Et3N (0.91 mL, 6.5 mmol, 1.3 equiv).  The 
resulting mixture was cooled to 0 °C and chlorodiphenylsilane (1.07 mL, 5.5 mmol, 1.1 
equiv) was added.  The cold bath was removed and the solution was allowed to thaw to 
room temperature.  After 30 min, the solution was concentrated down to a salty oil, 
retaken in hexanes and filtered over a flame-dried filter frit to remove the white 
Et3N•HCl salts.  The resulting filtrate was concentrated down to an orange/brown oil.  
Crude silyl-ether 4.24 was taken on to the next reaction without further purification.  1H 
NMR (300 MHz, CDCl3) δ  7.75-7.62 (m, 4H), 7.51-7.33 (m, 6H), 5.52 (s, 1H), 4.02-3.88 
(m, 1H), 2.39 (dtt, J = 8.4, 5.3, 2.9 Hz, 2H), 1.75 (t, J = 2.6 Hz, 3H), 1.71-1.49 (m, 2H), 
1.48-1.18 (m, 4H), 0.87 (t, J = 6.9 Hz, 2H); 13C NMR (100 MHz, CDCl3) δ 134.7, 134.3, 

















Crude silyl-ether 4.28 (ca. 1.6g, 5.0 mmol, 1.0 equiv) was solvated in anhydrous 
CH2Cl2 (10 mL, 0.5 M) and transferred to a glass bomb-liner.  The bomb-liner was 
inserted into a Parr bomb device, which was sealed and purged three times with CO gas 
(Note: the bomb was charged to 500 psi and vented down to 100 psi for each purge).  The 
bomb was charged with a final 500 psi H2 and stirred for 5 min to saturate the solvent 
with CO.  Following this initial saturation, the bomb was vented and temporarily opened 
to add Rh(acac)(CO)2 (13 mg, 0.05 mmol, 0.01 equiv) to the solution.  The bomb was 
subsequently resealed and purged three times with CO gas before being charged with a 
final 500 PSI H2.  After 16 h of vigorous stirring, the bomb was vented and opened.  The 
resulting brown solution was concentrated and purified by silica gel chromatography (5% 
EtOAc/Hexanes) to afford silacycle-aldehyde 4.25 (1.35g, 3.85 mmol, 77% Yield over 2 
steps) as a bright yellow oil.  (Note: the desired product exhibited mild degradation on 
silica gel.  Though the product was isolated above in high purity, it was also possible to 
filter the crude residue from this reaction over a short pad of pH 7 buffered SiO2 gel4 to 
afford the desired product in higher yields (ca. 85-90% over 2 steps) with acceptable 
purity for use in general procedure 2).  [α]D = -8° (c 3.5, CH2Cl2); Rf = 0.4 (5% 
EtOAc/Hexanes, PMA); 1H NMR (400 MHz, CDCl3) δ 9.59 (s, 1H), 7.67 (ddt, J = 8.3, 
6.6, 1.5 Hz, 4H), 7.52 ? 7.37 (m, 6H), 4.39-4.28 (m, 1H), 3.12 (ddd, J = 18.2, 5.5, 1.3 Hz, 
                                                
4 pH 7 buffered SiO2 gel was prepared my adding 10% pH 7 buffer (by mass) to a 
roundbotttom flask half filled with SiO2 gel.  The resulting mixture was rotated on a 












500 psi CO, O/N
1% Rh(acac)(CO)2
Filtered over Celite




1H), 2.57 (ddq, J = 18.2, 8.2, 1.9 Hz, 1H), 2.00 (t, J = 1.5 Hz, 3H), 1.83 (dddd, J = 17.3, 
10.1, 7.0, 5.1 Hz, 1H), 1.70 (ddt, J = 13.5, 10.9, 5.5 Hz, 1H), 1.60-1.32 (m, 3H), 0.94 (t, J 
= 7.2 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 192.7, 163.7, 144.7, 135.2, 135.1, 135.1, 
133.2, 132.8, 130.7, 130.6, 128.2, 128.2, 128.1, 76.1, 41.7, 38.3, 27.8, 22.7, 14.1, 13.3; 
IR (cast film) 2929, 2858, 1682, 1430, 1263, 1117, 1016, 920 cm-1 ; LRMS (FAB+) 
calc’d for C22H27O2Si [M+H]+ 351.54, found 351.27. 
 
 
Diene 4.58 (506 mg, 1.47 mmol, 1.0 equiv) was coupled with silacycle-aldehyde 
4.25 (516 mg, 1.47 mmol, 1.0 equiv) according to general procedure 2 using diamine 
(R,R)-4.1.  The crude material was purified by silica gel chromatography (15% 
EtOAc/Hexanes, pH 7 buffered SiO2 gel4) to afford compound 4.66 (783 mg, 1.12 mmol, 
76% Yield over 3 steps) as a yellow oil.  The diastereoselectivity of the reaction was 
determined to be >10:1 by 1H NMR analysis.  [α]D = +19° (c 2.5, CH2Cl2); Rf = 0.4 (20% 
EtOAc/Hexanes, PMA); 1H NMR (400 MHz, CDCl3) δ 7.71 (dt, J = 6.7, 1.6 Hz, 2H), 
7.59 (dt, J = 6.6, 1.5 Hz, 2H), 7.51-7.26 (m, 8H), 7.24-7.20 (m, 1H), 7.17 (dd, J = 8.0, 1.4 
Hz, 2H), 5.18 (dt, J = 9.3, 4.5 Hz, 1H), 5.05 (dt, J = 7.6, 5.0 Hz, 1H), 5.01-4.92 (m, 3H), 
3.54 (qt, J = 6.8, 3.4 Hz, 1H), 2.68-2.41 (m, 6H), 2.31 (dd, J = 14.2, 9.4 Hz, 1H), 2.05 (s, 
3H), 2.05 (d, J = 21.6 Hz, 1H), 2.00 (s, 3H), 1.98 ? 1.82 (m, 2H), 1.87 (s, 3H), 1.44-1.08 
(m, 6H), 1.01 (d, J = 6.9 Hz, 3H), 0.84 (t, J = 6.9 Hz, 3H), 0.75 (d, J = 6.9 Hz, 3H); 13C 























1) 10 mol % Sc(OTf)3
CH2Cl2, 0 °C, 2 hr
2) 1 equiv TBAF•3H2O
0 °C - RT, 16 h











130.1, 130.0, 128.4, 128.3, 127.9, 127.8, 126.0, 114.2, 86.2, 74.3, 72.3, 71.2, 40.5, 40.1, 
38.5, 37.2, 36.7, 33.7, 32.1, 27.8, 22.6, 21.1, 21.1, 14.0, 13.9, 11.4, 10.1; IR (cast film) 
3464, 2930, 2859, 1735, 1430, 1372, 1238, 1116, 1021, 991  cm-1 ; LRMS (FAB+) calc’d 
for C43H56O6Si [M+H]+ 698.00, found 697.62. 
 
 
Silacycle 4.66 (783 mg, 1.12 mmol, 1.0 equiv) was solvated in isopropanol (11 
mL, 0.1 M).  KHCO3 (561 mg, 5.60 mmol, 5.0 equiv) was added to the solution 
(sparingly soluble) followed by H2O2 as a 30% by weight solution in H2O (1.46 mL, 1.3 
ml/mmol, ca. 12 equiv).  The reaction mixture was vigorously stirred at room 
temperature, and the reaction progress was monitored by TLC analysis.  After 20 h, the 
reaction was quenched with brine (10 mL) and extracted with EtOAc (3 x 10 mL).  The 
combined organic phase was dried over MgSO4, filtered, and concentrated to a crude 
reaction residue.  This residue was purified by silica gel chromatography (35% 
EtOAc/Hexanes) to afford complex polyketide fragment 4.67 (362 mg, 0.68 mmol, 61% 
Yield) as a colorless oil.  The diastereoselectivity of the reaction was determined to be 
5:1 by 1H NMR analysis of the crude reaction residue.5  [α]D = +32° (c 1.0, CH2Cl2); Rf = 
0.4 (40% EtOAc/Hexanes, PMA); 1H NMR (400 MHz, CDCl3) δ  7.36-7.26 (m, 2H), 
7.26-7.15 (m, 3H), 5.10-4.98 (m, 3H), 4.93 (t, J = 1.2 Hz, 1H), 4.17-4.07 (m, 1H), 3.72 
(dt, J = 9.2, 2.7 Hz, 1H), 3.21 (d, J = 3.4 Hz, 1H), 2.83-2.69 (m, 2H), 2.70-2.54 (m, 3H), 
                                                
5 This	  ratio	  was	  further	  confirmed	  upon	  isolation	  of	  the	  minor	  methyl	  diastereomer	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2.48-2.35 (m, 2H), 2.21 (dd, J = 14.1, 9.9 Hz, 1H), 2.09 (s, 3H), 2.05 (d, J = 2.8 Hz, 1H), 
2.01 (s, 3H), 1.98-1.83 (m, 3H), 1.60-1.26 (m, 6H), 1.07 (d, J = 7.0 Hz, 3H), 1.00 (dd, J = 
6.9, 2.1 Hz, 6H), 0.97-0.90 (m, 3H); 13C NMR (100 MHz, CDCl3) δ 215.8, 170.6, 170.3, 
147.7, 141.1, 128.4, 128.3, 126.0, 114.6, 73.9, 73.0, 72.0, 67.5, 50.1, 48.4, 40.5, 39.9, 
38.9, 36.1, 33.7, 32.1, 27.7, 22.6, 21.0, 20.9, 14.0, 13.1, 11.1, 10.1; IR (cast film) 3457, 
2932, 1736, 1456, 1373, 1238, 1024, 975 cm-1 ; LRMS (FAB+) calc’d for C31H49O7 






Stereochemical Proofs.  For the coupled polyketide fragments 4.62, 4.63, and 4.65, 
stereochemical proofs of the newly formed alcohol stereocenter were achieved by 
Rychnovsky’s 13C NMR analysis of acetonides.2  For complex polyketide fragment 4.67, 
the orientation of the methyl stereocenter set during the tamao oxidation was established 
by nOe analysis from its acetonide derivitive 4.72.  All other stereocenters formed using 




Diol 4.62 (24 mg, 0.055 mmol, 1.0 equiv) was solvated in 2,2-dimethoxypropane 
(1 mL, 0.05 M).  p-TsOH•H2O (ca. 0.5 mg, 0.003 mmol, 0.05 equiv) was added, and the 
reaction was allowed to stir at room temperature.  After 20 min, the reaction was 
quenched with sat. NaHCO3 and extracted 3x with EtOAc.  The combined organic phase 
was dried over MgSO4, filtered, and concentrated.  The resulting residue was purified by 
silica gel chromatography (7% EtOAc/Hexanes) to afford syn-acetonide 4.68 (23 mg, 
0.048 mmol, 87% Yield) as a colorless oil.  The stereochemistry of the acetonide was 
verified by 13C NMR analysis (see below).  [α]D = +5° (c 2.3, CH2Cl2); Rf = 0.4 (10% 
EtOAc/Hexanes, PMA); 1H NMR (400 MHz, CDCl3) δ 7.36-7.26 (m, 4H), 7.21 (ddt, J = 
7.1, 3.1, 2.0 Hz, 6H), 5.17 (tt, J = 7.5, 5.4 Hz, 1H), 4.96-4.85 (m, 2H), 3.78 (ddd, J = 8.7, 
4.4, 2.1 Hz, 1H), 3.62 (dd, J = 10.1, 1.9 Hz, 1H), 2.81-2.55 (m, 4H), 2.42-2.27 (m, 2H), 























1H), 1.46 (s, 3H), 1.43 (s, 3H), 1.39 (dtd, J = 6.7, 4.7, 2.3 Hz, 1H), 1.07 (d, J = 6.7 Hz, 
3H), 0.86 (d, J = 6.7 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 170.7, 146.7, 142.1, 141.7, 
128.6, 128.4, 128.3, 126.0, 125.8, 113.4, 99.2, 77.2, 72.8, 72.2, 42.1, 39.2, 35.8, 34.5, 
33.2, 31.8, 31.7, 30.1, 21.2, 19.8, 17.9, 5.3; IR (cast film) 2939, 1736, 1455, 1376, 1240, 




Diol 4.63 (54 mg, 0.123 mmol, 1.0 equiv) was solvated in 2,2-dimethoxypropane 
(1.2 mL, 0.1 M).  p-TsOH•H2O (ca. 1 mg, 0.006 mmol, 0.05 equiv) was added, and the 
reaction was allowed to stir at room temperature.  After 30 min, the reaction was 
quenched with sat. NaHCO3 and extracted 3x with EtOAc.  The combined organic phase 
was dried over MgSO4, filtered, and concentrated.  The resulting residue was purified by 
silica gel chromatography (7% EtOAc/Hexanes) to afford anti-acetonide 4.69 (48 mg, 
0.100 mmol, 82% Yield) as a colorless oil.  The stereochemistry of the acetonide was 
verified by 13C NMR analysis (see below).  [α]D = -16° (c 1.4, CH2Cl2); Rf = 0.4 (10% 
EtOAc/Hexanes, PMA); 1H NMR (400 MHz, CDCl3) δ 7.35-7.26 (m, 4H), 7.22 (ddd, J = 
14.9, 6.9, 1.7 Hz, 6H), 5.11 (qd, J = 7.2, 4.8 Hz, 1H), 4.98 (s, 1H), 4.85 (d, J = 1.5 Hz, 
1H), 3.79 (dt, J = 9.2, 4.2 Hz, 1H), 3.30 (dd, J = 7.4, 3.7 Hz, 1H), 2.82 (ddd, J = 14.7, 
10.0, 5.2 Hz, 1H), 2.77-2.51 (m, 3H), 2.38 (dd, J = 14.6, 7.4 Hz, 1H), 2.30 (dd, J = 14.6, 























2H), 1.81 (dp, J = 14.2, 4.9 Hz, 1H), 1.76-1.68 (m, 1H), 1.63 (dtd, J = 13.3, 6.4, 3.2 Hz, 
1H), 1.35 (d, J = 1.3 Hz, 6H), 1.05 (d, J = 6.9 Hz, 3H), 0.86 (d, J = 6.8 Hz, 3H); 13C 
NMR (100 MHz, CDCl3) δ 170.6, 148.1, 142.3, 141.6, 128.4, 128.4, 128.3, 125.9, 125.7, 
112.8, 100.3, 76.9, 72.2, 68.9, 42.6, 40.3, 37.8, 35.8, 32.6, 32.4, 31.8, 25.4, 23.8, 21.2, 
14.1, 12.3; IR (cast film) 2936, 1736, 1496, 1455, 1378, 1239, 1166, 1140, 1023 cm-1 ; 
LRMS (FAB+) calc’d for C31H43O4 [M+H]+ 479.67, found 479.37. 
 
 
Diol 4.65 (29 mg, 0.054 mmol, 1.0 equiv) was solvated in 2,2-dimethoxypropane 
(1 mL, 0.05 M).  p-TsOH•H2O (ca. 0.5 mg, 0.003 mmol, 0.05 equiv) was added, and the 
reaction was allowed to stir at room temperature.  After 15 min, the reaction was 
quenched with sat. NaHCO3 and extracted 3x with EtOAc.  The combined organic phase 
was dried over MgSO4, filtered, and concentrated.  The resulting residue was purified by 
silica gel chromatography (10% EtOAc/Hexanes) to afford syn-acetonide 4.70 (48 mg, 
0.100 mmol, 82% Yield) as a pale yellow oil.  The stereochemistry of the acetonide was 
verified by 13C NMR analysis (see below).  [α]D = +6° (c 2.9, CH2Cl2); Rf = 0.3 (10% 
EtOAc/Hexanes, PMA); 1H NMR (500 MHz, CDCl3) δ 7.35-7.25 (m, 4H), 7.25-7.15 (m, 
6H), 5.16 (tt, J = 6.7, 2.9 Hz, 1H), 4.99 (q, J = 5.9 Hz, 1H), 4.91 (d, J = 17.8 Hz, 2H), 
3.78 (ddd, J = 8.4, 4.3, 2.0 Hz, 1H), 3.60 (dd, J = 10.1, 1.8 Hz, 1H), 2.75 (ddd, J = 14.2, 
9.2, 5.3 Hz, 1H), 2.69-2.54 (m, 3H), 2.30 (dt, J = 13.0, 6.6 Hz, 1H), 2.24 (d, J = 6.8 Hz, 
























7.3, 4.3 Hz, 1H), 1.45 (d, J = 11.1 Hz, 6H), 1.40-1.32 (m, 1H), 1.07 (d, J = 6.7 Hz, 3H), 
1.00 (d, J = 7.0 Hz, 3H), 0.87 (d, J = 6.7 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 170.6, 
170.4, 146.7, 142.1, 141.2, 128.6, 128.4, 128.3, 128.3, 126.0, 125.7, 113.6, 99.2, 77.2, 
74.3, 72.8, 72.7, 42.2, 39.3, 36.4, 34.5, 33.6, 33.3, 32.0, 31.7, 30.1, 21.1, 19.8, 17.8, 9.9, 
5.3; IR (cast film) 2986, 2939, 1736, 1455, 1373, 1233, 1199, 1020, 970 cm-1 ; LRMS 




A solution of diol 4.67 (60 mg, 0.113 mmol, 1.0 equiv) solvated in anhydrous 
CH2Cl2 was cooled to -78 °C.  2,6-Lutidine (20 µL, 0.170 mmol, 1.5 equiv) was added 
followed by TBS-OTf (31 µL, 1.2 equiv).  The solution was stirred for 20 min at -78 °C 
before being quenched with sat. NaHCO3.  The cold bath was removed, and the resulting 
mixture was allowed to thaw to room temperature.  The aqueous phase was extracted 3x 
with CH2Cl2, and the combined organic phase was dried over MgSO4, filtered, and 
concentrated.  The resulting residue was purified by silica gel chromatography (15% 
EtOAc/Hexanes) to afford TBS-ether 4.71 (61 mg, .094 mmol, 83% Yield) as a colorless 
oil.  [α]D = +23° (c 0.9, CH2Cl2); Rf = 0.3 (15% EtOAc/Hexanes, PMA); 1H NMR (400 
MHz, CDCl3) δ  7.36-7.25 (m, 2H), 7.25-7.14 (m, 3H), 5.07 (ddd, J = 9.2, 5.3, 3.6 Hz, 
1H), 5.04-4.94 (m, 2H), 4.91 (s, 1H), 4.24 (dt, J = 11.0, 5.5 Hz, 1H), 3.66 (dt, J = 8.5, 3.4 
Hz, 1H), 2.83-2.51 (m, 4H), 2.35 (dq, J = 13.8, 6.1, 4.8 Hz, 2H), 2.21 (dd, J = 14.3, 9.7 


























Hz, 3H), 1.55-1.39 (m, 2H), 1.31 (qd, J = 6.2, 5.2, 2.4 Hz, 5H), 1.06 (d, J = 7.1 Hz, 3H), 
1.00 (dd, J = 6.9, 2.1 Hz, 6H), 0.95-0.80 (m, 12H), 0.10 (s, 3H), 0.05 (s, 3H); 13C NMR 
(100 MHz, CDCl3) δ 213.5, 170.6, 170.4, 147.8, 141.2, 128.5, 128.3, 126.0, 114.3, 74.0, 
73.1, 71.9, 67.8, 51.2, 48.7, 40.4, 40.3, 38.6, 37.3, 33.6, 32.1, 27.2, 25.9, 22.8, 21.1, 21.0, 
18.0, 14.1, 13.0, 11.4, 10.2, -4.6; IR (cast film) 3517, 2956, 2931, 2858, 1738, 1459, 




A solution of ketone 4.71 (51 mg, 0.079 mmol, 1.0 equiv) in anhydrous THF (1.6 
mL, 0.05 M) was cooled to -78 °C.  A 1.0 M solution of DIBAl-H in hexanes (0.24 mL, 
0.237 mmol, 3.0 equiv) was slowly added over 1 min.  After 30 min, the reaction was 
quenched with a 1 M solution of tartaric acid at – 78 °C.  The resulting mixture was 
removed from the cold bath and allowed to thaw to room temperature.  The aqueous 
phase was extracted 3x with CH2Cl2, and the combined organic phase was dried over 
MgSO4, filtered, and concentrated.  The resulting residue was purified by silica gel 
chromatography (20% EtOAc/Hexanes) to afford the reduced product.  The isolated diol 
was determined to be an inseparable 2:1 mixture of diastereomers by 1H NMR analysis. 
The above mixture of diols (ca. 51mg, 0.079 mmol, 1.0 equiv) was solvated in 
2,2-dimethoxypropane (1 mL, 0.08 M).  p-TsOH•H2O (ca. 1 mg, 0.004 mmol, 0.05 
equiv) was added, and the reaction was allowed to stir at room temperature.  After 20 






























combined organic phase was dried over MgSO4, filtered, and concentrated.  The resulting 
residue was purified by silica gel chromatography (10% EtOAc/Hexanes) to afford a 2:1 
mixture of syn/anti-acetonides (45 mg, 0.065 mmol, 83% Yield over 2 steps) as a pale 
yellow oil.  The mixture of diastereomers was repurified by silica gel chromatography 
(15% Et2O/Hexanes) to afford a small amount of the major syn-acetonide 4.72 for full 
characterization. The stereochemistry of the major acetonide was verified by 13C NMR 
analysis (see below).  [α]D = +20° (c 0.9, CH2Cl2); Rf = 0.4 (10% EtOAc/Hexanes, 
PMA); 1H NMR (400 MHz, CDCl3) δ 7.36-7.25 (d, J = 4.6 Hz, 2H), 7.25-7.14 (m, 3H), 
5.12 (dt, J = 9.0, 4.6 Hz, 1H), 5.00 (q, J = 6.0 Hz, 1H), 4.92 (s, 1H), 4.83 (s, 1H), 3.90 
(qd, J = 8.0, 6.8, 4.0 Hz, 1H), 3.66-3.47 (m, 2H), 2.70-2.52 (m, 2H), 2.46-2.31 (m, 2H), 
2.25 (dd, J = 14.7, 8.6 Hz, 1H), 2.07 (s, 3H), 2.00 (s, 3H), 1.99-1.85 (m, 3H), 1.72 (ddd, J 
= 13.8, 9.2, 1.5 Hz, 1H), 1.48 (dddd, J = 9.1, 7.0, 4.9, 3.0 Hz, 2H), 1.39 (s, 3H), 1.37-1.22 
(m, 9H), 1.01 (dd, J = 7.1, 2.0 Hz, 6H), 0.92 (s, 12H), 0.79 (d, J = 6.5 Hz, 3H), 0.08 (d, J 
= 3.2 Hz, 6H); 13C NMR (100 MHz, CDCl3) δ 170.5, 170.3, 147.9, 141.3, 128.4, 128.3, 
125.9, 112.7, 97.4, 75.4, 74.4, 72.3, 71.2, 68.5, 41.7, 39.7, 39.0, 38.0, 37.8, 35.7, 34.0, 
32.0, 30.1, 26.6, 26.0, 23.0, 21.1, 21.1, 19.9, 18.1, 14.1, 12.5, 11.8, 10.0, -3.9, -4.4; IR 
(cast film) 2956, 2931, 2858, 1738, 1461, 1376, 1240, 1202, 1026 cm-1 ; LRMS (FAB+) 









nOe analysis of 4.72 unambiguously confirmed the orientation of the methyl stereocenter 
















1. Tokunaga, M.; Larrow, J. F.; Kakiuchi, F.; Jacobsen, E. N., Science 1997, 
277 (5328), 936-938. 
2. Rychnovsky, S. D.; Rogers, B.; Yang, G., J. Org. Chem. 1993, 58 (13), 
3511-3515. 





HPLC Chromatograms for Chapter 4 
All racemic dienes were prepared by reacting trichlorosilane 4.38 with the precursor 
aldehyde in a solution of DMF. 
 
 
HPLC chromatograms for compound 4.43: 
 
94% ee 















Acq. Operator   : Brian                        
Acq. Instrument : I strument 1                    Location : Vial 81
Injection Date  : 7/22/2011 2:38:03 PM         
                                                Inj Volume : 10.0 µl
Acq. Method     : C:\CHEM32\1\METHODS\SKL.M
Last changed    : 7/22/2011 1:18:00 PM by Brian
                  (modified after loading)
Analysis Method : C:\CHEM32\1\METHODS\ABS.M
Last changed    : 6/28/2012 4:38:45 PM by Jeff
                  (modified after loading)
Method Info     : This method is used to analyse the isocratic standard sample with standard
                  contitions.
 
Sample Info     : BSM-2-66a
                  Isoprenylation of hydrocinnamaldehyde
                  RACEMATE
                  OD 95:5 Hex:IPA
                  1 mL/min, 230 nm
                  
 






























                         Area Percent Report                         
=====================================================================
 
Sorted By             :      Retention Time
Multiplier:                   :      1.0000
Dilution:                     :      1.0000
Sample Amount:               :     10.00000  [wt%]   (not used in calc.)
Use Multiplier & Dilution Factor with ISTDs
 
Signal 1: DAD1 D, Sig=230,16 Ref=360,100
 
Peak RetTime Sig Type    Area      Height     Area  
  #   [min]            [mAU*s]     [mAU]        %
----|-------|---|----|----------|----------|--------|
   1   7.779  1  MM    161.61710   11.06059  49.7372
   2  11.374  1  MM    163.32510    7.30261  50.2628
 
Totals :               324.94220   18.36320
Data File C:\CHEM32\1\DATA\BSM\BSM-2-66A000005.D
Sample Name: BSM-2-66a
HPLC 6/28/2012 4:43:22 PM Jeff Page 1 of 2
=====================================================================
Acq. Operator   : Brian                        
Acq. Instrument : Instrument 1                    Location : Vial 81
Injection Date  : 7/22/2011 2:38:03 PM         
                                                Inj Volume : 10.0 µl
Acq. Method     : C:\CHEM32\1\METHODS\SKL.M
Last changed    : 7/22/2011 1:18:00 PM by Brian
                  (modified after loading)
Analysis Method : C:\CHEM32\1\METHODS\ABS.M
Last changed    : 6/28/2012 4:38:45 PM by Jeff
                  (modified after loading)
Method Info     : This method is used to analyse the isocratic standard sample with standard
                  contitions.
 
Sample Info     : BSM-2-66a
                  Isoprenylation of hydrocinnamaldehyde
                  RACEMATE
                  OD 95:5 Hex:IPA
                  1 mL/min, 230 nm
                  
 






























                         Area Percent Report                         
=====================================================================
 
Sorted By             :      Retention Time
Multiplier:                   :      1.0000
Dilution:                     :      1.0000
Sample Amount:               :     10.00000  [wt%]   (not used in calc.)
Use Multiplier & Dilution Factor with ISTDs
 
Signal 1: DAD1 D, Sig=230,16 Ref=360,100
 
Peak RetTime Sig Type    Area      Height     Area  
# [min]           [mAU*s] [mAU]     %
----|-------|---|----|----------|----------|--------|
   1   7.779  1  MM    161.61710   11.06059  49.7372
   2  11.374  1  MM    163.32510    7.30261  50.2628
 
Totals :               324.94220   18.36320
Data File C:\CHEM32\1\DATA\BSM\BSM-2-66A000005.D
Sample Name: BSM-2-66a
HPLC 6/28/2012 4:43:22 PM Jeff Page 1 of 2
=====================================================================
Acq. Operator   : Brian                        
Acq. Instrument : Instrument 1                    Location : Vial 81
Injection Date  : 7/23/2011 4:10:08 PM         
                                                Inj Volume : 10.0 µl
Acq. Method     : C:\CHEM32\1\METHODS\SKL.M
Last changed    : 7/23/2011 3:23:36 PM by Brian
                  (modified after loading)
Analysis Method : C:\CHEM32\1\METHODS\ABS.M
Last changed    : 6/29/2012 11:12:20 AM by Nate
                  (modified after loading)
Method Info     : This method is used to analyse the isocratic standard sample with standard
                 contitions.
 
Sample Info     : BSM-2-67a
                  Isoprenylation of hydrocinnamaldehyde
                  R,R
                 OD 95:5 Hex:IPA
                  1 mL/min, 230 nm
                  
 


























                      Area Percent Report                         
=====================================================================
 
Sorted By             :      Retention Time
Multiplier:                   :      1.0000
Dilution:                     :      1.0000
Sample Amount:               :     10.00000  [wt%]   (not used in calc.)
Use Multiplier & Dilution Factor with ISTDs
 




HPLC 6/29/2012 11:12:36 AM Nate Page 1 of 2
Peak RetTime Sig Type    Area      Height     Area  
  #   [min]            [mAU*s]     [mAU]        %
----|-------|---|----|----------|----------|--------|
1 8.138  1  MM     53.05380    3.50956   2.8410
   2  12.182  1  MM   1814.38416   73.03902  97.1590
 




                          *** End of Report ***
Data File C:\CHEM32\1\DATA\BSM\BSM-2-67A000006.D
Sample Name: BSM-2-67a






HPLC chromatograms for compound 4.45:   
 
86% ee 










Acq. Operator   : Brian                        
Acq. Instrument : Instrument 1                    Location : Vial 81
Injection Date  : 7/7/2011 5:37:03 PM          
                                                Inj Volume : 1.0 µl
Acq. Method     : C:\CHEM32\1\METHODS\SKL.M
Last changed    : 7/7/2011 5:20:49 PM by Brian
                  (modified after loading)
Analysis Method : C:\CHEM32\1\METHODS\ABS.M
Last changed    : 6/28/2012 5:08:58 PM by Jeff
                  (modified after loading)
Method Info     : This method is used to analyse the isocratic standard sample with standard
                  contitions.
 
Sample Info     : BSM-2-57A
                  *****A*****
                  Benzaldehyde Isoprenylation Racemate
                  OD 95:5 Hex:IPA
                  1 mL/min, 230 nm
                  
 


















                         Area Percent Report                         
=====================================================================
 
Sorted By             :      Retention Time
Multiplier:                   :      1.0000
Dilution:                     :      1.0000
Sample Amount:               :     10.00000  [wt%]   (not used in calc.)
Use Multiplier & Dilution Factor with ISTDs
 
Signal 1: DAD1 D, Sig=230,16 Ref=360,100
 
Peak RetTime Sig Type    Area      Height     Area  
  #   [min]            [mAU*s]     [mAU]        %
----|-------|---|----|----------|----------|--------|
   1  24.399  1  BB   1.43269e4   315.72733  49.9893
   2  26.739  1  BB   1.43331e4   290.96811  50.0107
 
Totals :              2.86600e4   606.69543
Data File C:\CHEM32\1\DATA\BSM\BSM-2-57A000004.D
Sample Name: BSM-2-57A
HPLC 6/28/2012 5:09:05 PM Jeff Page 1 of 2
=====================================================================
Acq. Operator   : Brian                        
Acq. Instrument : Instrument 1                    Location : Vial 81
Injection Date  : 7/7/2011 5:37:03 PM          
                                                Inj Volume : 1.0 µl
Acq. Method     : C:\CHEM32\1\METHODS\SKL.M
Last changed    : 7/7/2011 5:20:49 PM by Brian
                  (modified after loading)
Analysis Method : C:\CHEM32\1\METHODS\ABS.M
Last changed    : 6/28/2012 5:08:58 PM by Jeff
                  (modified after loading)
Method Info     : This method is used to analyse the isocratic standard sample with standard
                  contitions.
 
Sample Info     : BSM-2-57A
                  *****A*****
                  Benzaldehyde Isoprenylation Racemate
                  OD 95:5 Hex:IPA
       1 mL/min, 230 nm
                  
 


















                         Area Percent Report                         
=====================================================================
 
Sorted By             :      Retention Time
Multiplier:                   :      1.0000
Dilution:                     :      1.0000
Sample Amount:               :     10.00000  [wt%]   (not used in calc.)
Use Multiplier & Dilution Factor with ISTDs
 
Signal 1: DAD1 D, Sig=230,16 Ref=360,100
 
Peak RetTime Sig Type    Area      Height     Area  
  #   [min]            [mAU*s]     [mAU]        %
----|-------|---|----|----------|----------|--------|
   1  24.399  1  BB   1.43269e4   315.72733  49.9893
2  26.739  1  BB   1.43331e4   290.96811  50.0107
Totals :        2.86600e4   606.69543
Data File C:\CHEM32\1\DATA\BSM\BSM-2-57A000004.D
Sample Name: BSM-2-57A
HPLC 6/28/2012 5:09:05 PM Jeff Page 1 of 2
=====================================================================
Acq. Operator   : Brian                        
Acq. Instrument : Instrument 1                    Location : Vial 81
Injection Date  : 7/9/2011 5:03:00 PM          
                                                Inj Volume : 10.0 µl
Acq. Method     : C:\CHEM32\1\METHODS\SKL.M
Last changed    : 7/9/2011 5:49:30 PM by Brian
                 (modified after loading)
Analysis Method : C:\CHEM32\1\METHODS\ABS.M
Last changed    : 6/ 8/2012 4:58:56 PM by Jeff
                 (modified after loading)
Method Info     : This method is used to analyse the isocratic standard sample with standard
contitions.
 
Sample Info     : BSM-2-58A
                  Reaction *********A********
                  OD 99:1 Hex:IPA
                  1 mL/min, 230 nm
                  
 

































                         Area Percent Report                         
=====================================================================
 
Sorted By             :      Retention Time
Multiplier:                   :      1.0000
Dilution:                     :      1.0000
Sample Amount:               :     10.00000  [wt%]   (not used in calc.)
Use Multiplier & Dilution Factor with ISTDs
 
Signal 1: DAD1 G, Sig=220,16 Ref=360,100
 
Peak RetTime Sig Type    Area      Height     Area  
  #   [min]            [mAU*s]     [mAU]        %
----|-------|---|----|----------|----------|--------|
   1  25.107  1  MM   1.02578e5  1850.53357  93.1872
   2  28.747  1  MM   7499.36816  129.86911   6.8128
 




HPLC 6/28/2012 4:59:05 PM Jeff Page 1 of 2
=====================================================================
Acq. Operator   : Brian                        
Acq. Instrument : Instrument 1                    Location : Vial 81
Injection Date  : 7/9/2011 5:03:00 PM          
                                               Inj Volume : 10.0 µl
Acq. Method    : C:\CHEM32\1\METHODS\SKL.M
Last c anged    : 7/9/2011 5:49:30 PM by Bri n
              (modified after loading)
Analysis Method : C:\CHEM32\1\METHODS\ABS.M
Last changed    : 6/28/2012 4:58:56 PM by Jeff
                  (modified after loading)
Method Info     : This method is used to analyse the isocratic standard sample with standard
           contitions.
Sample Info     : BSM-2-58A
                  Reaction *********A********
                  OD 99:1 Hex:IPA
         1 mL/min, 230 nm
             
 

































                      Area Percent Report                         
=====================================================================
 
Sorted By             :      Retention Time
Multiplier:                   :      1.0000
Dilution:                  :      1.0000
Sample Amount:            :     10.00000  [wt%]   (not used in calc.)
Use Multiplier & Dilution Factor with ISTDs
 
Signal 1: DAD1 G, Sig=220,16 Ref=360,100
 
Peak RetTime Sig Type    Area      Height     Area  
  #   [min]            [mAU*s]     [mAU]        %
----|-------|---|----|----------|----------|--------|
   1  25.107  1  MM   1.02578e5  1850.53357  93.1872
   2  28.747  1  MM   7499.36816  129.86911   6.8128
 










HPLC chromatograms for compound 4.47:   
 
 86% ee 











Acq. Operator   : Brian                        
Acq. Instrument : Instrument 1                    Location : Vial 81
Injection Date  : 7/20/2011 4:30:23 PM         
                                                Inj Volume : 10.0 µl
Acq. Method     : C:\CHEM32\1\METHODS\SKL.M
Last changed    : 7/20/2011 4:07:25 PM by Brian
                  (modified after loading)
Analysis Method : C:\CHEM32\1\METHODS\ABS.M
Last changed    : 6/28/2012 5:05:12 PM by Jeff
                  (modified after loading)
Method Info     : This method is used to analyse the isocratic standard sample with standard
                  contitions.
 
Sample Info     : BSM-2-63a
                  Isopreny ation Racemate of cinnamalde yde
                  OD 95:5 Hex:IPA
                  1 mL/min, 230 nm
                  
 






























                         Area Percent Report                         
=====================================================================
 
Sorted By             :      Retention Time
Multiplier:                   :      1.0000
Dilution:                     :      1.0000
Sample Amount:               :     10.00000  [wt%]   (not used in calc.)
Use Multiplier & Dilution Factor with ISTDs
 
Signal 1: DAD1 A, Sig=254,4 Ref=500,100
 
Peak RetTime Sig Type    Area      Height     Area  
  #   [min]            [mAU*s]     [mAU]        %
----|-------|---|----|----------|----------|--------|
   1  11.391  1  MM   1.75598e4   815.82251  49.7891
   2  20.871  1  MM   1.77085e4   389.36655  50.2109
 




HPLC 6/28/2012 5:05:44 PM Jeff Page 1 of 2
=====================================================================
Acq. Operator   : Brian                        
Acq. Instrument : Instrument 1                    Location : Vial 81
Injection Date  : 7/20/2011 4:30:23 PM         
                                                Inj Volume : 10.0 µl
Acq. Method     : C:\CHEM32\1\METHODS\SKL.M
Last changed    : 7/20/2011 4:07:25 PM by Brian
                  (modified after loading)
Analysis Method : C:\CHEM32\1\METHODS\ABS.M
Last changed    : 6/28/2012 5:05:12 PM by Jeff
                  (modified after loading)
Method Info     : This method is used to analyse the isocratic standard sample with standard
                  contitions.
 
Sample Info     : BSM-2-63a
                  Isoprenylation Racemate of cinnamaldehyde
                  OD 95:5 Hex:IPA
                  1 mL/min, 230 nm
                  






























                       Area Percent Report                         
=====================================================================
 
Sorted By             :      Retention Time
Multiplier:                   :      1.0000
Dilution:                     :      1.0000
Sample Amount:               :     10.00000  [wt%]   (not used in calc.)
Use Multiplier & Dilution Factor with ISTDs
 
Signal 1: DAD1 A, Sig=254,4 Ref=500,100
 
Peak RetTime Sig Type    Area      Height     Area  
  #   [min]            [mAU*s]     [mAU]        %
----|-------|---|----|----------|----------|--------|
   1  11.391  1  MM   1.75598e4   815.82251  49.7891
2  20.871  1  MM   1.77085e4   389.36655  50.2109
 




HPLC 6/28/2012 5:05:44 PM Jeff Page 1 of 2
=====================================================================
Acq. Operator   : B ian            
Acq. Instrument : Instrument 1                    Location : Vial 81
Injection Date  : 7/21/2011 5:12:19 PM         
                                                Inj Volume : 10.0 µl
Acq. Method     : C:\CHEM32\1\METHODS\SKL.M
Last changed    : 7/21/2011 4:40:50 PM by Brian
                  (modified after loading)
Analysis Method : C:\CHEM32\1\METHODS\ABS.M
Last changed    : 6/28/2012 5:12:53 PM by Jeff
                  (modified after loading)
Method Info     : This method is used to analyse the isocratic standard sample with standard
                  contitions.
 
Sample Info     : BSM-2-65a
                  Isoprenylation of cinnamaldehyde
                  OD 95:5 Hex:IPA
                  1 mL/min, 230 nm
                 
 
































                         Area Percent Report                         
=====================================================================
 
Sorted By             :      Retention Time
Multiplier:                   :      1.0000
Dilution:                     :      1.0000
Sample Amount:               :     10.00000  [wt%]   (not used in calc.)
Use Multiplier & Dilution Factor with ISTDs
 
Signal 1: DAD1 D, Sig=230,16 Ref=360,100
 
Peak RetTime Sig Type    Area      Height     Area  
  #   [min]            [mAU*s]     [mAU]        %
----|-------|---|----|----------|----------|--------|
   1  12.334  1  MM   4140.47070  170.59232   7.2241
   2  23.493  1  MM   5.31738e4  1121.85962  92.7759
 




HPLC 6/28/2012 5:13:00 PM Jeff Page 1 of 2
=====================================================================
Acq. Operator   : Brian                        
Acq. Instrument : Instrument 1                    Location : Vial 81
Injection Date  : 7/21/2011 5:12:19 PM         
                                              Inj Volume : 10.0 µl
Acq. Method     : C:\CHEM32\1\METHODS\SKL.M
Last changed    : 7/21/2011 4:40:50 PM by Brian
                  (modified after loading)
Analysis Method : C:\CHEM32\1\METHODS\ABS.M
Last changed    : 6/28/2012 5:12:53 PM by Jeff
              (modi ied fter loading)
Method Info     : This method is used to analyse the isocratic standard sample with standard
                  contitions.
 
Sample Info     : BSM-2-65a
                  Isoprenylation of cinnamaldehyde
                  OD 95:5 Hex:IPA
                  1 mL/min, 230 nm
                  































                         Area Percent Report                         
=====================================================================
 
Sorted By          :    Retention Time
Multiplier:                   :      1.0000
Dilution:                  :      1.0000
Sample Amount:               :     10.00000  [wt%]   (not used in calc.)
Use Multiplier & Dilution Factor with ISTDs
 
Signal 1: DAD1 D, Sig=230,16 Ref=360,100
 
Peak RetTime Sig Type    Area      Height     Area  
  #   [min]            [mAU*s]     [mAU]        %
----|-------|---|----|----------|----------|--------|
   1  12.334  1  MM   4140.47070  170.59232   7.2241
2  23.493  1  MM   5.31738e4  1121.85962  92.7759
 










HPLC chromatograms for compound 4.49:   
 
 87% ee 











Acq. Operator   : Brian                        
Acq. Instrument : Instrument 1                    Location : Vial 81
Injection Date  : 7/7/2011 6:23:09 PM          
                                                Inj Volume : 10.0 µl
Acq. Method     : C:\CHEM32\1\METHODS\SKL.M
Last changed    : 7/7/2011 6:22:56 PM by Brian
                  (modified after loading)
Analysis Method : C:\CHEM32\1\METHODS\ABS.M
Last changed    : 6/28/2012 5:18:23 PM by Jeff
                  (modified after loading)
Method Info     : This method is used to analyse the isocratic standard sample with standard
                  contitions.
 
Sample Info     : BSM-2-57B
                  *****B*****
                  a-Methy -Cinnamaldehyde Isoprenylation R c mate
                  OD 95:5 Hex:IPA
                  1 mL/min, 230 nm
                  
 































                         Area Percent Report                         
=====================================================================
 
Sorted By             :      Retention Time
Multiplier:                   :      1.0000
Dilution:                     :      1.0000
Sample Amount:               :     10.00000  [wt%]   (not used in calc.)
Use Multiplier & Dilution Factor with ISTDs
 
Signal 1: DAD1 D, Sig=230,16 Ref=360,100
 
Peak RetTime Sig Type    Area      Height     Area  
  #   [min]            [mAU*s]     [mAU]        %
----|-------|---|----|----------|----------|--------|
   1   8.367  1  MM   1.95192e4  1229.96985  49.9015
   2   9.566  1  MM   1.95963e4  1064.27173  50.0985
 
Totals :              3.91155e4  2294.24158
Data File C:\CHEM32\1\DATA\BSM\BSM-2-57B000005.D
Sample Name: BSM-2-57B
HPLC 6/28/2012 5:18:34 PM Jeff Page 1 of 2
=====================================================================
Acq. Operator   : Brian                        
Acq. Instrument : Instrument 1                    Location : Vial 81
Injection Date  : 7/7/2011 6:23:09 PM          
                                                Inj Volume : 10.0 µl
Acq. Method     : C:\CHEM32\1\METHODS\SKL.M
Last changed    : 7/7/2011 6:22:56 PM by Brian
                  (modified after loading)
Analysis Method : C:\CHEM32\1\METHODS\ABS.M
Last changed    : 6/28/2012 5:18:23 PM by Jeff
                  (modified after loading)
Method Info     : This method is used to analyse the isocratic standard sample with standard
                  contitions.
 
Sample Info     : BSM-2-57B
                  *****B*****
                  a-Methyl-Cinnamaldehyde Isoprenylation Racemate
                  OD 95:5 Hex:IPA
                  1 mL/min, 230 nm
               






























                         Area Percent Report                         
=====================================================================
 
Sorted By             :      Retention Time
Multiplier:                   :      1.0000
Dilution:                     :      1.0000
Sample Amount:               :     10.00000  [wt%]   (not used in calc.)
Use Multiplier & Dilution Factor with ISTDs
 
Signal 1: DAD1 D, Sig=230,16 Ref=360,100
 
Peak RetTime Sig Type    Area      Height     Area  
  #   [min]            [mAU*s]     [mAU]        %
----|-------|---|----|----------|----------|--------|
   1   8.367  1  MM   1.95192e4  1229.96985  49.9015
   2   9.566  1  MM   1.95963e4  1064.27173  50.0985
 
Totals :              3.91155e4  2294.24158
Data File C:\CHEM32\1\DATA\BSM\BSM-2-57B000005.D
Sample Name: BSM-2-57B
HPLC 6/28/2012 5:18:34 PM Jeff Page 1 of 2
=====================================================================
Acq. Operator   : Brian                        
Acq. Instrument : Instrument 1        Location : Vial 81
Injection Date  : 7/9/2011 7:20:08 PM     
                                                Inj Volume : 10.0 µl
Acq. Method     : C:\CHEM32\1\METHODS\SKL.M
Last changed    : 7/9/2011 7:11:22 PM by Brian
                  (modified after loading)
Analysis Method : C:\CHEM32\1\METHODS\ABS.M
Last changed    : 6/28/2012 5:15:55 PM by Jeff
                  (modified after loading)
Method Info     : This method is used to analyse the isocratic standard sample with standard
                  contitions.
 
Sample Info     : BSM-2-58B
                  Reaction *********B********
                  OD 95:5 Hex:IPA
                  1 mL/min, 230 nm
                  
 































                         Area Percent Report                         
=====================================================================
 
Sorted By             :      Retention Time
Multiplier:                   :      1.0000
Dilution:                     :      1.0000
Sample Amount:               :     10.00000  [wt%]   (not used in calc.)
Use Multiplier & Dilution Factor with ISTDs
 
Signal 1: DAD1 D, Sig=230,16 Ref=360,100
 
Peak RetTime Sig Type    Area      Height     Area  
  #   [min]            [mAU*s]     [mAU]        %
----|-------|---|----|----------|----------|--------|
   1   8.355  1  MM   2490.49487  151.44154   6.6238
   2   9.572  1  MM   3.51085e4  1857.52759  93.3762
 
Totals :              3.75990e4  2008.96913
 
Data File C:\CHEM32\1\DATA\BSM\BSM-2-58B000 1.
Sample Name: BSM-2-58A
HPLC 6/28/2012 5:16:07 PM Jeff Page 1 of 2
=============== =====================================================
Acq. Operator   : Brian                        
Acq. Instrument : Instrument 1                    Location : Vial 81
Injection Date  : 7/9/2011 7:20:08 PM         
                                               Inj Volume : 10.0 µl
Acq. Met     : C:\CHEM32\1\METHODS\SKL.M
Last cha ged    : 7/9/2011 7:11:22 PM by Brian
                  (modified after loading)
Analysis Method : C:\CHEM32\1\METHODS\ABS.M
Last changed    : 6/28/2012 5:15:55 PM by Jeff
                  (modified after loading)
Method Info     : This method is used to analyse the isocratic standard sample with standard
                  contitions.
 
Sample Info : BSM-2-58B
                  Reaction *********B********
                 OD 95:5 Hex:IPA
        1 mL/min, 230 nm
           
 































                       Area Percent Report                         
=====================================================================
 
Sorted By             :      Retention Time
Multiplier:                   :      1.0000
Dilution:                     :      1.0000
Sample Amount:               :     10.00000  [wt%]   (not used in calc.)
Use Multiplier & Dilution Factor with ISTDs
 
Signal 1: DAD1 D, Sig=230,16 Ref=360,100
 
Peak RetTime Sig Type    Area      Height     Area  
 # [min]           [mAU*s]  [mAU]     %
----|-------|---|----|----------|----------|--------|
   1   8.355  1  MM   2490.49487  151.44154   6.6238
   2   9.572  1  MM   3.51085e4  1857.52759  93.3762
 










HPLC chromatograms for compound 4.51:   
 
  96% ee 










Acq. Operator   : Sam                          
Acq. Instrument : Instrument 1                    Location : Vial 11
Injection Date  : 9/7/2011 1:48:59 PM          
                                                Inj Volume : 5.0 µl
Acq. Method     : C:\CHEM32\1\METHODS\SKL.M
Last changed    : 9/7/2011 1:59:44 PM by Sam
                  (modified after loading)
Analysis Method : C:\CHEM32\1\METHODS\ABS.M
Last changed    : 6/28/2012 5:28:23 PM by Jeff
                  (modified after loading)
Method Info     : This method is used to analyse the isocratic standard sample with standard
                  contitions.
 
Sample Info     : SKR9-078a
                  (Racemate) Cis-Crotylation of Hydrocinnamaldehyde
                  AD-H Hex/IPA 95:5
                  1 mL/min, 254 nm
                  
 





























                         Area Percent Report                         
=====================================================================
 
Sorted By             :      Retention Time
Multiplier:                   :      1.0000
Dilution:                     :      1.0000
Sample Amount:               :     10.00000  [wt%]   (not used in calc.)
Use Multiplier & Dilution Factor with ISTDs
 
Signal 1: DAD1 A, Sig=254,4 Ref=500,100
 
Peak RetTime Sig Type    Area      Height     Area  
  #   [min]            [mAU*s]     [mAU]        %
----|-------|---|----|----------|----------|--------|
   1   7.123  1  MM    374.16617   39.00862  50.2568
   2   7.873  1  MM    370.34189   34.64413  49.7432
 




HPLC 6/28/2012 5:28:33 PM Jeff Page 1 of 2
=====================================================================
Acq. Operator   : Sam                          
Acq. Instrument : Instrument 1                    Location : Vial 11
Injection Date  : 9/7/2011 1:48:59 PM          
                                                Inj Volume : 5.0 µl
Acq. Method     : C:\CHEM32\1\METHODS\SKL.M
Last changed    : 9/7/2011 1:59:44 PM by Sam
                  (modified after loading)
Analysis Method : C:\CHEM32\1\METHODS\ABS.M
Last changed    : 6/28/2012 5:28:23 PM by Jeff
                  (modified after loading)
Method Info     : This method is used to analyse the isocratic standard sample with standard
                  contitions.
 
Sample Info     : SKR9-078a
                  (Racemate) Cis-Crotylation of Hydrocinnamaldehyde
                  AD-H Hex/IPA 95:5
                  1 mL/min, 254 nm
           





























                       Area Percent Report                         
=====================================================================
 
Sorted By            :      Retention Time
Multiplier:                   :      1.0000
Dilution:                     :      1.0000
Sample Amount:               :     10.00000  [wt%]   (not used in calc.)
Use Multiplier & Dilution Factor with ISTDs
 
Signal 1: DAD1 A, Sig=254,4 Ref=500,100
 
Peak RetTime Sig Type    Area      Height     Area  
  #   [min]            [mAU*s]     [mAU]        %
----|-------|---|----|----------|----------|--------|
   1   7.123  1  MM    374.16617   39.00862  50.2568
   2   7.873  1  MM    370.34189   34.64413  49.7432
 




HPLC 6/28/2012 5:28:33 PM Jeff Page 1 of 2
=====================================================================
Acq. Operator   : Sam             
Acq. Instrument : Instrument 1                    Location : Vial 12
Injection Date  : 9/7/2011 2:25:41 PM          
                                                Inj Volume : 10.0 µl
Acq. Method     : C:\CHEM32\1\METHODS\SKL.M
Last changed    : 9/7/2011 2:39:24 PM by Sam
                  (modified after loading)
Analysis Method : C:\CHEM32\1\METHODS\ABS.M
Last changed    : 6/28/2012 5:24:43 PM by Jeff
                  (modified after loading)
Method Info     : This method is used to analyse the isocratic standard sample with standard
                  contitions.
 
Sample Info     : SKR9-077a
                  (R,R) Cis-Crotylation of Hydrocinnamaldehyde
                  AD-H Hex/IPA 95:5
                  1 mL/min, 254 nm
                 
 































                         Area Percent Report                         
=====================================================================
 
Sorted By             :      Retention Time
Multiplier:                   :      1.0000
Dilution:                     :      1.0000
Sample Amount:               :     10.00000  [wt%]   (not used in calc.)
Use Multiplier & Dilution Factor with ISTDs
 
Signal 1: DAD1 A, Sig=254,4 Ref=500,100
 
Peak RetTime Sig Type    Area      Height     Area  
  #   [min]            [mAU*s]     [mAU]        %
----|-------|---|----|----------|----------|--------|
   1   7.150  1  MM     30.46707    3.78520   1.6076
   2   7.890  1  MM   1864.66418  170.56212  98.3924
 




HPLC 6/28/2012 5:24:50 PM Jeff Page 1 of 2
=====================================================================
Acq. Operator   : Sam                          
Acq. Instrument : Instrument 1                    Location : Vial 12
Injection Date  : 9/7/2011 2:25:41 PM          
                                               Inj Volume : 10.0 µl
Acq. Meth d     : C:\CHEM32\1\METHODS\SKL.M
Last changed    : 9/7/2011 2:39:24 PM by Sam
                  (modified after loading)
Analysis Method : C:\CHEM32\1\METHODS\ABS.M
Last changed    : 6/28/2012 5:24:43 PM by Jeff
                  (modified after loading)
Method Info     : This method is used to analyse the isocratic standard sample with standard
                  contitions.
 
Sample Info     : SKR9-077a
                  (R,R) Cis-Crotylation of Hydrocinnamaldehyde
                  AD-H Hex/IPA 95:5
                  1 mL/min, 254 nm
           































                       Area Percent Report                         
=====================================================================
 
Sorted By       :     Retention Time
Multiplier:                   :      1.0000
Dilution:                     :      1.0000
Sample Amount:               :     10.00000  [wt%]   (not used in calc.)
Use Multiplier & Dilution Factor with ISTDs
 
Signal 1: DAD1 A, Sig=254,4 Ref=500,100
 
Peak RetTime Sig Type    Area      Height     Area  
  #   [min]            [mAU*s]     [mAU]        %
----|-------|---|----|----------|----------|--------|
   1   7.150  1  MM     30.46707    3.78520   1.6076
2  7.890  1  MM   1864.66418  170.56212  98.3924
 










Chapter 7: Experimental Information for Chapter 5 
 
General Information. Unless otherwise stated, all chemical compounds were purchased from 
common commercial sources, and all reactions were carried out under an atmosphere of nitrogen 
in flame or oven-dried glassware with magnetic stirring unless otherwise indicated. Degassed 
solvents were purified by passage through an activated alumina column. Thin-layer 
chromatography (TLC) was carried out on glass backed silica gel TLC plates (250 µm) from 
Silicycle; visualization by UV light, phosphomolybdic acid (PMA), p-Anisaldehyde (p-Anis) or 
potassium permanganate (KMnO4) stain. Gas chromatographic analyses were performed on a 
Hewlett-Packard 6890 Series Gas Chromatograph equipped with a capillary split-splitless inlet 
and flame ionization detector with electronic pneumatics control using either a Supelco β-Dex 
120 (30 m x 0.25 mm) or Supelco β-Dex 325 (30 m x 0.25 mm) capillary GLC column. HPLC 
analysis was carried out on an Agilent 1200 Series using either a Chiralpak AD-H (250 × 4.5 mm 
ID) column or Chiralcel OD (250 × 4.5 mm ID) column. 1H NMR spectra were recorded on a 
Bruker DPX-300 (300 MHz), Bruker DRX-300 (300 MHz), Bruker AVIII nano bay-400 (400 
MHz), Bruker AVIII single bay-400 (400 MHz), Avance III 500 (500 mHz) or a Avance III 500 
Ascend magnet (500 MHz) spectrometer and are reported in ppm from CDCl3 internal standard 
(7.26 ppm). Data are reported as follows: (bs= broad singlet, s = singlet, d = doublet, t = triplet, q 
= quartet, p = quintet, h = hextet, sep = septet, m = multiplet, dd = doublet of doublets, ddd = 
doublet of doublet of doublets, dddd = doublet of doublet of doublet of doublets; coupling 
constant(s) in Hz; integration). Proton decoupled 13C NMR spectra were recorded on a Bruker 
DRX-300 (300 MHz), Bruker AVIII single bay-400 (400 MHz), Bruker AVIII nano bay-400 
(400 MHz), Avance III 500 (500 mHz) or a Avance III 500 Ascend magnet (500 MHz) 
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spectrometer and are reported in ppm from CDCl3 internal standard (77.0 ppm). Infrared spectra 
were recorded on a Nicolet Avatar 370DTGS FT-IR. Optical rotations were recorded on a Jasco 
DIP-1000 digital polarimeter. (APCI)-MS was conducted on a JMS-LCmate LCMS (JEOL). 
 
 
A 5 L, 2-neck roundbottom flask was evacuated and purged with N2.  (S,S)-(+)-1,2-
Diaminocyclohexane (60g, 525 mmol, 1.0 equiv) was chiseled out in 5g batches and added to the 
large roundbottom portionwise with minimal air exposure.  The diamine was solvated in MeOH 
(1.3 L, 0.4 M), and the flask was equipped with an overhead, mechanical stirrer and a N2 line.  p-
Bromobenzaldehyde (195g, 1,050 mmol, 2.0 equiv) was added at room temperature.  After 20 
min of stirring, newly formed diimine crashed out of the reaction solvent.  The heterogeneous 
mixture was stirred for a total of one hour before being cooled to 0 °C.  NaBH4 (43.7g, 1,155 
mmol, 2.2 equiv) was added in 5g portions every 5 min until the addition was complete.  
(Caution: The reaction bubbled vigorously during the NaBH4 addition!).  The 0 °C bath was then 
allowed to expire overnight while the reaction mixture stirred.  After 14 h, the reaction mixture 
was an opaque, solid slurry. Reaction aliquot 1H NMR analysis confirmed that all diimine had 
been consumed.  The reaction mixture was once again cooled to 0 °C and slowly quenched with 
deionized H2O (200 mL).  The resulting mixture was transferred portion-wise to a 2-L 
roundbottom flask and concentrated down to a yellow sludge.  This sludge was retaken in Et2O 
(800 mL) and H2O (600 mL), and the roundbottom was reequipped with a mechanical stirrer and 
cooled to 0 °C.  To this mixture, concentrated HCl (300 mL of a 12.1 M solution) was added in 
NH2


















50 mL portions.  (Caution: HCl addition caused a strong exotherm and salt formation!).  The 
heterogeneous solution was vigorously stirred for 1 h before being filtered over a large 2-L 
vacuum filter frit into a 4-L Erlenmeyer flask.  A red solution comes through with the desired, 
white diamine salt remaining in the funnel.  The desired solid was washed with 1 M HCl (2 L) 
solution and then Et2O (3 L) (Note: Purified Et2O was used for this wash.  A mixture of products 
was observed when Et2O stabilized with EtOH was employed).  The resulting wet solid was 
dried by aspirating open to air for 24 h, transferring to a large crystallizing dish and baking in an 
oven at 85 °C for 16 h to afford clean, dry Diamine•2 HCl (S,S)-5.13 (273g, 520 mmol, 99% 
yield) as a fluffy white powder. 1H NMR (500 MHz, DMSO-d6) δ 10.20 (bs, 2H), 9.95 (bs, 2H), 
8.02-7.50 (m, 8H), 4.25 (dd, J = 80.1, 13.2 Hz, 5H), 3.91-3.53 (m, 2H), 2.38-2.23 (m, 2H), 2.21-
1.70 (m, 5H), 1.22 (d, J = 10.5 Hz, 2H); 13C NMR (100 MHz, DMSO-d6) δ 133.16, 131.90, 
131.42, 122.87, 56.56, 47.29, 26.05, 22.65.  The remaining characterization data was consistent 





A flame-dried 1 L, 2-neck roundbottom flask was charged with Diamine•2HCl (S,S)-5.13 
(52.5g, 100 mmol, 1.0 equiv) and CH2Cl2 (330 mL, 0.3 M).  The slurry was cooled to 0 °C and 
allyltrichlorosilane (16 mL, 110 mmol, 1.1 equiv) was added.  Distilled DBU (64 mL, 430 mmol, 




• 2 HCl +
4 equiv DBU












solvated upon deprotonation and the solution took on an amber hue.  After an additional 5 min of 
stirring, the solution was thawed to room temperature.  After 1 h, a reaction aliquot NMR 
showed full conversion to the desired product.  The solvent was removed using air-free 
technique until the resulting oil became opaque and foamy. (Note: air-free technique involved 
placing the reaction flask in a room temperature water bath, connecting it to an adjacent -78 °C 
cold-finger and carefully reducing the pressure with a manometer partitioned through the pump 
manifold.  Upon satisfactory removal of solvent, the entire system was back-filled with N2). 
Pentane (330 mL) was then added to the oil at room temperature, and the solution was shaken 
vigorously for 5-15 min until the DBU•HCl salts powdered out into a fine white precipitate.  
This heterogeneous solution was stirred vigorously for an additional 1 h.  The tinted yellow 
supernatant was collected by filter-cannulation using Teflon tubing into a dry 1 L, 2-neck 
roundbottom flask.  Pentane (100 mL) was added to the remaining DBU•HCl salts and the flask 
was shaken vigorously.  The supernatant was again filter cannulated into the new 1-L, 2-Neck rb.  
This process was repeated a second time with a pentane (50 mL) wash.  The solvent was again 
removed using air-free technique until the resulting oil became opaque and foamy.  The product 
oil was retaken in boiling pentane (50 mL, 2.0 M) and a seed crystal of previously purified 
prepared (S,S)-5.8 was added to the flask.  The flask was placed in a -20 °C freezer for ≥12 h to 
fully crystallize the product.  While the flask was still cold, the supernatant pentane was rotated 
away from the solid product and thawed to room temperature.  The pentane was removed from 
the flask via syringe and residual solvent was pumped off under vacuum.  The desired solid was 
broken up in the flask under a flow of N2 and transferred to a dry, tared flask to afford allyl-
silane (S,S)-5.8 (46g, 83 mmol, 83% yield) as a white, crystalline solid.  1H NMR (500 MHz, 
CDCl3) δ 7.48-7.38 (m, 4H), 7.33-7.22 (m, 4H), 5.64 (ddt, J = 15.9, 10.8, 7.8 Hz, 1H), 4.97-4.87 
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(m, 2H), 4.15 (d, J = 16.2 Hz, 1H), 4.00 (d, J = 15.0 Hz, 1H), 3.85 (d, J = 15.2 Hz, 2H), 2.76 
(dddd, J = 33.8, 12.0, 9.2, 3.1 Hz, 2H), 1.88-1.70 (m, 2H), 1.70-1.56 (m, 2H), 1.23-1.05 (m, 2H), 
1.05-0.87 (m, 2H); 13C NMR (125 MHz, CDCl3) δ 141.3, 140.4, 131.4, 131.2, 130.1, 129.2, 
120.8, 120.5, 116.5, 66.5, 65.6, 48.1, 47.4, 30.9, 30.5, 25.0, 24.9, 24.8. The remaining 




A flame-dried 2 L roundbottom flask was charged with allyl-silane reagent (S,S)-5.8 
(66.6g, 120 mmol, 1.2 equiv).  The allyl-silane was solvated in anhydrous CHCl3 (1 L, 0.1 M) 
and the flask was placed in a room temperature water bath.  Acetylacetone 5.7 (12 mL, 10g, 100 
mmol, 1.0 equiv) was rapidly added via syringe with vigorous reaction stirring.  (Note: the 
external water bath helps to maintain room temperature as the reaction begins with a mild 
exotherm).  The solution becomes bright yellow at first and goes on to turn a dark red with fine 
white salts floating in the solution as the reaction continues.  After stirring for 4 h, the reaction 
was cooled to 0 °C and TBAF•3H2O (37.9g, 120 mmol, 1.2 equiv) was added to quench the 
reaction.  The resulting solution was allowed to thaw to room temperature for 1 hr before being 
concentrated to a thick, red oil.  (Note: concentration by rotary evaporation must be done at 0-10 
°C to avoid evaporating the desired volatile product).  This oil was retaken in Et2O (500 mL, 0.2 
M) and the solution was shaken vigorously to crash out insoluble salts. 1 M HCl (500 mL, 0.2 M, 




O 1) CHCl3, RT, 4 hrs
2) 1.2 equiv TBAF•3H2O











9.3g / 65 mmol 92% Recovered
58g / 110 mmol
10g /100 mmol












crash out the diamine•HCl salts.  This heterogeneous mixture was filtered over a large, coarse 
filter frit and washed with Et2O (3 x 300 mL).  The filtrate was kept separate from the remaining 
solids on top of the filter frit.  These red/white solids were washed with 1 M HCl (1 L) until the 
solids were completely white.  These white solids were then washed with Et2O (1 L), aspirated 
open to air for ≥ 2 h, and baked in the oven at 85 °C for 16 h to afford recovered diamine•2HCl 
(S,S)-5.13 (58g, 110 mmol, 92% recovered) as a fluffy white powder.  The filtrate from above 
was concentrated at 0-10 °C down to a wet, red oil.  This oil was purified directly by silica gel 
chromatography (gradient 20%, 30%, 50%, 60% Et2O/Pentane, concentrated at 0-10 °C) to 
afford keto-alkene 5.9 (9.3g, 65 mmol, 65% yield) as a pale orange oil.  The enantiomeric excess 
of 5.9 was determined to be 89% by chiral GC (see GC trace below).  [α]D = -6° (c 4.7, CH2Cl2); 
Rf = 0.4 (25% EtOAc/Hexanes, PMA); 1H NMR (400 MHz, CDCl3) δ 5.81 (ddt, J = 17.5, 10.2, 
7.4 Hz, 1H), 5.16-4.97 (m, 2H), 3.83 (s, 1H), 2.64 (d, J = 17.3 Hz, 1H), 2.52 (d, J = 17.2 Hz, 
1H), 2.33-2.19 (m, 2H), 2.15 (s, 3H), 1.20 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 211.2, 134.2, 
118.6, 71.6, 51.9, 46.8, 32.1, 27.2; IR (cast film) 3459, 3077, 2977, 2932, 1702, 1641 cm-1; 




A flame-dried 1 L roundbottom flask was charged with CH2Cl2 (650 mL, 0.1 M).  
Tertiary alcohol 5.9 (9.3g, 65.4 mmol, 1.0 equiv) was added to the flask, followed by 2,6-lutidine 
(9.2 mL, 78.5 mmol, 1.2 equiv).  The roundbottom flask was equipped with a flame-dried 60 mL 
addition funnel and cooled to -78 °C.  TESOTf (16.3 mL, 72.0 mmol, 1.1 equiv) was carefully 
Me
O Me OH CH2Cl2, -78 °C




9.3g / 65 mmol 97% Yield




added to the addition funnel via syringe and dripped into the cold reaction mixture at a rate of  
~1 drop/sec.  The addition was complete in ca. 25 min, at which time TLC analysis confirmed 
full conversion to the desired product.  The reaction was quenched at -78 °C with MeOH (3.5 
mL, 85.0 mmol, 1.3 equiv) followed by sat. NH4Cl (250 mL).  The resulting mixture was 
allowed to thaw to room temperature for 1 h.  Lutidine salts were observed at the aqueous layer 
interface, and the organic phase was separated.  The organic phase was washed with 1 M AcOH 
(250 mL), then sat. NaHCO3 (250 mL) before being concentrated to a yellow oil.  This oil was 
retaken in 8% EtOAc/Hex and filtered over a pad of SiO2 gel (rinsed with four bed-lengths worth 
of 8% EtOAc/Hexanes – approximately 1.2 L of solvent).  The resulting solution was 
concentrated to afford tertiary silyl-ether 5.14 (16.3 g, 63.6 mmol, 97% yield) as a pale yellow 
oil. [α]D = +41° (c 2.0, CH2Cl2); Rf = 0.8 (10% EtOAc/Hexanes, PMA); 1H NMR (400 MHz, 
CDCl3) δ 5.83 (dddd, J = 17.0, 10.4, 8.0, 6.6 Hz, 1H), 5.14-4.98 (m, 2H), 2.58 (d, J = 13.5 Hz, 
1H), 2.46 (d, J = 13.5 Hz, 1H), 2.37 (ddt, J = 13.6, 6.5, 1.3 Hz, 1H), 2.27 (ddt, J = 13.6, 6.5, 1.3 
Hz, 1H), 2.17 (s, 3H), 1.31 (s, 3H), 0.95 (t, J = 7.9 Hz, 9H), 0.60 (q, J = 7.9 Hz, 6H); 13C NMR 
(100 MHz, CDCl3) δ 208.6, 134.6, 118.2, 75.1, 54.7, 47.7, 32.8, 28.0, 7.3, 7.0; IR (cast film) 
2956, 2912, 2877, 1711, 1640, 1457, 1356, 1239, 1139, 1080, 1030, 1005 cm-1; LRMS (FAB+) 









3) Cannulate into 
2 equiv LHMDS
4) 1 equiv AcCl






22g / 185 mmol bp = 15 mm Hg / 113 °C
1) 1 equiv LHMDS
   -78 °C, THF (1.0 M)
2) 1 equiv AcCl
83% Yield 




A 100 mL graduated cylinder, a 1 L roundbottom flask equipped with a large stir bar, and 
a 500 mL roundbottom flask equipped with a large stir bar were flame-dried.  A 1.0 M solution 
of lithium bis(trimethylsilyl)amide (LiHMDS) in THF was cannulated into the dry graduated 
cylinder for precise measurement and then re-cannulated into the roundbottom flask until the 1 L 
flask contained 370 mL of LiHMDS (370 mmol, 2.0 equiv) and the 500 mL flask contained 185 
mL of LiHMDS (185 mmol, 1.0 equiv).  Both flasks were cooled to -78 °C, and 
trimethylsilylethanol 5.28 (26.5 mL, 21.9g, 185 mmol, 1.0 equiv) was added to the 500 mL flask 
over 5 min.  A mild exotherm was observed and lithiated salts crashed out of the solution.  This 
mixture was stirred for an additional 5 min followed by the addition of acetyl chloride (AcCl) 
(13.2 mL, 185 mmol, 1.0 equiv) over 2 min.  Following AcCl addition, a vigorous exotherm was 
observed with some white HCl smoke fuming off the reaction.  The lithiated salts solvated 
completely during this process.  After 10 min of stirring, the exotherm subsided. 
 At this point, the reaction mixture containing intermediate ester 5.25 was cannulated into 
the 1 L flask also at -78 °C.  A mild exotherm was observed as well as a thickening of the 
reaction mixture.  The original 500 mL flask was rinsed with dry THF (2 x 20 mL) and 
cannulated into the 1 L flask.  Still at -78 °C, the second equivalent of acetyl chloride (13.2 mL, 
185 mmol, 1.0 equiv) was added to the reaction mixture over 1 h via syringe pump.  The reaction 
was stirred for an additional 15 min following the AcCl addition before being quenched by the 
addition of a 1.0 M HCl solution (300 mL) at -78 °C.  The reaction mixture was removed from 
the -78 °C bath and allowed to thaw to room temperature over 1.5 h before being poured into a 2-
L sepratory funnel and diluted with EtOAc (600 mL).  The 1 M HCl aqueous layer was 
separated, and the organic phase was washed with a mixture of 1 M HCl/Brine (200 mL 1 M 
HCl / 100 mL brine) mixture followed by a final brine wash (100 mL).  The organic phase was 
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dried over MgSO4, filtered and concentrated.  Distillation (b.p. 113 °C at 15 mm Hg) afforded β-
keto ester 5.29 (31g, 153 mmol, 83% yield) as a colorless oil, which exists as a ~10:1 mixture of 
Keto-Enol tautomers by NMR.  Rf = 0.5 (15% EtOAc/Hexanes, p-Anis); 1H NMR (500 MHz, 
CDCl3): Keto Form - δ 4.24 (m, 2H), 3.43 (s, 2H), 2.27 (s, 3H), 1.02 (m, 2H), 0.05 (s, 9H). Enol 
Form - δ 12.14 (s, 1H), 4.96 (s, 1H), 4.23 (m, 2H), 1.95 (s, 3H), 1.00 (m, 2H), 0.04 (s, 9H); 13C 
NMR (125 MHz, CDCl3): Keto Form - δ 200.8, 167.4, 63.9, 50.5, 30.3, 17.5, -1.4.  Enol Form - 
δ 90.1, 62.3, 21.4, 17.5, -1.5; IR (NaCl neat) 2956, 2900, 1742, 1720, 1650, 1414, 1361, 1317, 




A flame-dried 1 L roundbottom flask equipped with a large stir bar was charged with 
NaH (60% in suspension in mineral oil, 6.17g, 154 mmol, 1.05 equiv).  The NaH was solvated in 
THF (300 mL, 0.5 M) and the resulting slurry was cooled to 0 °C.  β-keto ester 5.29 (30g, 147 
mmol, 1.0 equiv) was added dropwise over 15 min.  During this addition, the solution yellowed 
and significant H2 gas evolution was observed.  This gas was vented from the reaction vessel 
using two 16G vent needles.  The reaction was stirred for an additional 20 min until the bubbling 
subsided.  The solution was then cooled to -78 °C and n-Buli (70 mL of a 2.3 M solution in 
hexanes, 160 mmol, 1.10 equiv) was added over 20 min. The solution changed color from yellow 
to dark orange and exothermed throughout the addition.  The resulting mixture was stirred for an 






1) 1.05 equiv NaH, THF, 0 °C
2) 1.1 equiv n-BuLi, -78 °C
3) 1.0 equiv BOM-Cl






30g / 147 mmol 65% Yield / 86% BRSM




was allowed to stir for an additional 10 min before being warmed to 0 °C in an ice bath.  As the 
solution warmed to 0 °C, the solution went from dark orange to yellow.  After 30 min, the 
reaction was quenched at 0 °C by slowly adding 1.0 M HCl (300 mL).  After 5 min, the 
quenched solution was allowed to thaw to room temperature.  The mixture was poured into a 2 L 
sepratory funnel and diluted with EtOAc (600 mL).  The aqueous layer was separated, and the 
organic phase was washed with brine (300 mL).  The organic phase was dried over MgSO4, 
filtered and concentrated.  Benzyl alcohol and unreacted starting material 5.29 was removed 
from the crude mixture by distillation to provide clean compound 5.29 (8g, 39 mmol, 26% 
recovered, b.p. 113 °C at 15 mm Hg). The remaining distillation residue was purified by silical 
gel column chromatography (gradient 10%, 15% EtOAc/Hexanes) to afford benzyl ether 5.24 
(31g, 96 mmol, 65% Yield, 86% BRMS) as a pale yellow oil, which exists as a ~9:1 mixture of 
Keto-Enol tautomers by NMR.  Rf = 0.4 (15% EtOAc/Hexanes, p-Anis); 1H NMR (400 MHz, 
CDCl3): Keto Form - δ 7.40-7.17 (m, 5H), 4.52 (s, 2H), 4.22 (m, 2H), 3.76 (t,  J = 6.2 Hz, 2H), 
3.48 (s, 2H), 2.84 (t, J = 6.2 Hz, 2H) 1.01 (m, 2H), 0.05 (s, 9H). Enol Form - δ 12.18 (s, 1H), 
7.40-7.17 (m, 5H), 5.05 (s, 1H), 4.54 (s, 2H), 4.24 (m, 2H), 3.71 (t, J = 6.5 Hz, 2H), 2.52 (t, J = 
6.5 Hz, 2H), 1.03 (m, 2H), 0.06 (s, 9H); 13C NMR (100 MHz, CDCl3): Keto Form - δ 201.6, 
167.4, 138.2, 128.6, 127.9, 73.5, 65.2, 63.9, 50.2, 43.3 36.0, 17.5, -1.3; IR (NaCl neat) 3436, 
3065, 3032, 2955, 2899, 1742, 1717, 1648, 1496, 1454, 1409, 1367, 1311, 1251 cm-1; LRMS 




















β-keto ester 5.24 (34g, 105 mmol, 1.0 equiv) was transferred to a large glass bomb-liner 
and solvated in a mixture of THF and MeOH (52 mL of each, 1.0 M total).  (R)-BINAP-RuCl2 
(420 mg, 0.53 mmol, 0.005 equiv) was added to the solution, which was stirred for about one 
minute.  The bomb-liner was inserted into a large Parr bomb device, which was sealed and 
purged three times with H2 gas (charged to 500 psi and vented down to 100 psi for each purge).  
The bomb was charged with a final 500 psi H2 and placed in an 80 °C oil bath.  After stirring for 
2 h at 80 °C, the bomb was carefully removed from the oil bath and allowed to cool to room 
temperature for an additional hour.  Once cool, the bomb was vented, and the reaction mixture 
was retaken in a solution of 25% EtOAc/Hexanes and filtered over a pad of SiO2 gel (rinsed with 
four bed-lengths worth of 25% EtOAc/Hexanes – approximately 1.2 L of solvent).  The resulting 
brown solution was concentrated to a dark brown oil and taken on to the next reaction without 
further purification.  A small portion of this crude material was purified by silica gel 
chromatography (15% EtOAc/Hexanes) to afford clean alcohol 5.30 for characterization.  The 
enantiomeric excess of 5.30 was determined to be 96% by chiral HPLC (see HPLC trace below).  
[α]D = +12° (c 2.0, CH2Cl2); Rf = 0.4 (20% EtOAc/Hexanes, PMA); 1H NMR (400 MHz, CDCl-
3) δ 7.47-7.17 (m, 5H), 4.53 (s, 2H), 4.34-4.13 (m, 3H), 3.84-3.54 (m, 2H), 3.39 (d, J = 3.4 Hz, 
1H), 2.49 (d, J = 6.3 Hz, 2H), 1.94-1.73 (m, 2H), 1.10-0.92 (m, 2H), 0.05 (s, 9H); 13C NMR (100 
MHz, CDCl3) δ 172.8, 138.3, 128.6, 127.9, 127.8, 73.5, 68.1, 67.1, 63.1, 41.9, 36.3, 17.5, -1.3; 
IR (cast film) 3506, 2953, 1730, 1454, 1250, 1168, 1100 cm-1; LRMS (FAB+) calc’d for 






Crude alcohol 5.30 (ca. 34g, 105 mmol, 1.0 equiv) was azeotroped with benzene (350 
mL, 0.3 Mz) in a 1 L roundbottom flask to remove adventitious water.  The resulting oil was 
pumped on, purged with N2, and solvated in CH2Cl2 (350 mL, 0.3 M).  Et3N (17.6 mL, 126 
mmol, 1.2 equiv) was added to the solution at room temperature.  The reaction mixture was 
cooled to 0 °C and TES-Cl (17.6 mL, 105 mmol, 1.0 equiv) was added over 5 min (the addition 
of TES-Cl caused a mild exotherm and HCl gas fumed off the reaction).  DMAP (642 mg, 5.25 
mmol, 0.05 equiv) was added at 0 °C and the reaction mixture was stirred for 5 min before being 
allowed to thaw to room temperature.  The reaction quickly became thick with Et3N•HCl salts.  
The reaction progress was monitored by TLC analysis, and showed complete conversion in less 
than 30 min.  At 30 min, the reaction was quenched by adding MeOH (8.5 mL, 210 mmol, 2.0 
equiv) to react with any remaining TES-Cl.  The resulting mixture was concentrated down to a 
brown, salty sludge, which was subsequently retaken in a solution 15% EtOAc/Hexanes and 
filtered over a pad of SiO2 gel (rinsed with four bed-lengths worth of 15% EtOAc/Hexanes – 
approximately 1.2 L of solvent).  The resulting amber solution was concentrated to a dark amber 
oil which was taken on to the next reaction without further purification.  A small portion of this 
crude material was purified by silica gel chromatography (15% EtOAc/Hexanes) to afford clean 
silyl ether 5.31 for characterization. [α]D = -5° (c 1.7, CH2Cl2); Rf = 0.8 (15% EtOAc/Hexanes, 
PMA); 1H NMR (500 MHz, CDCl3) δ 7.40-7.21 (m, 5H), 4.55-4.45 (m, 2H), 4.33 (dt, J = 11.8, 
6.2 Hz, 1H), 4.21-4.11 (m, 2H), 3.56 (td, J = 6.4, 1.6 Hz, 2H), 2.48 (d, J = 6.3 Hz, 2H), 1.91-1.76 
(m, 2H), 1.03- 0.97 (m, 2H), 0.95 (t, J = 8.0 Hz, 10H), 0.60 (q, J = 8.1 Hz, 6H), 0.05 (s, 9H); 13C 
NMR (100 MHz, CDCl3) δ 171.9, 138.7, 128.5, 127.8, 127.6, 73.1, 67.1, 66.8, 62.7, 43.5, 37.7, 


















17.5, 7.0, 5.2, -1.3; IR (cast film) 2953, 2876, 1733, 1453, 1414, 1384, 1249, 1164, 1098 cm-1; 




A 1 L roundbottom flask was evacuated and purged with N2.  The flask was charged with 
Pearlman’s catalyst, Pd(OH)2 - 20% by weight (3.69g, 5.25 mmol, 0.05 equiv) and again 
pump/purged with N2. THF (100 mL) was added to the Pd(OH)2 to givea black slurry.  Crude 
benzyl ether 5.31 (ca. 46g, 105 mmol, 1.0 equiv) was transferred into the flask with THF (600 
mL, 0.15 M total).  The roundbottom flask’s head space was then purged three times with a 1 L 
balloon of H2 gas.  A full 1 L H2 balloon was left on the reaction following the final purge.  After 
2 h of vigorous stirring, TLC analysis showed mostly the desired primary alcohol with some 
starting material remaining and some undesired diol formation seen as well. (NOTE:  Based on 
the quality of Pd(OH)2 used in the reaction, reaction times varied from 1.5-6 h.  The reaction was 
carefully monitored by TLC and stopped before overreaction occurred).  The reaction mixture 
was filtered over a pad of celite to remove the activated palladium.   The celite was rinsed with 
EtOAc until the eluent came through as a colorless liquid (ca. 500 mL).  The reaction crude was 
concentrated and purified by silica gel chromatography (gradient 10%, 15%, 20% 
EtOAc/Hexanes) to afford primary alcohol 5.32 (26.4g, 75.6 mmol, 72% yield over 3 Steps) as a 
pale yellow oil.  [α]D = -3° (c 2.8, CH2Cl2); Rf = 0.25 (15% EtOAc/Hexanes, KMnO4); 1H NMR 
(500 MHz, CDCl3) δ 4.48-4.30 (m, 1H), 4.23-4.10 (m, 2H), 3.90-3.67 (m, 2H), 2.55 (qd, J = 
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2H), 0.98 (d, J = 8.0 Hz, 9H), 0.63 (q, J = 8.1 Hz, 6H), 0.05 (s, 9H);  13C NMR (100 MHz, 
CDCl3) δ 171.7, 68.5, 62.9, 60.0, 42.8, 39.0, 17.5, 6.9, 6.9, 5.0, -1.3. IR (cast film) 3453, 2954, 
2878, 1733, 1459, 1415, 1385, 1310, 1250, 1162, 1090 cm-1; LRMS (FAB+) calc’d for 
C16H37O4Si2 [M+H]+ 349.64, found 349.30. 
 
 
A flame-dried, 1 L 2-neck roundbottom flask was charged with CH2Cl2 (350 mL, 0.1 M) 
and equipped with a flame-dried 60 mL addition funnel at room temperature.  Oxalyl chloride 
(5.5 mL, 64.2 mmol, 2.0 equiv) was added at room temperature and the resulting solution was 
cooled to -78 °C.  DMSO (6.8 ml, 96.4 mmol, 3.0 equiv) was rapidly added (Note: It is 
important to add the DMSO quickly so the liquid does not freeze in the syringe needle).  An 
exotherm as well as vigorous gas evolution were observed, and the resulting gas was vented with 
two 16G needles.  After stirring the reaction mixture for 20 min, alcohol 5.32 (11.2g, 32.1 mmol, 
1.0 equiv) was solvated in CH2Cl2 (20 mL) and transferred to the addition funnel.  The solution 
of alcohol 5.32 was dripped into the cold reaction at a rate of  ~1 drop/sec.  The addition was 
complete in ca. 30 min, and the addition funnel was rinsed with CH2Cl2 (10 mL).   The reaction 
was stirred at – 78 °C for an additional 30 min before Et3N was added to the reaction via the 
addition funnel over ca. 15 min.  The resulting thick white slurry was stirred vigorously at – 78 
°C for an additional 15 min before thawing to room temperature.  The solution yellowed and 
solvated many of the salts as it thawed to room temperature.  After 2 h, the reaction mixture was 












11g / 33 mmol
5.32




EtOAc/Hexanes and filtered over a pad of pH 7 buffered SiO2 gel6 (rinsed with four bed-lengths 
worth of 15% EtOAc/Hexanes – approximately 1.2 L of solvent).  The resulting solution was 
concentrated to a pale yellow oil which was taken on to the next reaction without further 
purification (Note: the resulting aldehyde was often stored as a solution frozen in benzene 
overnight, but not for longer than 24 h).  A small portion of this crude material was purified by 
silica gel chromatography (15% EtOAc/Hexanes, pH 7 buffered SiO2 gel) to afford clean 
aldehyde 5.33 for characterization. [α]D = -11° (c 1.4, CH2Cl2); Rf = 0.6 (10% EtOAc/Hexanes, 
p-Anis); 1H NMR (500 MHz, CDCl3) δ 9.83 (t, J = 2.1 Hz, 1H), 4.67 (qd, J = 6.4, 5.1 Hz, 1H), 
4.27-4.11 (m, 2H), 2.77-2.59 (m, 2H), 2.64-2.49 (m, 2H), 1.05-0.99 (m, 2H), 0.96 (t, J = 7.9 Hz, 
9H), 0.63 (q, J = 8.1 Hz, 6H);  13C NMR (100 MHz, CDCl3) δ 201.04, 170.90, 64.86, 62.90, 
50.97, 42.86, 17.30, 6.76, 4.78, -1.51; IR (cast film) 2955, 2878, 1729, 1459, 1414,1386, 1250, 




A 50 mL roundbottom flask was flame-dried and used to retrieve (-)-DIP-Chloride7 
(13.6g, 42.5 mmol, 1.3 equiv) from an argon glove-box.  This white, crystalline solid was 
quickly transferred to a flame-dried 500 mL roundbottom flask equipped with a large stir bar, 
which was subsequently pumped on for 5 min before being back-filled with N2.  The (-)-DIP-
                                                
6 pH 7 buffered SiO2 gel was prepared my adding 10% pH 7 buffer (by mass) to a roundbotttom 
flask half filled with SiO2 gel.  The resulting mixture was rotated on a rotary evaporated for >12 
h (at atmospheric pressure) and then stored for future use. 
7 Sigma-Aldrich Trademark 
Me
O OTESMe
1) (-)Ipc2BCl, Et3N, 0 °C
2)  -78 °C, Aldehyde 5.33
3) H2O2 in MeOH / pH 7








Chloride was solvated in Et2O (140 mL, 0.23 M) and the flask was cooled to 0 °C.  Et3N (6.85 
mL, 49.1 mmol, 1.5 equiv) was added to the cold solution with minimal Et3N•HCl salts 
observed.  Ketone 5.14 (9.34g, 36.4 mmol, 1.1 equiv) was azeotroped with benzene, pumped on, 
and back-filled with N2 before being transferred over 10 min to the 0 °C reaction mixture with 
Et2O (40 mL, 1.2 M).  Upon ketone addition, significant Et3N•HCl salt formation was 
immediately observed and full boron enolate formation was confirmed by reaction aliquot NMR.  
After 30 min of stirring, the reaction mixture was cooled to -78 °C.  Crude aldehyde 5.33 (ca. 
11.3g, 32.7 mmol, 1.0 equiv) was azeotroped with benzene, pumped on, and back-filled with N2 
before being transferred over 10 min to the -78 °C reaction mixture with Et2O (40 mL, 1.2 M).  
Upon aldehyde addition, a mild exotherm was observed.  The reaction was stirred at -78 °C for 3 
h and then placed in a 0 °C bath for an additional 15 min before being quenched with pH 7 
buffer (220 mL, 0.15 M).  The resulting mixture was allowed to thaw to room temperature.  The 
aqueous layer was separated from the yellow organic layer and then back extracted twice with 
Et2O (200 mL, 100 mL).  The combined organic phases were combined in a 2 L roundbottom 
flask and concentrated down to a yellow, oily mixture.  This mixture was retaken in MeOH (220 
mL, 0.15 M) and pH 7 buffer (220 mL, 0.15 M) and cooled to 0 °C.  H2O2 as a 30% by weight 
solution in H2O (43 mL, 1.3 ml/mmol, ca. 12 equiv) was added to the cold solution, resulting in a 
mild exotherm.  The mixture was stirred for 5 min before being allowed to thaw to room 
temperature.  After stirring for an additional 30 min, the reaction mixture was diluted with 
CH2Cl2 (250 mL) and the organic phase was separated.  The aqueous phase was extracted twice 
more with CH2Cl2 (200 mL, 100 mL).  The combined organic phases were dried over MgSO4, 
filtered and concentrated to a thick yellow oil.  Though full chromatographic purification was not 
required at this point, it was possible to recover all unreacted, starting material ketone through a 
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partial purification of the reaction mixture by silica gel chromatography (gradient 1%, 5%, 10% 
EtOAc/Hexanes,) to afford the starting material ketone 5.14 (2.5g, 9.9 mmol, 0.3 equiv) and the 
impure aldol adduct 5.34 which was taken on to the next reaction without further purification.  
The diastereoselectivity of the reaction was determined by 1H NMR to be 10:1 dr (inseparable), 
and a small portion of aldol adduct XX was more rigorously purified for characterization. [α]D = 
+20° (c 1.7, CH2Cl2); Rf = 0.3 (10% EtOAc/Hexanes, p-Anis – stains purple); 1H NMR (500 
MHz, CDCl3) δ 5.91-5.75 (m, 1H), 5.13-5.00 (m, 2H), 4.39 (p, J = 6.2 Hz, 1H), 4.21-4.09 (m, 
3H), 3.32 (d, J = 2.6 Hz, 1H), 2.70-2.42 (m, 6H), 2.38 (dd, J = 13.6, 6.5 Hz, 1H), 2.28 (dd, J = 
13.6, 8.0 Hz, 1H), 1.71 (ddt, J = 12.4, 9.0, 4.5 Hz, 1H), 1.61 (ddd, J = 13.9, 6.6, 3.1 Hz, 1H), 
1.32 (s, 3H), 0.96 (td, J = 7.9, 1.3 Hz, 20H), 0.61 (p, J = 8.0 Hz, 12H), 0.05 (s, 9H); 13C NMR 
(125 MHz, CDCl3) δ 210.9, 171.8, 134.5, 118.4, 75.2, 67.8, 65.5, 62.8, 54.4, 52.3, 47.8, 43.9, 
42.9, 28.1, 17.5, 7.3, 7.0, 5.1, -1.3; IR (cast film) 3532, 2964, 2913, 2878, 1734, 1415, 1379, 
1250, 1163, 1083, 1006 cm-1; LRMS (FAB+) calc’d for C30H62O6Si3 [M]+ 603.07, found 603.61. 
 
 
Semi-crude alcohol 5.34 (ca. 19.7g, 32.7 mmol, 1.0 equiv) was azeotroped with toluene, 
pumped on, and back-filled with N2 in a 1-L roundbottom flask.  THF (220 mL, 0.15 M) and 
Et3N (13.7 mL, 98.1 mmol, 3.0 equiv) were added at room temperature, and the resulting 
solution was cooled to 0 °C.  Ac2O (6.2 mL, 65.4 mmol, 2.0 equiv) and DMAP (1.0g, 8.2 mmol, 
0.25 equiv) were added to the cold mixture (Note: excess Ac2O was employed to acetylate any 
residual Ipc-OH from the Paterson aldol reaction).  After 5 min, the DMAP was fully solvated 






Et3N, CH2Cl2, 0 °C - RT
72% Yield over 3 Steps




by TLC and quenched after 45 min with MeOH (4mL, 98.1 mmol, 3.0 equiv).  The resulting 
mixture was concentrated to a cloudy, amber oil, retaken in a solution 15% EtOAc/Hexanes and 
filtered over a pad of SiO2 gel (rinsed with four bed-lengths worth of 15% EtOAc/Hexanes – 
approximately 1.2 L of solvent).  This solution was concentrated down to a crude residue and 
purified by silica gel chromatography (gradient 1%, 6%, 7%, 60% EtOAc/Hexanes) to afford 
acetate 5.35 (15.1g, 23.4 mmol, 72% yield over 3 Steps) as a pale yellow oil.  [α]D = -2° (c 2.0, 
CH2Cl2); Rf = 0.5 (10% EtOAc/Hexanes, p-Anis – stains purple); 1H NMR (400 MHz, CDCl3) δ 
5.83 (dddd, J = 16.9, 10.4, 8.0, 6.5 Hz, 1H), 5.26 (tt, J = 7.0, 5.4 Hz, 1H), 5.14-4.98 (m, 2H), 
4.27-4.06 (m, 3H), 2.85 (dd, J = 17.1, 7.0 Hz, 1H), 2.73 (dd, J = 17.1, 5.6 Hz, 1H), 2.65-2.41 (m, 
4H), 2.37 (ddt, J = 13.5, 6.5, 1.3 Hz, 1H), 2.28 (dd, J = 13.6, 8.0 Hz, 1H), 2.01 (s, 3H), 1.92-1.75 
(m, 2H), 1.31 (s, 3H), 1.07-0.84 (m, 20H), 0.61 (qd, J = 7.9, 2.8 Hz, 12H), 0.05 (s, 9H); 13C 
NMR (100 MHz, CDCl3) δ 206.6, 171.7, 170.3, 134.6, 118.3, 75.2, 67.5, 66.5, 62.7, 54.2, 49.7, 
47.5, 42.2, 42.2, 28.1, 21.2, 17.5, 7.3, 7.0, 7.0, 5.0, -1.3; IR (cast film) 2955, 2878. 1739, 1373, 





Alkene 5.35 (19.9g, 30.8 mmol, 1.0 equiv) was solvated in CH2Cl2 (310 mL, 0.1 M) in a 
1 L roundbottom flask.  Oxygen was bubbled through the reaction solvent as the flask was 
cooled to -78 °C.  After 5 min, the ozonizer was initiated and O3 was bubbled throught the -78 







1) O3, -78 °C , CH2Cl2
2) 1.2 equiv PPh3




analysis confirmed full conversion of the starting material (Rf = 0.8, 15% EtOAc/Hexanes, p-
Anis - stains light blue) to the intermediate ozonides (Rf = 0.6, 15% EtOAc/Hexanes, p-Anis - 
stains maroon).  After an additional 10 min of O3 bubbling, the ozonizer was turned off and O2 
was bubbled through the reaction solvent to purge out the excess O3.  After 20 min of purging 
with O2, the blue color dissipated.  After purging for an additional 20 min, PPh3 (9.71g, 37.0 
mmol, 1.2 equiv) was added at -78 °C.  The reaction mixture was removed from the cold bath 
and allowed to thaw to room temperature under an atmosphere of N2.  As the solution warmed, it 
took on a pale yellow color.  At 15 h, TLC analysis confirmed full consumption of the ozonide, 
and the reaction mixture was concentrated to a thick yellow oil.  This oil was retaken in hexanes 
(310 mL, 0.1 M), which immediately triturated out most of the crude phosphines.  This 
heterogeneous mixture was stirred vigorously for 10 min before being filtered into a 1 L 
roundbottom flask.  The phosphines were rinsed with additional hexanes (2 x 100 mL) and the 
resulting filtrate was concentrated down to a yellow oil.  The trituration process above was 
repeated a second time to provide the crude product as a pale yellow oil which was taken on to 
the next reaction without further purification (crude NMR analysis showed ca. 10 mol% 
phosphines remained mixed with the desired product).  A small portion of this crude material 
was purified by silica gel chromatography (10% EtOAc/Hexanes, pH 7 buffered SiO2 gel8) to 
afford relatively clean aldehyde 5.36 for characterization. [α]D = -13° (c 2.3, CH2Cl2); Rf = 0.5 
(15% EtOAc/Hexanes, p-Anis); 1H NMR (500 MHz, CDCl3) δ 9.81 (t, J = 2.5 Hz, 1H), 5.28 (pd, 
J = 7.2, 6.1, 1.8 Hz, 1H), 4.25-4.08 (m, 3H), 2.85-2.59 (m, 6H), 2.56 (dd, J = 15.2, 5.1 Hz, 1H), 
2.45 (dd, J = 15.2, 7.3 Hz, 1H), 2.01 (s, 3H), 1.82 (qdd, J = 14.2, 9.9, 4.9 Hz, 2H), 1.43 (s, 3H), 
                                                
8 pH 7 buffered SiO2 gel was prepared my adding 10% pH 7 buffer (by mass) to a roundbotttom 
flask half filled with SiO2 gel.  The resulting mixture was rotated on a rotary evaporated for >12 
h (at atmospheric pressure) and then stored for future use. 
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1.03-0.88 (m, 20H), 0.68-0.53 (m, 12H), 0.04 (s, 9H); 13C NMR (125 MHz, CDCl3) δ 205.6, 
202.0, 171.7, 170.3, 73.6, 67.3, 66.5, 62.8, 54.7, 54.6, 49.6, 42.4, 42.0, 29.2, 21.2, 17.5, 7.2, 7.0, 
6.9, 5.1, -1.3; IR (cast film) 2955, 2878, 1732, 1274, 1239, 1166, 1100, 1010 cm-1; LRMS 




Crude aldehyde 5.36 (ca. 20g, 30.8 mmol, 1.0 equiv) was azeotroped with toluene (2 x 
250 mL) in a 1 L roundbottom flask.  The flask was evacuated and back-filled with N2 before 
being charged with CH2Cl2 (310 mL, 0.1 M).  The solution was cooled to 0 °C and 
isoprenylation reagent (R,R)-5.37 (57 mL of a ~0.6 M stock solution in CH2Cl2, 34.0 mmol, 1.1 
equiv) was added followed by Sc(OTf)3 (759 mg, 1.54 mmol, 0.05 equiv).  The solution was 
vigorously stirred at 0 °C and took on a bright yellow color over time.  After 2 h, reaction aliquot 
NMR analysis indicated that all of the starting material had been consumed, and the reaction was 
quenched at 0 °C with TBAF•3H2O (10.7g, 34.0 mmol, 1.1 equiv).  The cold bath was allowed 
to expire overnight as the solution was stirred for an additional 12 h to allow for full silane 
cleavage and lactol formation.  The reaction mixture was concentrated down to a thick amber oil.  
This crude oil was retaken in a minimal amount of CH2Cl2 and filtered over a pad of SiO2 gel 
(rinsed with four bed-lengths worth of 10% EtOAc/Hexanes – approximately 1.2 L of solvent) to 
remove the TBAF and diamine byproducts.  The resulting solution was concentrated to a yellow 
oil which was retaken in 10% EtOAc/Hexanes and subjected to a second filtration over a pad of 






1) 5 mol% Sc(OTf)3
CH2Cl2, 0 °C, 2 h
2) 1.1 equiv
TBAF•3H2O
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(Note: A second filtration was only required due to the large scale of this reaction.  When the 
reaction procedure was performed on ca. 10g of 5.36, only one filtration was required).  The 
resulting crude yellow oil was taken on to the next reaction without further purification.  A small 
portion of this crude material was purified by silica gel chromatography (8% EtOAc/Hexanes) to 
afford relatively clean lactol 5.38 for characterization. 1D nOe analysis confirmed that the 
isolated lactol exists in the expected doubly anomeric form.  [α]D = -13° (c 1.8, CH2Cl2); Rf = 0.4 
(10% EtOAc/Hexanes, PMA); 1H NMR (400 MHz, CDCl3) δ 6.37 (dd, J = 17.5, 10.9 Hz, 1H), 
5.97 (s, 1H), 5.28 (d, J = 17.6 Hz, 1H), 5.27-5.14 (m, 1H), 5.09 (dt, J = 10.4, 4.4 Hz, 3H), 4.24 
(dtd, J = 13.4, 5.5, 2.7 Hz, 1H), 4.21-4.08 (m, 3H) 2.60 (ddd, J = 15.0, 4.4, 2.1 Hz, 2H), 2.41 (dd, 
J = 15.0, 8.2 Hz, 1H), 2.20 (dd, J = 13.9, 8.1 Hz, 1H), 2.02 (s, 3H), 2.06-1.89 (m, 2H), 1.89-1.78 
(m, 2H), 1.76 (dd, J = 13.5, 2.3 Hz, 1H), 1.68 (dt, J = 13.5, 2.2 Hz, 1H), 1.56 (d, J = 14.5 Hz, 
1H), 1.29 (s, 3H), 1.14 (dd, J = 13.5, 11.4 Hz, 1H), 1.04-0.86 (m, 20H), 0.60 (qd, J = 8.4, 8.0, 2.3 
Hz, 12H), 0.04 (s, 9H); 13C NMR (100 MHz, CDCl3) δ 171.9, 170.5, 142.7, 139.0, 118.3, 114.0, 
97.0, 74.0, 67.9, 66.8, 64.0, 62.6, 46.6, 45.5, 43.5, 43.5, 42.6, 38.0, 30.7, 21.6, 17.5, 7.1, 7.0, 6.7, 
5.1, -1.3; IR (cast film) 3455, 2955, 2878, 1736, 1374, 1244, 1168, 1084, 1044, 1011 cm-1; 




  Crude lactol 5.38 (ca. 22g, 30.8 mmol, 1.0 equiv) was solvated with a 1:1 mixture of THF 


















RT, t = 1.5 hH
Ca. 22g / Ca. 31 mmol
5.38
66% Yield over 3 Steps




0.25 equiv) was added to the reaction and the mixture was stirred at room temperature.  The 
yellow solution tinged brown over time, and the reaction progress was monitored by TLC.  At 
1.5 h, the reaction was quenched with Et3N (3.2 mL, 23.1 mmol, 0.75 equiv) and concentrated.  
The resulting crude oil was purified by silica gel chromatography (gradient 1%, 15%, 25% 
EtOAc/Hexanes) to afford clean spiroketal 5.39 (9.6g, 20.5 mmol, 66% Yield over 3 steps) as a 
single diastereomer.  The desired relative stereochemistry of 5.39 was rigorously confirmed by 
2D COSY and NOESY analyses.  [α]D = -55° (c 4.1, CH2Cl2); Rf = 0.2 (15% EtOAc/Hexanes, 
PMA); 1H NMR (400 MHz, CDCl3) δ 6.41 (dd, J = 17.6, 10.9 Hz, 1H), 5.30 (d, J = 17.6 Hz, 
1H), 5.18 (dt, J = 23.9, 1.6 Hz, 2H), 5.09 (d, J = 10.8 Hz, 1H), 5.04 (dt, J = 5.7, 2.8 Hz, 1H), 
4.43 (dddd, J = 11.1, 8.7, 4.4, 2.1 Hz, 1H), 4.30 (s, 1H), 4.31-4.23 (m, 1H), 4.21-4.10 (m, 2H), 
2.55 (ddd, J = 14.4, 6.5, 1.0 Hz, 1H), 2.51-2.38 (m, 2H), 2.34 (ddd, J = 14.3, 6.4, 1.0 Hz, 1H), 
2.05 (s, 3H), 2.02 (d, J = 15.0 Hz, 1H), 1.81 (dd, J = 14.2, 2.4 Hz, 1H), 1.77-1.67 (m, 2H), 1.62 
(dd, J = 15.1, 3.9 Hz, 1H), 1.60-1.52 (m, 1H), 1.45 (d, J = 13.9 Hz, 1H), 1.24 (dd, J = 13.5, 11.7 
Hz, 1H), 1.16 (s, 3H), 1.00 (ddd, J = 9.2, 8.1, 0.9 Hz, 2H), 0.04 (s, 9H); 13C NMR (125 MHz, 
CDCl3) δ 171.1, 171.0, 142.7, 139.2, 118.0, 113.9, 98.4, 68.0, 66.4, 65.0, 63.3, 62.3, 46.1, 43.6, 
40.8, 37.9, 37.4, 34.5, 30.2, 21.6, 17.5, -1.3; IR (cast film) 3530, 2953, 1731, 1402, 1366, 1249, 
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Tertiary alcohol 5.39 (13.7g, 29.2 mmol, 1.0 equiv) was azeotroped with benzene (250 
mL) in a 1 L roundbottom.  The flask was then evacuated and back-filled with N2 before being 
charged with THF (300 mL, 0.1 M).  Distilled pyridine (3.5 mL, 44.0 mmol, 1.5 equiv) was 
added to the solution at room temperature and the resulting mixture was cooled to 0 °C.  
Trifluoroacetic anhydride (TFAA) (5.0 mL, 35.2 mmol, 1.2 equiv) was added to the cold 
solution via syringe over 10 min.   A minor exotherm was observed upon TFAA addition.  The 
reaction was monitored by TLC and quenched at 0 °C with Et3N (5.0 mL, 35.2 mmol, 1.2 equiv) 
after 1 h.  Significant smoke was observed as Et3N•TFA salts formed.  After 5 min of vigorous 
stirring, sat. NaHCO3 (400 mL) was added to the cold solution, causing many salts to crash out 
of the solution.  The resulting mixture was allowed to thaw to room temperature and then diluted 
with EtOAc (250 mL).  The aqueous phase was separated and then back extracted with EtOAc (2 
x 200 mL).  The combined organic phases were dried over MgSO4, filtered and concentrated.  
The resulting crude oil was purified by silica gel chromatography (gradient 1%, 15%, 20% 
EtOAc/Hexanes) to afford clean tertiary trifluoroacetate 5.41 (16.0g, 28.3 mmol, 97% Yield) as a 
pale yellow oil.  (Note: For immediate use, the desired product can simply be filtered over a pad 
of SiO2 gel with 20% EtOAc/Hexanes to remove any remaining polar reaction byproducts.  Full 
chromatography was employed to obtain large quantities of highly pure material for long-term 
storage as a solution frozen in benzene).  [α]D = -68° (c 3.9, CH2Cl2); Rf = 0.5 (20% 
EtOAc/Hexanes, PMA); 1H NMR (500 MHz, CDCl3) δ 6.42 (dd, J = 17.6, 10.9 Hz, 1H), 5.30 (d, 
J = 17.6 Hz, 1H), 5.24-5.14 (m, 2H), 5.10 (d, J = 10.9 Hz, 1H), 5.04 (t, J = 3.2 Hz, 1H), 4.42 
(dddd, J = 13.4, 7.6, 5.7, 1.9 Hz, 1H), 4.33 (dtd, J = 11.4, 6.6, 1.8 Hz, 1H), 4.23-4.08 (m, 2H), 
2.85 (dd, J = 15.3, 2.2 Hz, 1H), 2.58 (dd, J = 14.2, 6.6 Hz, 1H), 2.49 (dd, J = 16.2, 5.8 Hz, 1H), 
2.36 (dd, J = 14.2, 6.8 Hz, 1H), 2.27 (dd, J = 16.2, 7.6 Hz, 1H), 2.05 (s, 3H), 2.16 (dt, J = 15.0, 
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2.1 Hz, 1H), 1.97 (dt, J = 15.0, 2.1 Hz, 1H), 1.87-1.78 (m, 1H), 1.60 (dd, J = 15.0, 4.2 Hz, 1H), 
1.57-1.46 (m, 4H), 1.38 (d, J = 15.2 Hz, 1H), 1.28 (dd, J = 14.1, 11.4 Hz, 1H), 0.98 (dd, J = 9.4, 
7.7 Hz, 2H), 0.05 (s, 9H); 13C NMR (125 MHz, CDCl3) δ 171.0, 170.9, 156.5 (q, J = 41.1 Hz), 
142.3, 139.1, 118.4, 114.5 (q, J = 286.5 Hz), 113.9, 97.0, 84.3, 66.8, 63.8, 62.7, 61.6, 41.9, 41.0, 
40.0, 37.6, 37.5, 33.9, 26.5, 21.6, 17.5, -1.4; IR (cast film) 2953, 1777, 1733, 1377, 1248, 1215, 




Tertiary trifluoroacetate 5.41 (14mg, 0.025 mmol, 1.0 equiv) was solvated in a 2.0 M 
solution of NH3 in EtOH (1 mL).  The solution was stirred at room temperature and the 
deprotection was monitored by TLC.  At 24 h, the reaction mixture was concentrated and the 
resulting oil was purified by silica gel chromatography (15% EtOAc/Hexanes) to afford clean 
tertiary alcohol 5.39 (11mg, 0.023 mmol, 94% Yield) as a pale yellow oil. The spectral 
properties of the isolated product were consistent with the characterization data reported above.  
(Note:  This reaction was performed to demonstrate that the removal of the TFA group is both 



























A flame-dried sealed tube was charged with Pd(PPh3)4 (18mg, 0.015 mmol, 0.01 equiv), 
evacuated and back-filled with N2.  AB-Fragment Diene 5.41 (847mg, 1.5 mmol, 1.0 equiv) was 
transferred to the sealed tube in a solution of anhydrous C6H6 (15 mL, 0.1 M) under an 
atmosphere of N2. Trichlorolsilane (0.30 mL, 3.0 mmol, 2.0 equiv) was added to the solution and 
the sealed tube was screwed closed.  The reaction vessel was placed in a 70 °C bath and the light 
yellow solution was stirred for 11 h.  The resulting light brown solution was allowed to cool to 
room temperature before being cannulated into a flame-dried, 100 mL roundbottom flask.  The 
sealed tube was rinsed with anhydrous C6H6 (2 x 3 mL), and the wash solution was cannulated 
into the 2-neck roundbottom flask.  The reaction mixture was concentrated down to a crude 
amber oil using air-free technique.  (Note: air-free technique involved placing the roundbottom 
flask in a 40 °C water bath, connecting it to an adjacent -78 °C cold-finger and carefully 
reducing the pressure with a manometer partitioned through the pump manifold.  Upon complete 
removal of solvent, the entire system was back-filled with N2).  The crude trichlorosilane was 













1 mol% Pd(PPh3)4 
2.0 equiv HSiCl3




































1) 4 equiv DBU



















Crude hydrosilylated product 5.45 was retaken in anhydrous CH2Cl2 (15 mL, 0.1 M) and 
diamine•2HCl salt (R,R)-5.13 (788mg, 1.5 mmol, 1.0 equiv) was added at room temperature.  
The resulting white slurry was cooled to 0 °C and distilled DBU (0.90 mL, 6.0 mmol, 4.0 equiv) 
was added to the reaction mixture over 10 min.  As DBU was added, the white salts solvated 
upon deprotonation and the solution took on an amber hue.  After an additional 5 min of stirring, 
the solution was thawed to room temperature.  After 2 h, the solvent was removed using air-free 
technique until the resulting yellow oil became opaque and foamy. (Note: air-free technique 
involved placing the roundbottom flask in a room temperature water bath, connecting it to an 
adjacent -78 °C cold-finger and carefully reducing the pressure with a manometer partitioned 
through the pump manifold.  Upon complete removal of solvent, the entire system was back-
filled with N2). The resulting oil was retaken in anhydrous Et2O (15 mL, 0.1 M) and shaken 
vigorously for 10 min until the DBU•HCl salts precipitated out as a white solid.  This 
heterogeneous solution was stirred vigorously for an additional 6.5 h to until the DBU•HCl salts 
became a very fine white precipitate.  The tinted yellow supernatant was filter-cannulated 
through a flame-dried, air-free filter frit into a flame-dried, 100 mL roundbottom flask.  Et2O (2x 
5 mL) was added to rinse the leftover DBU•HCl salts and the flask was shaken vigorously.  The 
supernatant was again filter-cannulated into the new 100 mL roundbottom flask. The solvent was 
again removed using air-free technique (room temperature bath) until the resulting yellow oil 
became opaque and foamy.  The resulting angelic-silane (R,R)-5.46 was retaken in anhydrous 






Angelic-silane (R,R)-5.46 (ca. 810 mg, 0.75 mmol, 1.0 equiv) in CH2Cl2 (7.5 mL, 0.1 M) 
from above was cooled to 0 °C.  Aldehyde coupling partner 5.53 (230 mg, 0.75 mmol, 1.0 equiv) 
was added to the cooled mixture followed by Sc(OTf)3 (37mg, 0.075 mmol, 0.10 equiv).  The 
reaction mixture was stirred vigorously at 0 °C for 2 h and then quenched with TBAF•3H2O (237 
mg, 0.75 mmol, 1.0 equiv).  The surrounding 0 °C bath was allowed to slowly expire over 16 h.  
This quenched reaction mixture was then concentrated down to a thick oil and purified by silica 
gel chromatography (gradient, 15%, 20% EtOAc/Hexanes) to afford coupled fragment 5.54 
(383mg, 0.44 mmol, 59% yield over 3 Steps from 5.41) as a pale yellow oil.  [α]D = -44° (c 2.6, 
CH2Cl2); Rf = 0.4 (20% EtOAc/Hexanes, PMA); 1H NMR (500 MHz, CDCl3) δ 7.32-7.24 (m, 
2H), 7.22-7.15 (m, 3H), 5.15 (s, 1H), 5.05-5.00 (m, 2H), 4.38-4.25 (m, 2H), 4.19-4.07 (m, 2H), 
4.04 (ddd, J = 7.6, 4.8, 2.2 Hz, 1H), 3.66 (dd, J = 9.7, 2.2 Hz, 1H), 3.33 (bs, 1H), 2.85 (dd, J = 
15.2, 2.2 Hz, 1H), 2.78 (ddd, J = 13.4, 11.3, 5.3 Hz, 1H), 2.56-2.42 (m, 2H), 2.43-2.34 (m, 2H), 
2.29-2.18 (m, 2H), 2.02 (s, 3H), 2.02-1.91 (m, 2H), 1.90-1.75 (m, 3H), 1.60 (dd, J = 15.0, 4.3 
Hz, 1H), 1.52 (s, 3H), 1.50-1.41 (m, 1H), 1.38 (d, J = 15.2 Hz, 1H), 1.32-1.24 (m, 2H), 1.06 (d, J 

































59% Yield over 3 Steps from 5.41
Significant TES deprotection
1) 10 mol% Sc(OTf)3
     CH2Cl2, 0 °C, 2 h
2) 1.0 equiv TBAF•3H2O










9H); 13C NMR (100 MHz, CDCl3) δ 171.1, 170.6, 156.4 (q, J = 41.6 Hz) 148.0, 142.4, 128.5, 
128.5, 126.0, 114.5 (q, J = 286.9 Hz), 113.4, 96.8, 84.3, 75.7, 72.4, 66.5, 63.6, 62.6, 61.5, 42.5, 
41.3, 41.1, 40.1, 40.0, 37.7, 35.4, 33.8, 33.4, 26.5, 21.6, 17.4, 11.5, 10.6, 7.1, 5.3, -1.4; IR (cast 
film) 3513, 2957, 2882, 1776, 1735, 1378, 1248, 1215, 1164, 1100, 1060, 1000, 977 cm-1; 




Angelic-silane (R,R)-5.46 (ca. 810 mg, 0.75 mmol, 1.0 equiv) in CH2Cl2 (7.5 mL, 0.1 M) 
from above was cooled to 0 °C.  Silacycle-aldehyde coupling partner 5.55 (263 mg, 0.75 mmol, 
1.0 equiv) was added to the cooled mixture followed by Sc(OTf)3 (37mg, 0.075 mmol, 0.10 
equiv).  The reaction mixture was stirred vigorously at 0 °C for 2 h and then quenched with 
TBAF•3H2O (237 mg, 0.75 mmol, 1.0 equiv).  The surrounding 0 °C bath was allowed to slowly 
expire over 10 h.  This quenched reaction mixture was then concentrated down to a thick oil and 
purified by silica gel chromatography (gradient, 15%, 20% EtOAc/Hexanes using pH 7 buffered 







































74% Yield over 3 Steps from 5.41
1) 10 mol% Sc(OTf)3
     CH2Cl2, 0 °C, 2 h
2) 1.0 equiv TBAF•3H2O







viscous, pale yellow oil.  [α]D = -33° (c 3.8, CH2Cl2); Rf = 0.3 (20% EtOAc/Hexanes, PMA); 1H 
NMR (500 MHz, CDCl3) δ 7.75-7.65 (m, 2H), 7.65-7.52 (m, 2H), 7.53-7.31 (m, 5H), 5.11 (dd, J 
= 7.2, 1.5 Hz, 2H), 5.05 (t, J = 3.2 Hz, 1H), 4.99 (s, 1H), 4.41 (dt, J = 13.0, 6.5 Hz, 2H), 4.23-
4.07 (m, 2H), 3.54 (bs, 1H), 2.89 (dd, J = 15.2, 2.2 Hz, 1H), 2.77-2.67 (m, 1H), 2.63-2.38 (m, 
5H), 2.30 (dd, J = 16.4, 7.3 Hz, 1H), 2.13 (dt, J = 14.5, 2.2 Hz, 1H), 2.02-1.97 (m, 1H), 2.01 (s, 
3H), 1.88 (s, 3H), 1.86-1.77 (m, 1H), 1.62 (dd, J = 15.0, 4.1 Hz, 1H), 1.58-1.50 (m, 1H), 1.56 (s, 
3H), 1.42 (d, J = 15.2 Hz, 1H), 1.39-1.08 (m, 9H), 0.98 (t, J = 8.5 Hz, 2H), 0.88-0.78 (m, 6H), 
0.06 (s, 9H); 13C NMR (100 MHz, CDCl3) δ 170.9, 170.5, 156.3 (q, J = 41.1 Hz), 155.9, 147.1, 
135.9, 135.1, 135.0, 134.5, 130.1, 130.1, 130.0, 127.8, 127.8, 114.3 (q, J = 287.4 Hz), 112.9, 
96.7, 86.4, 84.3, 71.2, 66.5, 63.4, 62.5, 61.3, 42.0, 41.7, 40.9, 40.2, 39.9, 37.5, 37.2, 36.8, 33.7, 
27.8, 26.4, 22.5, 21.4, 17.3, 14.0, 13.8, 11.4, -1.5; IR (cast film) 3517, 3075, 2961, 2930, 2862, 
1777, 1734, 1372, 1249, 1214, 1163, 1059, 1016, 997 cm-1; LRMS (FAB+) calc’d for 















































 Silacycle 5.56 (440 mg, 0.48 mmol, 1.0 equiv) was solvated in isopropanol (5 mL, 0.1 
M).  KHCO3 (240 mg, 2.40 mmol, 5.0 equiv) was added to the solution (sparingly soluble) 
followed by H2O2 as a 30% by weight solution in H2O (0.63 mL, 1.3 ml/mmol, ca. 12 equiv).  
The reaction mixture was vigorously stirred at room temperature, and the reaction progress was 
monitored by TLC analysis.  After 24 h, the reaction was quenched with brine (10 mL) and 
extracted with EtOAc (3 x 10 mL).  The combined organic phase was dried over MgSO4, 
filtered, and concentrated to a crude reaction residue.  The resulting crude residue was purified 
by silica gel chromatography (40% EtOAc/Hexanes) to afford keto-diol 5.57 (271mg, 0.36 
mmol, 75% yield) as a pale yellow oil.  The diastereoselectivity of the isolated product was 
determined to be 5:1 by 1H NMR analysis.  Rf = 0.4 (40% EtOAc/Hexanes, PMA); 1H NMR 
(500 MHz, CDCl3) δ 5.23 (s, 1H), 5.06-4.99 (m, 2H), 4.44-4.27 (m, 2H), 4.19-4.04 (m, 4H), 3.77 
(dt, J = 9.3, 2.2 Hz, 1H), 3.22 (bs, 1H), 2.85 (dd, J = 15.3, 2.4 Hz, 1H), 2.82-2.76 (m, 1H), 2.73 
(dd, J = 16.9, 2.5 Hz, 1H), 2.64-2.51 (m, 2H), 2.45 (dd, J = 16.7, 7.0 Hz, 1H), 2.35-2.19 (m, 4H), 
2.04 (s, 3H), 1.95-1.87 (m, 1H), 1.81-1.72 (m, 1H), 1.65-1.56 (m, 3H), 1.54 (s, 3H), 1.52-1.45 
(m, 1H), 1.43-1.24 (m, 7H), 1.15 (dd, J = 9.9, 7.0 Hz, 1H), 1.06 (d, J = 4.0 Hz, 3H), 1.05 (d, J = 
4.1 Hz, 3H), 0.95 (dd, J = 9.2, 7.9 Hz, 2H), 0.90 (t, J = 6.9 Hz, 3H), 0.03 (s, 9H); 13C NMR (125 
MHz, CDCl3) δ 216.2, 171.0, 170.8, 156.3 (q, J = 41.0 Hz) 147.4, 114.5, 114.3 (q, J = 286.7 Hz), 
96.9, 84.2, 73.2, 67.6, 66.5, 63.5, 62.7, 61.4, 50.8, 48.4, 42.6, 41.3, 41.2, 40.2, 40.0, 37.7, 36.3, 
33.8, 27.9, 26.5, 22.8, 21.6, 17.4, 14.2, 13.1, 11.0, -1.4; IR (cast film) 3497, 2947, 2933, 1778, 
1735, 1378, 1249, 1216, 1165, 1136, 1060, 1000 cm-1; LRMS (FAB+) calc’d for C36H59F3O11Si 
[M]+  753.93, found 753.45. 
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HPLC chromatograms for compound 5.30: 
 
96% ee 






















Acq. Operator   : Sam                          
Acq. Instrument : Instrument 1                    Location : Vial 21
Injection Date  : 1/7/2011 6:06:15 PM          
                                                Inj Volume : 20.0 µl
Acq. Method     : C:\CHEM32\1\METHODS\WAC.M
Last changed    : 1/7/2011 6:26:17 PM by Sam
                  (modified after loading)
Analysis Method : C:\CHEM32\1\METHODS\ABS.M
Last changed    : 6/28/2012 5:38:55 PM by Jeff
                  (modified after loading)
Method Info     : This method is used to analyse the isocratic standard sample with standard
                  contitions.
 
Sample Info     : Racemic Aldol Pdt SKR7-086
                  AD-H, Hex/IPA 98:2
                  1mL/min, 254 nm
                  
                  
                  
 

































                         Area Percent Report                         
=====================================================================
 
Sorted By             :      Retention Time
Multiplier:                   :      1.0000
Dilution:                     :      1.0000
Use Multiplier & Dilution Factor with ISTDs
 
Signal 1: DAD1 C, Sig=210,8 Ref=360,100
 
Peak RetTime Sig Type    Area      Height     Area  
  #   [min]            [mAU*s]     [mAU]        %
----|-------|---|----|----------|----------|--------|
   1  12.454  1  MM   1.05244e4   606.62604  49.9473
   2  13.368  1  MM   1.05466e4   575.89166  50.0527
 
Totals :              2.10711e4  1182.51770
 
Data File C:\CHEM32\1\DATA\SKR\SKR7086000002.D
Sample Name: Racemic Aldol
HPLC 6/28/2012 5:39:31 PM Jeff Page 1 of 2
=====================================================================
Acq. Operator   : Sam                          
Acq. Instrument : Instrument 1                    Location : Vial 21
Injection Date  : 1/7/2011 6:06:15 PM          
                                                Inj Volume : 20.0 µl
Acq. Method     : C:\CHEM32\1\METHODS\WAC.M
Last changed    : 1/7/2011 6:26:17 PM by Sam
                  (modified after loading)
Analysis Method : C:\CHEM32\1\METHODS\ABS.M
Last changed    : 6/28/2012 5:38:55 PM by Jeff
                  (modified after loading)
Method Info     : This method is used to analyse the isocratic standard sample with standard
                  contitions.
 
Sample Info     : Racemic Aldol Pdt SKR7-086
                  AD-H, Hex/IPA 98:2
                  1mL/min, 254 nm
                  
        
                  
 

































                         Area Percent Report                         
=====================================================================
 
Sorted By             :      Retention Time
Multiplier:                   :      1.0000
Dilution:                     :      1.0000
Use Multiplier & Dilution Factor with ISTDs
 
Signal 1: DAD1 C, Sig= 10,8 Ref=360,100
 
Peak RetTime Sig Type    Area      Height     Area  
  #   [min]            [mAU*s]     [mAU]        %
----|-------|---|----|----------|----------|--------|
   1  12.454  1  MM   1.05244e4   606.62604  49.9473
   2  13.368  1  MM   1.05466e4   575.89166  50.0527
 
Totals :              2.10711e4  1182.51770
 
Data File C:\CHEM32\1\DATA\SKR\SKR7086000002.D
Sample Name: Racemic Aldol
HPLC 6/28/2012 5:39:31 PM Jeff Page 1 of 2
=====================================================================
Acq. Operator   : sam                          
Acq. Instrument : Instrument 1                    Location : Vial 51
Injection Date  : 2/16/2012 1:01:03 PM         
                                                Inj Volume : 10.0 µl
Acq. Method     : C:\CHEM32\1\METHODS\ABS.M
Last changed    : 2/16/2012 1:16:45 PM by sam
                  (m dified after loading)
Analysis Method : C:\CHEM32\1\METHODS\ABS.M
Last changed    : 6/28/2012 5:35:52 PM by Jeff
                  (modified after loading)
Method Info     : This method is used to analyse the isocratic standard sample with standard
                  contitions.
 
Sample Info     : skr10-060a (R)-Noyori
                  AD-H 97:3 Hex/IPA
                  1.0 ml/min
                210nm
                  
                  
 






























                         Area Percent Report                         
=====================================================================
 
Sorted By             :      Retention Time
Multiplier:                   :      1.0000
Dilution:                     :      1.0000
Sample Amount:               :     10.00000  [wt%]   (not used in calc.)
Use Multiplier & Dilution Factor with ISTDs
 
Signal 1: DAD1 C, Sig=210,8 Ref=360,100
 
Peak RetTime Sig Type    Area      Height     Area  
  #   [min]            [mAU*s]     [mAU]        %
----|-------|---|----|----------|----------|--------|
   1  12.372  1  MM   8533.68750  428.80310  97.7871
   2  13.273  1  MM    193.11183    9.09061   2.2129
 
Totals :              8726.79933  437.89371
Data File C:\CHEM32\1\DATA\SKR\SKR10-060A0000 .D
Sample Name: skr10-060a
HPLC 6/28/2012 5:35:58 PM Jeff Page 1 of 2
=====================================================================
Acq. Operator   : sam                          
Acq. Instrument : Instrument 1                    Location : Vial 51
Injection Date  : 2/16/2012 1:01:03 PM         
                                                Inj Volume : 10.0 µl
Acq. Method     : C: CHE 32\1\METHODS\ABS.M
Last changed    : 2/16/2012 1:16:45 PM by sam
                  (modified after loading)
Analysis Method : C:\CHEM32\1\METHODS\ABS.M
Last chang    : 6/28/2012 5:35:52 PM by Jeff
            (modifi d aft r load ng)
Method Info     : This method is used to analyse the isocratic standard sample with standard
                  contitions.
Sample Info    : skr10-060a (R)-Noyori
                  AD-H 97:3 Hex/IPA
                1.0 ml/min
                 210nm
                
 





























          Area Percent Report                         
=====================================================================
 
Sorted By       :  Retention Time
Multiplier:                   :      1.0000
Dilution:                     :      1.0000
Sample Amount:               :     10.00000  [wt%]   (not used in calc.)
Use Multiplier & Dilution Factor with ISTDs
 
Signal 1: DAD1 C, Sig= 10,8 Ref=360,100
 
Peak RetTime Sig Type    Area      Height     Area  
  #   [min]            [mAU*s]     [mAU]        %
----|-------|---|----|----------|----------|--------|
   1  12.372  1  MM   8533.68750  428.80310  97.7871
   2  13.273  1  MM    193.11183    9.09061   2.2129
 
Totals :           8726.79933  437.89371
Data File C:\CHEM32\1\DATA\SKR\SKR10-060A00001.D
Sample Name: skr10-060a
HPLC 6/28/2012 5:35:58 PM Jeff Page 1 of 2
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GC chromatograms for compound 5.9: 
 
89% ee 







O 1) CH2Cl2, RT, 4 hrs
2) 1.2 equiv TBAF•3H2O











BrB3-P25 Dione allylation racemic
Isothermal 90oC 
beta-dex 120 & 325
=====================================================================
Injection Date  : 5/17/2010 6:30:39 PM         
Sample Name     : B3-P25rac                       Location : Vial 1
Acq. Operator   : wesman                               Inj :   1
                                                Inj Volume : Manually
Acq. Method     : C:\HPCHEM\2\METHODS\WESMAN.M
Last changed    : 5/17/2010 6:27:06 PM by wesman
                  (modified after loading)
Analysis Method : C:\HPCHEM\2\METHODS\SHUTDOWN.M
Last changed    : 2/9/2011 4:45:57 PM by greg
                  (modified after loading)
Shutdown





























                         Area Percent Report                         
=====================================================================
Sorted By             :      Signal
Multiplier            :      1.0000
Dilution              :      1.0000
Use Multiplier & Dilution Factor with ISTDs
Signal 1: FID1 A, 
Peak RetTime Type  Width     Area      Height     Area  
  #   [min]        [min]   [pA*s]      [pA]         %
----|-------|----|-------|----------|----------|--------|
   1  14.799 MM    0.1604  502.05014   52.17256 50.11322
   2  15.693 MM    0.1913  499.78159   43.53556 49.88678
Totals :                  1001.83173   95.70812
 Results obtained with enhanced integrator!
=====================================================================
                          *** End of Report ***
Data File C:\HPCHEM\2\DATA\WES\B3-P2501.D                                       Sample Name: B3-P25rac
Agilent 6890A GC 2/9/2011 4:46:01 PM greg Page 1 of 1
B3-P25 Dione allylation racemic
Isothermal 90oC 
beta-dex 120 & 325
=====================================================================
Injection Date  : 5/17/2010 6:30:39 PM         
Sample Name     : B3-P25rac                       Location : Vial 1
Acq. Operator   : wesman                               Inj :   1
                                                Inj Volume : Manually
Acq. Method     : C:\HPCHEM\2\METHODS\WESMAN.M
Last changed    : 5/17/2010 6:27:06 PM by wesman
                  (modified after loading)
Analysis Method : C:\HPCHEM\2\METHODS\SHUTDOWN.M
Last changed    : 2/9/2011 4:45:57 PM by greg
                  (modified after loading)
Shutdown





























                         Area Percent Report                         
=====================================================================
Sorted By             :      Signal
Multiplier            :      1.0000
Dilution              :      1.0000
Use Multiplier & Dilution Factor with ISTDs
Signal 1: FID1 A, 
Peak RetTime Type  Width     Area      Height     Area  
  #   [min]        [min]   [pA*s]      [pA]         %
----|-------|----|-------|----------|----------|--------|
 1 14.799 MM    0.1604  502.05014   52.17256 50.11322
   2  15.693 MM    0.1913  499.78159   43.53556 49.88678
Totals :                  1001.83173   95.70812
 Results obtained with enhanced integrator!
=====================================================================
                          *** End of Report ***
Data File C:\HPCHEM\2\DATA\WES\B3-P2501.D                                       Sample Name: B3-P25rac
Agilent 6890A GC 2/9/2011 4:46:01 PM greg Page 1 of 1
B5-P27 - diluted
90oC isothermal (50:1 sp t)
B-dex 125 & 325 
=====================================================================
Injection Date  : 1/31/2011 5:09:13 PM         
Sample Name     : B5-P27                          Location : Vial 1
Acq. Operator   : Wesman                               Inj :   1
                                                Inj Volume : Manually
Acq. Method    : C:\HPCHEM\2\METHODS\WESMAN.M
Last changed  : 1/31/2011 3:51:36 PM by Corinne
                  (modified after loading)
Analysis Method : C:\HPCHEM\2\METHODS\SHUTDOWN.M
Last changed   : 2/9/2011 4:47:16 PM by greg
                  (modified after loading)
Shutdown

































                         Area Percent Report                         
=====================================================================
Sorted By             :      Signal
Multiplier            :      1.0000
Dilution              :      1.0000
Use Multiplier & Dilution Factor with ISTDs
Signal 1: FID1 A, 
Peak RetTime Type  Width     Area      Height     Area  
  #   [min]        [min]   [pA*s]      [pA]         %
----|-------|----|-------|----------|----------|--------|
   1  15.011 MM    0.1164   61.97166    8.87497  5.49564
   2  15.628 MM    0.2308 1065.67969   76.95920 94.50436
Totals :                  1127.65134   85.83417
 Results obtained with enhanced integrator!
=====================================================================
                          *** End of Report ***
Data File C:\HPCHEM\2\DATA\WES\B5P27002.D                                          Sample Name: B5-P27
Agilent 6890A GC 2/9/2011 4:48:33 PM greg Page 1 of 1
B5-P27 - diluted
90oC isothermal (50:1 split)
B-dex 125 & 325 
=====================================================================
Injection Date : 1/31/2011 5:09:13 PM        
Sample Name     : B5-P27                         Location : Vial 1
Acq. Operator    Wesman                               Inj :   1
                                                Inj Volume : Manually
Acq. Method    : C:\HPCHEM\2\METHODS\WESMAN.M
Last changed    : 1/31/2011 3:51:36 PM by Corinne
                (modified after loading)
Analysis Method : C:\HPCHEM\2\METHODS\SHUTDOWN.M
Last changed    : 2/9/2011 4:47:16 PM by greg
                  (modified after loading)
Shutdown

































                        Area Percent Report                         
=====================================================================
Sorted By             :      Signal
Multiplier            :      1.0000
Dilution              :      1.0000
Use Multiplier & Dilution Factor with ISTDs
Signal 1: FID1 A, 
Peak RetTime Type  Width     Area      Height     Area  
  #   [min]        [min]   [pA*s]      [pA]         %
----|-------|----|-------|----------|----------|--------|
   1  15.011 MM    0.1164   61.97166    8.87497  5.49564
   2  15.628 MM    0.2308 1065.67969   76.95920 94.50436
Totals :                  1127.65134   85.83417
 Results obtained with enhanced integrator!
=====================================================================
                  *** End of Report ***
Data File C:\HPCHEM\2\DATA\WES\B5P27002.D                                          Sample Name: B5-P27


































Propyne Opening of Epoxyhexane



































Propyne Opening of Epoxyhexane




































































Ph2SiClH Rxn w/Homopropargylic Alcohol







































Silylformylation Rxn (Model Alcohol)







































Silylformylation Rxn (Model Alcohol)









































(R,R) Isoprenylation Silane Reagent

















































(R,R) Isoprenylation Silane Reagent




































































































H-SiCl3 / Et3N / CuCl Rxn w/AllylBromide


































H-SiCl3 / Et3N / CuCl Rxn w/AllylBromide















































































































































































































































































































































































































TES Protected Cis-Crotylated Hydrocinnamaldehyde






































TES Protected Cis-Crotylated Hydrocinnamaldehyde















































































































































































































































































Hydrosilylated for t = 17 hrs at 70 deg C






































Hydrosilylated for t = 17 hrs at 70 deg C



























































































































Hydrosilylation of Bis-Acetylated Diene









































Hydrosilylation of Bis-Acetylated Diene
























































































(R,R) Angelic-Silane coupled w/Hydrocinnamaldehyde









































1x-OAc Diol Angelication Pdt










































1x-OAc Diol Angelication Product






































































































































2x-OAc, 1x-OH Angelicaiton Pdt












































2x-OAc, 1x-OH Angelication Pdt
















































Angelication Pdt 2x-OAc Diol


















































Angelication Pdt 2x-OAc Diol


















































2x-OAc Silacycle (Angelication Rxn)









































2x-OAc Silacycle Angelication Pdt


























































Tamao Oxidation of 2x-OAc Silacycle














































Tamao of 2x-OAc Silacycle















































































































































Syn-Anti-Syn Acetonide Pdt (Reflashed)





































































































































































































TBSOTf protection at -78 deg C
















































TBSOTf protection at -78 deg C








































































































Acetonide Formation from Tamao Compound


























































Synthesized (S,S)-Allyl Diamine Reagent











































Synthesized (S,S)-Allyl Diamine Reagent








































(S,S)-Diamine Allylation of Acetylacetone (1g Scale) 


































(S,S)-Diamine Allylation of Acetylacetone (1g Scale)







































White Crystalline Solid (Concentrated)





































White Crystalline Solid (Concentrated)









































































































































































Two-Pot, Bis-Acetylation of TMS-EtOH







































Two-Pot, Bis-Acetylation of TMS-EtOH






























(R)-Noyori Hydrogenation (Small Rxn)




































(R)-Noyori Hydrogenation (Small Rxn)




































TES-Cl Protection of Noyori Crude






































TES-Cl Protection on Noyori Crude





































Pd(OH)2 Hydrogenation (~60 mmol Rxn)






































Pd(OH)2 Hydrogenation (~60 mmol Rxn)






































Swern Oxidation (Small Scale - 0.1 mmol)



































Swern Oxidation (Small Scale - 0.1 mmol)
































Large Scale Paterson Aldol







































Large Scale Paterson Aldol









































Acetylated Paterson Aldol Pdt








































Acetylated Paterson Aldol Pdt
















































Large Scale Ozonolysis Rxn










































Large Scale Ozonolysis Rxn











































































































































Spiroketalization (0.25 eq CSA)





















































Spiroketalization (0.25 eq CSA)
Rxn t = 1.5 hrs, Quenched w/Et3N































































































































































































































































































































































































Tamao of AB-Silacycle Coupled Fragment



























































Tamao of AB-Silacycle Coupled Fragment
All Pdt Frxns, 13C CDCl3
-1.4
11.0
13.1
14.2
17.4
21.6
22.8
26.5
27.9
33.8
36.3
37.7
40.2
41.2
41.3
48.4
50.8
61.4
62.7
63.5
66.5
67.6
73.2
84.2
96.8
113.3
114.5
115.6
147.4
156.3
156.6
170.8
171.0
216.2
290
